var title_f7_36_7744="Dx WD unexplained liver dz";
var content_f7_36_7744=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56720&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56720&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 589px\">",
"   <div class=\"ttl\">",
"    Approach to diagnosis of Wilson disease (WD) in a patient with unexplained liver disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 569px; height: 468px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Molecular testing means confirming homozygosity for one mutation or defining two mutations constituting compound heterozygosity.",
"    <br>",
"     Conversion to SI units: CPN &lt;20 mg/dL or 0.2 g/L; 24-hour urinary Cu &gt;40 micrograms/day or 0.6 micromol/day.",
"     <br>",
"      Note that normal ranges for CPN may vary slightly between laboratories.",
"      <div class=\"footnotes\">",
"       CPN: ceruloplasmin; KF: Kayser-Fleischer.",
"       <br>",
"        * Assure adequacy of urine collection.",
"       </br>",
"      </div>",
"      <div class=\"reference\">",
"       Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47:2089.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7744=[""].join("\n");
var outline_f7_36_7744=null;
var title_f7_36_7745="Pediculosis pubis 2";
var content_f7_36_7745=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F58267&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F58267&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pediculosis pubis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A small brown living crab louse is seen at the base of hairs (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7745=[""].join("\n");
var outline_f7_36_7745=null;
var title_f7_36_7746="Long axis poststenotic dilation";
var content_f7_36_7746=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aortic dilation in aortic stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 229px; height: 395px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Aortic pathology can be better seen by imaging the ascending aorta one interspace above the usual long axis precordial window. The normal appearance of the sinuses and ascending aorta (Asc Ao) is seen in panel A. For comparison, panel B shows poststenotic dilatation which is quite typical and almost always found in aortic stenosis.",
"    <div class=\"footnotes\">",
"     AV: aortic valve; LA: left atrium; LV: left ventricle.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7746=[""].join("\n");
var outline_f7_36_7746=null;
var title_f7_36_7747="Patient information: Knee pain (The Basics)";
var content_f7_36_7747=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16333\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/20/28993\">",
"         Osteoarthritis of the knee",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/2/26671\">",
"          Knee bursa (prepatellar bursa)",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/21/10578\">",
"           Front view of the knee",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?7/12/7362\">",
"         Patient information: Anterior cruciate ligament tear (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/6/35937\">",
"         Patient information: Baker&rsquo;s (popliteal) cyst (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/23/3443\">",
"         Patient information: Bursitis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/37/11858\">",
"         Patient information: Chondromalacia patella (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/27/5554\">",
"         Patient information: Iliotibial band syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/50/29474\">",
"         Patient information: Knee replacement (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/29/3539\">",
"         Patient information: Meniscal tear (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/15/40178\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/3/43058\">",
"         Patient information: Osteoarthritis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/10/18594\">",
"         Patient information: Patellofemoral pain syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?1/48/1797\">",
"         Patient information: Anterior cruciate ligament injury (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?43/27/44467\">",
"         Patient information: Bursitis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/4/24642\">",
"         Patient information: Knee pain (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/46/16098\">",
"         Patient information: Osteoarthritis symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Knee pain (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/knee-pain-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H10434858\">",
"      <span class=\"h1\">",
"       What causes knee pain?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many different conditions can cause knee pain, including:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Bending or using the knee too much &mdash; This can cause pain in the front of the knee that worsens with running, climbing steps, or sitting for a long time.",
"       </li>",
"       <li>",
"        Arthritis &mdash; Arthritis is a general term that means inflammation of the joints. There are lots of types of arthritis. The most common type, called osteoarthritis, often comes with age. It can cause pain, stiffness, and swelling (",
"        <a class=\"graphic graphic_figure graphicRef73149 \" href=\"UTD.htm?28/20/28993\">",
"         figure 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Bursitis &mdash; Bursitis happens when fluid-filled sacs around the knee (called &ldquo;bursae&rdquo;) get irritated or swollen (",
"        <a class=\"graphic graphic_figure graphicRef59257 \" href=\"UTD.htm?26/2/26671\">",
"         figure 2",
"        </a>",
"        ). Bursitis can cause pain and swelling.",
"       </li>",
"       <li>",
"        A collection of fluid in the knee &mdash; This can happen after a knee injury.",
"       </li>",
"       <li>",
"        A tear in the meniscus &mdash; The meniscus is a cushion of rubbery material (cartilage) between the thigh bone and the leg bone (",
"        <a class=\"graphic graphic_figure graphicRef77293 \" href=\"UTD.htm?10/21/10578\">",
"         figure 3",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        A tear in a ligament &mdash; Ligaments are bands of tissue that connect 1 bone to another. There are 4 ligaments in each knee (",
"        <a class=\"graphic graphic_figure graphicRef77293 \" href=\"UTD.htm?10/21/10578\">",
"         figure 3",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Muscle strain &mdash; Different leg muscles move the knee joint, causing the knee to bend and straighten. If 1 of these muscles doesn&rsquo;t work well, moving the knee can cause pain.",
"       </li>",
"       <li>",
"        A knee injury",
"       </li>",
"       <li>",
"        Conditions that don&rsquo;t involve the knee &mdash; For example, problems in the hip can sometimes cause knee pain.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10434865\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To ease your symptoms, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Put ice on the knee to reduce pain and swelling &mdash; Put a cold gel pack, bag of ice, or bag of frozen vegetables on the injured area every 1 to 2 hours, for 15 minutes each time. Put a thin towel between the ice (or other cold object) and your skin. To reduce swelling, sit or lie down and raise your leg above the level of your heart when you put ice on it.",
"       </li>",
"       <li>",
"        Rest your knee and avoid movements that worsen the pain &mdash; Try not to squat, kneel, or run. Also, don&rsquo;t use exercise machines, such as stair steppers or rowing machines. Instead, you can walk or swim (the front and back crawl strokes) for exercise.",
"       </li>",
"       <li>",
"        Take a pain-relieving medicine, such as",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"         acetaminophen",
"        </a>",
"        (sample brand name: Tylenol&reg;) or",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample brand names: Advil&reg;, Motrin&reg;).",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10434872\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        You are unable to put weight on your knee or your knee &ldquo;gives out&rdquo;",
"       </li>",
"       <li>",
"        Your knee is very swollen and painful",
"       </li>",
"       <li>",
"        You have a fever with knee pain, swelling, and redness",
"       </li>",
"       <li>",
"        Your knee pain doesn&rsquo;t get better or gets worse after you treat it on your own for a few days",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10434879\">",
"      <span class=\"h1\">",
"       How is knee pain treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The right treatment for knee pain depends on what is causing it. Treatments might include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Wearing a knee brace or shoe insert",
"       </li>",
"       <li>",
"        Doing exercises to strengthen and stretch the muscles that move the knee joint &mdash; Ask your doctor or nurse which exercises can help with the cause of your pain.",
"       </li>",
"       <li>",
"        Having physical therapy",
"       </li>",
"       <li>",
"        Getting a shot of medicine in the knee",
"       </li>",
"       <li>",
"        Other medicines",
"       </li>",
"       <li>",
"        Surgery",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10434886\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/3/43058?source=see_link\">",
"       Patient information: Osteoarthritis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/23/3443?source=see_link\">",
"       Patient information: Bursitis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/12/7362?source=see_link\">",
"       Patient information: Anterior cruciate ligament tear (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/15/40178?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?28/50/29474?source=see_link\">",
"       Patient information: Knee replacement (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/29/3539?source=see_link\">",
"       Patient information: Meniscal tear (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/10/18594?source=see_link\">",
"       Patient information: Patellofemoral pain syndrome (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/37/11858?source=see_link\">",
"       Patient information: Chondromalacia patella (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/27/5554?source=see_link\">",
"       Patient information: Iliotibial band syndrome (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/6/35937?source=see_link\">",
"       Patient information: Baker&rsquo;s (popliteal) cyst (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/4/24642?source=see_link\">",
"       Patient information: Knee pain (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?15/46/16098?source=see_link\">",
"       Patient information: Osteoarthritis symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/27/44467?source=see_link\">",
"       Patient information: Bursitis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/48/1797?source=see_link\">",
"       Patient information: Anterior cruciate ligament injury (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?7/36/7747?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16333 Version 6.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-2BB6473422-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7747=[""].join("\n");
var outline_f7_36_7747=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10434858\">",
"      What causes knee pain?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10434865\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10434872\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10434879\">",
"      How is knee pain treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10434886\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16333\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/20/28993\">",
"      Osteoarthritis of the knee",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/2/26671\">",
"       Knee bursa (prepatellar bursa)",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/21/10578\">",
"        Front view of the knee",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/48/1797?source=related_link\">",
"      Patient information: Anterior cruciate ligament injury (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/12/7362?source=related_link\">",
"      Patient information: Anterior cruciate ligament tear (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/6/35937?source=related_link\">",
"      Patient information: Baker&rsquo;s (popliteal) cyst (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/27/44467?source=related_link\">",
"      Patient information: Bursitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/23/3443?source=related_link\">",
"      Patient information: Bursitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/37/11858?source=related_link\">",
"      Patient information: Chondromalacia patella (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/27/5554?source=related_link\">",
"      Patient information: Iliotibial band syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/4/24642?source=related_link\">",
"      Patient information: Knee pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?28/50/29474?source=related_link\">",
"      Patient information: Knee replacement (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/29/3539?source=related_link\">",
"      Patient information: Meniscal tear (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/15/40178?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/3/43058?source=related_link\">",
"      Patient information: Osteoarthritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/46/16098?source=related_link\">",
"      Patient information: Osteoarthritis symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/10/18594?source=related_link\">",
"      Patient information: Patellofemoral pain syndrome (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_36_7748="Atrial septal defect anatomy";
var content_f7_36_7748=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F52106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F52106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 475px\">",
"   <div class=\"ttl\">",
"    Atrial septal defects",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 455px; height: 544px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal atrial septum (panel A) as well as various types of atrial septal defects (ASD) are shown. Panel B: secundum ASD is formed by the poor growth of the septum secundum or excessive absorption of the septum primum. Panel C: Primum ASD is formed by the failure of the septum primum to fuse with the endocardial cushions. The fossa ovalis is normal. The frontal view of the primum ASD shows the caudal location of the ASD just above the endocardial cushion. Panel D: Sinus venosus ASD is caused by the malposition of the insertion of the superior or inferior vena cava and is outside the area of the fossa ovalis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7748=[""].join("\n");
var outline_f7_36_7748=null;
var title_f7_36_7749="Tositumomab radioconjugate: Patient drug information";
var content_f7_36_7749=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tositumomab radioconjugate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/45/29398?source=see_link\">",
"     see \"Tositumomab radioconjugate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F229529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Bexxar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10017890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700525",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Some patients have very bad side effects during the infusion. Tell your doctor if you have any bad effects during the infusion.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may have unsafe effects on the bone marrow. The bone marrow may not be able to make cells found in the blood as well as it used to for a few weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat lymphoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tositumomab, iodine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017896\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696743",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not donate blood while using this drug and for 1 year after stopping.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696962",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow what you were told to do by your doctor after leaving the hospital to stop exposing others to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697723",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust during care and for 12 months after care ends.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy during care and for 12 months after care ends. Use birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697902",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698291",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Other kinds of cancer may rarely happen later in life.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark, tarry-black stool.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694377",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Acetaminophen and diphenhydramine may be given before this drug to lower fever and chills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3681322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A drug to protect the thyroid gland will be given 24 hours before this drug and for 2 weeks after getting this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11921 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-89768E4622-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7749=[""].join("\n");
var outline_f7_36_7749=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229529\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017890\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017892\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017891\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017896\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017897\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017899\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017894\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017901\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?28/45/29398?source=related_link\">",
"      Tositumomab radioconjugate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_36_7750="Pouchitis Light";
var content_f7_36_7750=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Pouchitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 188px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low (left panel) and high (right panel) power view of a biopsy specimen from a patient with pouchitis. There is a moderately severe acute inflammatory infiltrate with superficial ulceration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sydney Phillips, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7750=[""].join("\n");
var outline_f7_36_7750=null;
var title_f7_36_7751="Moyamoya disease: Prognosis and treatment";
var content_f7_36_7751=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Moyamoya disease: Prognosis and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7751/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7751/contributors\">",
"     Nijasri Charnnarong Suwanwela, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7751/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7751/contributors\">",
"     Jose Biller, MD, FACP, FAAN, FAHA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7751/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7751/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7751/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/36/7751/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moyamoya disease is a unique chronic progressive cerebrovascular disease characterized by bilateral stenosis or occlusion of the arteries around the circle of Willis with prominent arterial collateral circulation.",
"   </p>",
"   <p>",
"    This topic will review the prognosis and treatment of moyamoya. Other aspects of the disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3786?source=see_link\">",
"     \"Moyamoya disease: Etiology, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of moyamoya disease tends to be progressive, even in adult patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The vascular pathology usually worsens with extensive intracranial large artery occlusion and collateral circulation. Patients often suffer cognitive and neurologic decline due to repeated ischemic stroke or hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/3\">",
"     3",
"    </a>",
"    ]. The range of outcomes is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In studies with long-term follow-up of untreated patients, progressive neurologic deficits and poor outcome were reported in 50 to 66 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/4-6\">",
"       4-6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 40 adult Japanese patients with clinically asymptomatic moyamoya discovered incidentally or by screening, infarction was present on initial brain MRI in 12 (30 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/7\">",
"       7",
"      </a>",
"      ]. In a subset of 34 patients who were treated nonsurgically and followed for a mean period of 44 months, ischemic stroke and intracranial hemorrhage developed in one and three patients (3 and 9 percent), respectively.",
"     </li>",
"     <li>",
"      Moyamoya may have a more rapid progression and a worse prognosis in younger than in older children, as evidenced by a single-center observational study of 204 patients from Korea who had surgical treatment for moyamoya [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/8\">",
"       8",
"      </a>",
"      ]. Infarctions were significantly more frequent at initial presentation in children age six and under compared with children older than six years, as were subsequent preoperative infarctions. The median interval between the onset of symptoms and preoperative infarction was three months (range 1 to 14). The rate of favorable clinical outcomes was significantly lower in children less than three years old compared with those who were three to six or older than six years, mainly because of preoperative infarctions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The natural history of moyamoya may be different in North America, where patients tend to present with later onset and are less likely to have hemorrhagic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/2,9-11\">",
"     2,9-11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ACUTE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children and adults with moyamoya and acute stroke, acute treatment is mainly symptomatic and directed towards reducing elevated intracranial pressure, improving cerebral blood flow, and controlling seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/12\">",
"     12",
"    </a>",
"    ]. Ventricular drainage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematoma removal is often required for patients with intracerebral hemorrhage. Measures to minimize pain, crying, and hyperventilation in children may reduce the risk of worsening ischemia. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Inpatient management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Unfortunately, there is no acute intervention that is known to improve stroke outcome in patients with moyamoya. The use of thrombolytic therapy or antithrombotic agents during the acute phase of ischemic stroke associated with moyamoya disease has not been studied in any systematic way. Because of the risk of hemorrhage in areas of extensive moyamoya collateral vessels, many experts are reluctant to use thrombolytic therapy to treat acute ischemic stroke in patients with moyamoya [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/13\">",
"     13",
"    </a>",
"    ]. Guidelines from the ACCP suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    over no treatment as initial therapy for children with acute arterial ischemic stroke secondary to moyamoya [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The general approach to the evaluation and management of acute ischemic stroke is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/37/43608?source=see_link\">",
"     \"Ischemic stroke in children: Evaluation, initial management, and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=see_link\">",
"     \"Initial assessment and management of acute stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rehabilitation to improve functional outcome is recommended in patients with persistent neurologic deficits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SECONDARY PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no curative treatment for moyamoya disease. Secondary prevention for patients with symptomatic moyamoya is largely centered on surgical revascularization techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/15\">",
"     15",
"    </a>",
"    ]. In patients with moyamoya syndrome, it is also important to search for and treat the underlying condition. The main example is sickle cell disease, where transfusion therapy is effective in primary and secondary stroke prevention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/11/31930?source=see_link\">",
"     \"Cerebrovascular complications of sickle cell disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antiplatelet agents, usually",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , have been use to treat some patients with moyamoya disease or moyamoya syndrome, particularly those who are asymptomatic or have mildly symptomatic ischemic disease, or those considered to have a high risk for poor surgical outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/16\">",
"     16",
"    </a>",
"    ]. In addition, some centers use aspirin for all patients after surgical revascularization [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/17\">",
"     17",
"    </a>",
"    ]. However, evidence of benefit with antiplatelets in these settings is limited and equivocal [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oral anticoagulants are seldom used in children with ischemic moyamoya disease because of the risk of hemorrhage after incidental trauma and because of the difficulty maintaining therapeutic levels [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/16\">",
"     16",
"    </a>",
"    ]. In adults, hemorrhage is the predominant manifestation of moyamoya, and anticoagulation is generally not indicated.",
"   </p>",
"   <p>",
"    Calcium channel blockers have also been used to treat patients with moyamoya, but only anecdotal evidence is available concerning their effectiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endovascular embolization has been evaluated in small uncontrolled studies to obliterate ruptured intracranial aneurysms or pseudoaneurysms associated with moyamoya disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/22,23\">",
"     22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Revascularization surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of surgical treatment for moyamoya disease is to reduce the risk of ischemic stroke by improving the cerebral circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/24\">",
"     24",
"    </a>",
"    ]. Thus, surgical procedures are used most often for patients with ischemic-type moyamoya who have cognitive decline or progressive symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical techniques can be divided into direct and indirect revascularization procedures and their combinations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/16,25,26\">",
"     16,25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Direct revascularization is used by many centers, and it is thought to improve the angiographic and cerebral blood flow abnormalities, as well as the prognosis associated with moyamoya [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]. Superficial temporal artery to middle cerebral artery (MCA) bypass or middle meningeal artery to MCA bypass are the most common direct techniques [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/29\">",
"       29",
"      </a>",
"      ]. Direct methods are technically difficult to perform in children because of the small size of donor",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recipient vessels.",
"     </li>",
"     <li>",
"      Indirect revascularization is preferred at other centers, particularly in cases where the cortical recipient artery is not available for anastomosis [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/17,24,27,30,31\">",
"       17,24,27,30,31",
"      </a>",
"      ]. Indirect techniques enhance the collateral system and include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Encephaloduroarteriosynangiosis and a modification called pial synangiosis",
"     </li>",
"     <li>",
"      Encephalomyosynangiosis",
"     </li>",
"     <li>",
"      Encephaloarteriosynangiosis",
"     </li>",
"     <li>",
"      Omentum transplantation",
"     </li>",
"     <li>",
"      Craniotomy with inversion of the dura",
"     </li>",
"     <li>",
"      Simple burr holes without vessel synangiosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Combinations of direct and indirect revascularization methods",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There have been no randomized, controlled studies to determine the effectiveness of surgical treatment for moyamoya. The available evidence consists of retrospective case series and case reports.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A systematic review published in 2005 identified 55 studies with data for 1156 children (mainly from Japan) who had surgical revascularization for moyamoya disease or moyamoya syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/25\">",
"       25",
"      </a>",
"      ]. Most patients were treated with indirect surgical techniques or a combination of direct and indirect methods (73 and 23 percent, respectively). Over a mean postoperative follow-up of 58 months, the following observations were reported:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Symptomatic benefit, defined as complete disappearance or reduction in symptomatic cerebral ischemia, was reported in 1003 children (87 percent). In detail, outcomes were asymptomatic, improved, unchanged, or worse in 51, 36, 11, and 3 percent of patients, respectively.",
"     </li>",
"     <li>",
"      The perioperative stroke rate was 4 percent",
"     </li>",
"     <li>",
"      There was no statistically significant difference in outcome between the indirect and direct plus combined treatment groups",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series from the United States of 143 children with moyamoya disease or syndrome and ischemic episodes who were treated with pial synangiosis, perioperative stroke occurred in 11 (8 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/17\">",
"       17",
"      </a>",
"      ]. Among 126 patients followed for more than one year, late-onset stroke occurred in four (3 percent). In 46 patients who presented with stroke and were followed for more than five years, late-onset stroke occurred in two (4 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to perioperative stroke, complications of revascularization surgery for moyamoya include cerebral hyperperfusion syndrome and subdural hematoma [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/16,32-34\">",
"     16,32-34",
"    </a>",
"    ]. The cerebral hyperperfusion syndrome is uncommon though well-described following internal carotid artery revascularization procedures (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/27/40378?source=see_link&amp;anchor=H93838598#H93838598\">",
"     \"Carotid endarterectomy\", section on 'Hyperperfusion syndrome'",
"    </a>",
"    ). The mechanism is related to changes in cerebral autoregulation induced by chronic cerebral hemodynamic insufficiency, leading to compensatory vasodilation of cerebral vessels. After revascularization, blood flow is restored to a normal or elevated perfusion pressure within the previously hypoperfused hemisphere. The chronically dilated cerebral vessels are unable to vasoconstrict quickly enough to protect the capillary bed because of impaired cerebral blood flow autoregulation. Breakthrough perfusion pressure then causes the clinical manifestations that may include headache, seizures, reversible focal neurologic deficits, cerebral edema, and rarely intracerebral hemorrhage.",
"   </p>",
"   <p>",
"    The reported incidence of clinically symptomatic cerebral hyperperfusion syndrome following bypass surgery for moyamoya disease ranges from 15 to 22 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. The incidence in children appears to be lower than that in adults. In nearly all cases, complete resolution occurs over several days to weeks. However, some patients with hyperperfusion syndrome, mainly those with intracerebral hemorrhage, can have persistent neurological deficits. Prophylactic postoperative blood pressure lowering may prevent or ameliorate symptomatic cerebral hyperperfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of surgery for hemorrhagic moyamoya is controversial because of concern that revascularization might increase the risk of recurrent hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. In an observational study from China of patients with moyamoya who presented with hemorrhagic stroke, the rate of recurrent bleeding at a median follow-up of seven years was significantly lower in 54 patients treated with revascularization surgery compared with 43 who received conservative therapy (7 versus 43 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/38\">",
"     38",
"    </a>",
"    ]. However, there was",
"    <strong>",
"     no",
"    </strong>",
"    significant difference between groups for the proportion of patients with a good or poor outcome. In addition, one study found that surgical treatment for asymptomatic patients was beneficial for reducing both ischemic and hemorrhagic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Limited evidence suggests that revascularization surgery is more effective in children than in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/24\">",
"     24",
"    </a>",
"    ], especially in children who present with ischemic symptoms. Early surgery for young patients with moyamoya seems warranted based on the evidence that younger age at presentation is associated with increased rates of infarction and a worse prognosis, especially for children younger than three to six years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Natural history and prognosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Preoperative evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative cerebral angiography with bilateral injections of the internal and external carotid arteries and vertebral arteries is generally recommended to evaluate the sites of occlusion and collateral circulation and to identify donor vessels. Cerebral perfusion and autoregulation studies using xenon CT, perfusion CT,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    perfusion MRI, with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    , may also be helpful in evaluating cerebrovascular reserve.",
"   </p>",
"   <p>",
"    At select centers, the recipient artery has been identified preoperatively using high resolution 3-Tesla MRI with MRA and regional cerebral blood flow determination with either positron emission tomography (PET) or single photon emission computed tomography (SPECT) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Surgery versus conservative therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no studies directly comparing medical and surgical therapy for moyamoya, and indirect evidence is equivocal. In a large survey study from Japan, there was no statistically significant difference in outcome between patients with moyamoya disease treated with revascularization surgery or medical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/41\">",
"     41",
"    </a>",
"    ]. However, in another large survey study from Japan, children with moyamoya who were initially managed nonoperatively developed progressive symptoms that prompted surgery in 38 percent, a rate much higher than the rate of reoperation in children initially managed with surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Treatment choices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the data outlined above, we suggest initial therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    (2 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily) for children with asymptomatic moyamoya disease or moyamoya syndrome. We also suggest aspirin for children (2 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    daily) and adults (50 to 100 mg daily) with mildly symptomatic ischemic-type moyamoya.",
"   </p>",
"   <p>",
"    We suggest surgical revascularization for patients with moyamoya disease or moyamoya syndrome who have progressive symptoms due to cerebral infarction and ischemia and no contraindication to surgery. Current guidelines from the American College of Chest Physicians (ACCP) and the American Heart Association (AHA) Stroke Council also favor revascularization [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/14,16\">",
"     14,16",
"    </a>",
"    ]. The AHA guidelines note that revascularization surgery is useful for patients who have evidence of low blood flow or inadequate cerebral perfusion reserve [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no convincing data that one method of revascularization surgery is more effective than another. However, indirect revascularization is generally preferred in younger children [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We recommend",
"    <strong>",
"     not",
"    </strong>",
"    using long-term anticoagulation for children or adults with moyamoya.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Inpatient management",
"    </span>",
"    &nbsp;&mdash;&nbsp;During hospitalization, the following management issues deserve special attention in children [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Precautions to minimize crying and hyperventilation: both can lower PaCO2 and thereby induce or worsen cerebral ischemia by causing vasoconstriction [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Pain control measures: these may reduce the risk of stroke and the length of hospitalization [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/43\">",
"       43",
"      </a>",
"      ]. Specific methods include periprocedural sedation, painless wound-handling techniques (eg, Steri-Strip closure, use of paraffin gauze, avoidance of adhesive tapes), and postoperative pain management.",
"     </li>",
"     <li>",
"      Avoidance of hypotension, hypovolemia, hyperthermia, and hypocarbia [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/17,44\">",
"       17,44",
"      </a>",
"      ]. Intravenous hydration with isotonic fluids at 1.25 to 1.5 times the normal maintenance rate is suggested [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/15,43\">",
"       15,43",
"      </a>",
"      ]. Some experts keep blood pressure slightly elevated [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Administration of supplemental oxygen [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7751/abstract/15,45\">",
"       15,45",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The natural history of moyamoya disease tends to be progressive. Untreated patients often suffer cognitive and neurologic decline due to repeated ischemic stroke or hemorrhage. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Natural history and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children and adults with moyamoya and acute stroke, symptomatic treatments are aimed at reducing elevated intracranial pressure, improving cerebral blood flow, and controlling seizures. In cases with hemorrhagic stroke, ventricular drainage,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hematoma, removal is often required. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Acute management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Secondary stroke prevention for patients with symptomatic moyamoya is largely centered on surgical revascularization techniques. Evidence regarding the benefit of antiplatelet agents is limited and equivocal. Oral anticoagulants are seldom used in children with ischemic moyamoya disease because of the risk of hemorrhage and because of the difficulty maintaining therapeutic levels. In adults, hemorrhage is the predominant manifestation of moyamoya, and anticoagulation is generally not indicated. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Secondary prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For children with asymptomatic moyamoya disease or moyamoya syndrome, we suggest initial therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      rather than no medical therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For children and adults with mildly symptomatic ischemic-type moyamoya, we suggest treatment with aspirin rather than surgical revascularization (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Secondary prevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children and adults with moyamoya disease or moyamoya syndrome who have progressive symptoms or cognitive decline due to cerebral infarction, we suggest surgical revascularization (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). There are no convincing data that one method of revascularization surgery is more effective than another. However, indirect revascularization techniques are generally preferred in younger children. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Secondary prevention'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Revascularization surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For children or adults with moyamoya disease or syndrome, we recommend",
"      <strong>",
"       not",
"      </strong>",
"      treating with long-term anticoagulation (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During hospitalization and the perioperative period, the following management issues deserve special attention in children (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Inpatient management'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Precautions to minimize crying and hyperventilation",
"     </li>",
"     <li>",
"      Pain control measures",
"     </li>",
"     <li>",
"      Avoidance of hypotension, hypovolemia, hyperthermia, and hypocarbia",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/1\">",
"      Kuroda S, Ishikawa T, Houkin K, et al. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005; 36:2148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/2\">",
"      Hallemeier CL, Rich KM, Grubb RL Jr, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006; 37:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/3\">",
"      Morioka M, Hamada J, Todaka T, et al. High-risk age for rebleeding in patients with hemorrhagic moyamoya disease: long-term follow-up study. Neurosurgery 2003; 52:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/4\">",
"      Choi JU, Kim DS, Kim EY, Lee KC. Natural history of moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg 1997; 99 Suppl 2:S11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/5\">",
"      Kurokawa T, Tomita S, Ueda K, et al. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol 1985; 1:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/6\">",
"      Ezura M, Yoshimoto T, Fujiwara S, et al. Clinical and angiographic follow-up of childhood-onset moyamoya disease. Childs Nerv Syst 1995; 11:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/7\">",
"      Kuroda S, Hashimoto N, Yoshimoto T, et al. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 2007; 38:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/8\">",
"      Kim SK, Seol HJ, Cho BK, et al. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 2004; 54:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/9\">",
"      Yilmaz EY, Pritz MB, Bruno A, et al. Moyamoya: Indiana University Medical Center experience. Arch Neurol 2001; 58:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/10\">",
"      Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke 1998; 29:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/11\">",
"      Numaguchi Y, Gonzalez CF, Davis PC, et al. Moyamoya disease in the United States. Clin Neurol Neurosurg 1997; 99 Suppl 2:S26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/12\">",
"      Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99 Suppl 2:S238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/13\">",
"      Pollak L. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 361:98; author reply 98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/14\">",
"      Monagle P, Chan AK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e737S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/15\">",
"      Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 360:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/16\">",
"      Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39:2644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/17\">",
"      Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004; 100:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/18\">",
"      Horn P, Bueltmann E, Buch CV, Schmiedek P. Arterio-embolic ischemic stroke in children with moyamoya disease. Childs Nerv Syst 2005; 21:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/19\">",
"      McLean MJ, Gebarski SS, van der Spek AF, Goldstein GW. Response of moyamoya disease to verapamil. Lancet 1985; 1:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/20\">",
"      Spittler JF, Smektala K. Pharmacotherapy in moyamoya disease. Hokkaido Igaku Zasshi 1990; 65:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/21\">",
"      Hosain SA, Hughes JT, Forem SL, et al. Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease. J Child Neurol 1994; 9:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/22\">",
"      Yu JL, Wang HL, Xu K, et al. Endovascular treatment of intracranial aneurysms associated with moyamoya disease or moyamoya syndrome. Interv Neuroradiol 2010; 16:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/23\">",
"      Kim SH, Kwon OK, Jung CK, et al. Endovascular treatment of ruptured aneurysms or pseudoaneurysms on the collateral vessels in patients with moyamoya disease. Neurosurgery 2009; 65:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/24\">",
"      Ueki K, Meyer FB, Mellinger JF. Moyamoya disease: the disorder and surgical treatment. Mayo Clin Proc 1994; 69:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/25\">",
"      Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 2005; 21:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/26\">",
"      Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke 2011; 42:3304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/27\">",
"      Matsushima T, Inoue T, Suzuki SO, et al. Surgical treatment of moyamoya disease in pediatric patients--comparison between the results of indirect and direct revascularization procedures. Neurosurgery 1992; 31:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/28\">",
"      Ikezaki K, Matsushima T, Kuwabara Y, et al. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 1994; 81:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/29\">",
"      Golby AJ, Marks MP, Thompson RC, Steinberg GK. Direct and combined revascularization in pediatric moyamoya disease. Neurosurgery 1999; 45:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/30\">",
"      Kawaguchi T, Fujita S, Hosoda K, et al. Multiple burr-hole operation for adult moyamoya disease. J Neurosurg 1996; 84:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/31\">",
"      Kim SK, Cho BK, Phi JH, et al. Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol 2010; 68:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/32\">",
"      Fujimura M, Mugikura S, Kaneta T, et al. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 2009; 71:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/33\">",
"      Hayashi K, Horie N, Suyama K, Nagata I. Incidence and clinical features of symptomatic cerebral hyperperfusion syndrome after vascular reconstruction. World Neurosurg 2012; 78:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/34\">",
"      Uchino H, Kuroda S, Hirata K, et al. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study. Stroke 2012; 43:2610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/35\">",
"      Fujimura M, Inoue T, Shimizu H, et al. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis 2012; 33:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/36\">",
"      Aoki N. Cerebrovascular bypass surgery for the treatment of Moyamoya disease: unsatisfactory outcome in the patients presenting with intracranial hemorrhage. Surg Neurol 1993; 40:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/37\">",
"      Han DH, Kwon OK, Byun BJ, et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 2000; 142:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/38\">",
"      Liu X, Zhang D, Shuo W, et al. Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry 2013; 84:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/39\">",
"      Kikuta K. Experiences using 3-tesla magnetic resonance imaging in the treatment of Moyamoya disease. Acta Neurochir Suppl 2008; 103:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/40\">",
"      Kikuta K, Takagi Y, Fushimi Y, et al. \"Target bypass\": a method for preoperative targeting of a recipient artery in superficial temporal artery-to-middle cerebral artery anastomoses. Neurosurgery 2008; 62:1434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/41\">",
"      Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol 1997; 47:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/42\">",
"      Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol 2000; 15:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/43\">",
"      Nomura S, Kashiwagi S, Uetsuka S, et al. Perioperative management protocols for children with moyamoya disease. Childs Nerv Syst 2001; 17:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/44\">",
"      Soriano SG, Sethna NF, Scott RM. Anesthetic management of children with moyamoya syndrome. Anesth Analg 1993; 77:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7751/abstract/45\">",
"      Fujiwara J, Nakahara S, Enomoto T, et al. The effectiveness of O2 administration for transient ischemic attacks in moyamoya disease in children. Childs Nerv Syst 1996; 12:69.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1112 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-D9A34E86B4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7751=[""].join("\n");
var outline_f7_36_7751=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NATURAL HISTORY AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ACUTE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SECONDARY PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Revascularization surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Preoperative evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Surgery versus conservative therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Treatment choices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Inpatient management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/27/40378?source=related_link\">",
"      Carotid endarterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/11/31930?source=related_link\">",
"      Cerebrovascular complications of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=related_link\">",
"      Initial assessment and management of acute stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/37/43608?source=related_link\">",
"      Ischemic stroke in children: Evaluation, initial management, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3786?source=related_link\">",
"      Moyamoya disease: Etiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_36_7752="Entomology and control of imported fire ants";
var content_f7_36_7752=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Entomology and control of imported fire ants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7752/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7752/contributors\">",
"     David F Williams, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7752/contributors\">",
"     Richard D deShazo, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7752/contributors\">",
"     Jerome Goddard, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7752/contributors\">",
"     Robin Rockhold, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7752/contributors\">",
"     Stephen F Kemp, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7752/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7752/contributors\">",
"     David B Golden, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7752/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7752/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/36/7752/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The imported fire ant (IFA) is an aggressive, venomous insect that inhabits the Southeastern United States and is spreading westward and northward. Originally from South America, it has also become established in Australia and some of the Caribbean islands.",
"   </p>",
"   <p>",
"    This topic review discusses the medical entomology of the IFA, its clinical impact, recommendations to prevent the indoor infestation of health care facilities, and the chemical and biological control of this insect pest. Treatment of IFA stings and allergy to IFA venom are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=see_link\">",
"     \"Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MEDICAL ENTOMOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Species",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term imported fire ant refers to two members of the Solenopsis species [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The red imported fire ant (RIFA), Solenopsis invicta (a native of Brazil, Argentina, and Paraguay)",
"     </li>",
"     <li>",
"      The black imported fire ant (BIFA), Solenopsis richteri (a native of Argentina and Uruguay)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    IFAs are believed to have entered the United States through the port of Mobile, Alabama in the early 1900s. They have subsequently spread through natural behaviors, the shipment of infested agricultural products, and floods [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/2\">",
"     2",
"    </a>",
"    ]. The RIFA is the most abundant, widespread, and damaging species.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Territory",
"    </span>",
"    &nbsp;&mdash;&nbsp;The RIFA infests more than 320 million acres in 14 states (Alabama, Arkansas, California, Florida, Georgia, Louisiana, Mississippi, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, and Virginia) with limited infestations in Arizona, Maryland, and Delaware (",
"    <a class=\"graphic graphic_figure graphicRef51744 \" href=\"UTD.htm?29/48/30472\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/3\">",
"     3",
"    </a>",
"    ]. Regularly updated maps of the fire ant range and agriculture quarantine areas are available online at",
"    <a class=\"external\" href=\"file://www.aphis.usda.gov/plant_health/plant_pest_info/fireants/downloads/fireant.pdf\">",
"     file://www.aphis.usda.gov/plant_health/plant_pest_info/fireants/downloads/fireant.pdf",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Infestations also occur in several Caribbean islands including Puerto Rico, the Bahamas, the British and US Virgin Islands, Antigua, and Trinidad. RIFAs have also been detected in Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/4\">",
"     4",
"    </a>",
"    ], New Zealand (Ministry of Agriculture and Forestry, New Zealand,",
"    <a class=\"external\" href=\"file://www.maf.govt.nz/\">",
"     www.maf.govt.nz",
"    </a>",
"    ), China, and Taiwan.",
"   </p>",
"   <p>",
"    The habitat of the BIFA is significantly smaller. It is now limited to a small area of northwestern Alabama and northeastern Mississippi.",
"   </p>",
"   <p>",
"    IFAs will continue to appear in new areas because of large-scale movement of agricultural products, especially nursery stock, throughout the United States. Although their ultimate range in North America is unknown, a temperature-dependent model suggests that they will likely inhabit at least 25 percent of the continental United States [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/5\">",
"     5",
"    </a>",
"    ]. Global warming",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increased cold tolerance could allow them to expand further north within the United States.",
"   </p>",
"   <p>",
"    By the time new infestations are discovered, they may be several years old and well-established. Although the United States Department of Agriculture, Animal Plant Health and Inspection Service, Plant Protection and Quarantine (USDA, APHIS, PPQ) regularly updates quarantine regulations and maps of IFA infestations, these maps will always lag behind the actual infestations and not indicate the true expansion of imported fire ants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Mounds",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imported fire ants live in dome-shaped mounds (nests) of soil 2.5 to 3.0 feet (0.8 to 0.9 meters) across and up to 1.5 feet (0.5 meters) high that are easily visible during most times of the year (",
"    <a class=\"graphic graphic_picture graphicRef69747 \" href=\"UTD.htm?25/43/26292\">",
"     picture 1",
"    </a>",
"    ). The internal structure of these nests is complex (",
"    <a class=\"graphic graphic_figure graphicRef57987 \" href=\"UTD.htm?16/1/16403\">",
"     figure 2",
"    </a>",
"    ). Most are located in sunny, open areas, such as pastures, lawns, and along roadsides; however, they can also be found at the base of trees, in rotten logs, and in landscape timbers.",
"   </p>",
"   <p>",
"    Mounds may be less visible in sandy soils or drought conditions. During dry conditions, ant colonies may move under paved areas, such as highways and sidewalks, and even into buildings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Ant identification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mounds house the colony and provide security for the queen and her brood. Each colony contains one or more mated queens [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/1,2\">",
"     1,2",
"    </a>",
"    ], thousands of workers, immature ants (eggs, larvae, and pupae), winged males, and winged females (unmated queens).",
"   </p>",
"   <p>",
"    The ants responsible for stings are worker ants. Workers are sterile females, and are of two types that are distinguishable by size: the smaller minor workers and the larger major workers, which can weigh up to 10 times more (",
"    <a class=\"graphic graphic_figure graphicRef73265 \" href=\"UTD.htm?7/44/7873\">",
"     figure 3",
"    </a>",
"    ). As a group, workers are one-eighth to one-fourth inch long (three to six mm) and reddish brown to black in color. The minor workers are far more numerous. All workers are very aggressive and will attack anything that disturbs them.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Feeding behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;IFAs are omnivorous, feeding on many invertebrates, small animals, plant tissues, and seed oils [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/2\">",
"     2",
"    </a>",
"    ]. Workers ingest only liquid foods, with solid foods being eaten only by the fourth larval stages of a colony.",
"   </p>",
"   <p>",
"    Movement of food through the colony takes place by a process called trophallaxis, in which one worker feeds several other workers that in turn pass this food along to others including the queen and larvae. If dye-containing oil is experimentally fed to worker IFAs, it will travel through an entire colony within 24 to 48 hours.",
"   </p>",
"   <p>",
"    This behavior is exploited in different control strategies (see",
"    <a class=\"local\" href=\"#H16\">",
"     'Control of imported fire ants'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mating behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;\"Mating flights\" are seminal events in the lifecycle of the IFA, in which large numbers of winged males and females fly out from mature colonies (over a year old), rise several hundred feet above the ground, and mate in a swarm. Depending upon temperature, mating flights occur several times a year, usually in the spring, early summer, or fall. They take place in the late morning hours a day or two after a rain.",
"   </p>",
"   <p>",
"    After mating, the males fall to the ground and die. Although the majority of newly mated queens land within a mile of their original nest, a queen can fly 12 or more miles with the aid of wind. Newly mated queens can be collected by the thousands for research purposes as they drop to the ground in open areas, such as parking lots. After finding a suitable nesting site, the queens chew off their wings, dig a small hole in the soil, seal the entrance, and begin to lay eggs.",
"   </p>",
"   <p>",
"    Once the first workers (minims) are produced, they assume full-time care of the queen, who now spends the rest of her life producing eggs. Queens maintain complete control over the colony through the use of pheromones and egg production. A single queen can lay more than 2000 eggs per day and can live an average of six to seven years.",
"   </p>",
"   <p>",
"    Workers mature from egg to adult in 20 to 45 days, depending on the temperature, and then live for two to six months. A new colony contains several thousand workers by the time it is six months old. The youngest workers, called nurses, feed and groom the queen and brood and move the eggs to the most favorable locations within the colony. Mature workers are responsible for colony maintenance, some food recruitment, and defense. The oldest workers are the foragers who constantly search for food sources outside the colony [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Implications of polygyne colonies",
"    </span>",
"    &nbsp;&mdash;&nbsp;When IFAs were first observed in the United States, all the colonies had a single functional queen (monogyny). However, in the early 1970s, multiple queen (polygyne) colonies were discovered that contained 20 to 60 egg-laying queens. Polygyne colonies now occur throughout infested regions of the United States.",
"   </p>",
"   <p>",
"    There are several differences between these two colony forms. Single-queen colonies have about 100,000 to 240,000 workers that are fiercely territorial and limit the number of colonies that occupy the area to 40 to 150 mounds per acre. In contrast, multiple-queen colonies have 200,000 to 500,000 workers and are not territorial. Thus, more colonies can coexist per area. This adaptation has allowed for greater population densities and up to 200 to 800 mounds per acre. Therefore, polygyne populations cause more economic and environmental damage and have greater impact on humans.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     IMPACT OF FIRE ANTS ON HUMANS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imported fire ants cause environmental and economic damage as well as a variety of medical problems for humans, pets, and livestock.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Environmental impact",
"    </span>",
"    &nbsp;&mdash;&nbsp;In infested areas, IFAs may become the dominant arthropods and reduce biodiversity by decimation of other arthropod species, as well as ground-nesting birds, turtles, and frogs [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Agricultural damage",
"    </span>",
"    &nbsp;&mdash;&nbsp;IFAs are also responsible for damage to crops, such as soybeans, citrus, potatoes, corn, okra, and eggplants. Additional costs to agriculture arise from quarantine regulations mandating that all nursery stock, grass sod, and other plant materials must be treated with approved insecticides before being transported to non-infested areas [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/7\">",
"     7",
"    </a>",
"    ]. Although the economic costs of fire ant damage and control are unknown, estimates for the southeastern United States are a half billion to several billion dollars per year [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Indoor infestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Under extreme weather conditions (drought, cold, or flooding)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    food shortages, IFAs will move indoors to inhabit wall voids, attics, spaces under carpets, cardboard boxes, and even clothing in drawers. Indoor fire ants present major risks in health care facilities where debilitated individuals reside [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Invasion of health care facilities'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Because fire ants are attracted to electrical equipment, large numbers of worker ants can accumulate in computers, fuse boxes, circuit breakers, and air-conditioners and cause short circuits or mechanical failures [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     General medical impact",
"    </span>",
"    &nbsp;&mdash;&nbsp;IFAs inflict painful stings on humans, pets, domestic animals, and wildlife. A significant majority of people residing in an IFA infested area are stung each year. IFA venom is also highly allergenic, and a variety of allergic reactions are observed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=see_link\">",
"     \"Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     INVASION OF HEALTH CARE FACILITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients in long-term care facilities may not be aware of their surroundings, may be immobilized by disease or otherwise unable to respond if ants come into contact with them. Once foraging fire ants have made contact with a potential victim, a variety of stimuli, including simple movement of the patient, might trigger a stinging event, leading to multiple stings in a very short period of time.",
"   </p>",
"   <p>",
"    Clinicians may be asked to help formulate institutional management plans for the control of fire ants. In parallel with professional pest control services, a medically-oriented plan should be devised that provides clear and detailed instructions on how to proceed when ants are encountered in rooms or on patients.",
"   </p>",
"   <p>",
"    Some common sense suggestions for prevention of outdoor and indoor fire ant infestations have been developed (",
"    <a class=\"graphic graphic_table graphicRef51581 \" href=\"UTD.htm?19/36/20043\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef72595 \" href=\"UTD.htm?17/48/18187\">",
"     table 2",
"    </a>",
"    ). If IFAs are found inside, attempts should be made to mitigate their effects. An algorithm is provided to summarize this approach (",
"    <a class=\"graphic graphic_algorithm graphicRef77768 \" href=\"UTD.htm?0/10/175\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A facility's medical staff, as well as the maintenance and housekeeping staff, should be educated regarding the appearance, stinging behavior, and potential health risks of the IFA. Some form of pest documentation should be in place (eg, a pest sighting log) to inform the pest control technician of pest sightings, locations, times, etc. Sighting of ants in patient rooms should trigger an established plan of action. When fire ants are spotted in a room, patients should be removed until the pest control service has had a chance to investigate and perform adequate control measures (",
"    <a class=\"graphic graphic_algorithm graphicRef77768 \" href=\"UTD.htm?0/10/175\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Policies for facility staff regarding how to evaluate a patient who appears to have sustained one or more fire ant stings have been published (",
"    <a class=\"graphic graphic_algorithm graphicRef65915 \" href=\"UTD.htm?36/13/37086\">",
"     algorithm 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CONTROL OF IMPORTED FIRE ANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;At present, insecticides are the only effective method for control of fire ants [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/11\">",
"     11",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_table graphicRef53647 \" href=\"UTD.htm?1/43/1725\">",
"     table 3",
"    </a>",
"    ). There are no methods that permanently control IFAs in an area and none that can eradicate them.",
"   </p>",
"   <p>",
"    In the past, large-scale aerial applications of environmentally damaging chemicals, such as heptachlor and dieldrin were used for control. However, they were soon banned.",
"   </p>",
"   <p>",
"    This led to the development of less toxic chemicals and baits. The mammalian toxicities of these newer formulated insecticides are much less than those of the past and therefore less hazardous to humans and pets. However, the chemical insecticides used today are only effective for short-term control (3 to 12 months), require periodic re-application, and are costly [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/2\">",
"     2",
"    </a>",
"    ]. Although not economical for large-acreage situations, such as farms, ranches, roadsides, and natural areas, they can be used effectively to control infestations of individual properties and institutional facilities.",
"   </p>",
"   <p>",
"    An understanding of the general approaches to fire ant control is useful for the clinician practicing in an IFA-endemic area, as questions about how to deal with this formidable pest frequently arise. The four basic strategies used for controlling fire ants with chemicals today are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Broadcast bait or granular applications",
"     </li>",
"     <li>",
"      Individual mound treatments",
"     </li>",
"     <li>",
"      A combination of broadcast bait and individual mound treatments",
"     </li>",
"     <li>",
"      Barrier and spot treatments",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some of these methods are approved for indoor use (see",
"    <a class=\"local\" href=\"#H22\">",
"     'Indoor treatments'",
"    </a>",
"    below). Biological control of IFAs through the use of natural predators and pathogens is also discussed (see",
"    <a class=\"local\" href=\"#H23\">",
"     'Biological control agents'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OUTDOOR TREATMENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Broadcast bait and granular applications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Broadcast bait application is generally considered the most effective and efficient method to control many colonies over a large area. Baits reduce fire ant populations by using a small amount of insecticide dissolved into an attractant food source (eg, soybean oil) (",
"    <a class=\"graphic graphic_table graphicRef53647 \" href=\"UTD.htm?1/43/1725\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The attractant oil containing the toxicant is then absorbed into a carrier (such as corn grits) to allow easy handling and then the preparation is dispersed over an area. Regular applications should be made in the spring and fall to reduce or prevent reinvasion, as adjacent untreated areas serve as reservoirs.",
"   </p>",
"   <p>",
"    Insecticides used in baits are usually slow acting, so the foraging worker ant can pick up the bait, extract the toxic oil, and feed it to the queen and other ants before dying. Depending on the active ingredient, the queen dies, no longer produces eggs, or does not produce workers, leading to the eventual death of the colony. There are now fast-acting baits that cause colony death in three days or less, as compared to the older baits that took two weeks or longer [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Broadcast bait applications eliminate the need to locate individual ant mounds, instead depending on foraging ants to take the bait back to the rest of the colony. In addition, there is no colony relocation because the mound is not disturbed and most bait applications eliminate the colony queen. Because large areas can be treated, this method can result in slower reinfestation by colonies migrating from untreated areas.",
"   </p>",
"   <p>",
"    Granular insecticides are rarely used for broadcasting now, with the exception of one chemical, fipronil, which is available in both a granular form for broadcasting and also as a bait [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/11\">",
"     11",
"    </a>",
"    ]. In one study, fipronil granules were broadcasted over several acres containing high fire ant densities, resulting in over 96 percent control that was maintained for over 30 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/13\">",
"     13",
"    </a>",
"    ]. In contrast to fipronil, most other chemicals used in fire ant baits are only efficacious as baits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Individual mound treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individual IFA mounds can be treated by application of an insecticide or by nonchemical means (hot water, physical removal). The chemicals used are formulated as baits, drenches, granules, dusts, aerosols, or liquid fumigants, and should be specifically labeled for use on IFAs (",
"    <a class=\"graphic graphic_table graphicRef53647 \" href=\"UTD.htm?1/43/1725\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Ideally, contact insecticides should kill worker ants quickly, as slower-acting chemicals may cause the ants to relocate. Other difficulties of this method are locating and treating small colonies and assuring that the queen is killed. If the queen is not destroyed, she will continue to lay eggs and the colony will recover. Even if the queen dies, surviving workers may rebuild a mound and live for over a month.",
"   </p>",
"   <p>",
"    When treating multiple-queen colonies, which may contain hundreds of queens, all must be killed, thus making effective individual mound treatments extremely difficult. However, if the queen(s) is successfully killed, colonies treated individually may be eliminated faster than colonies treated with broadcast bait applications. This is important if fire ant mounds are located in areas where humans are at immediate risk, such as around homes, school yards, athletic fields, nursing homes, medical facilities, or other such areas.",
"   </p>",
"   <p>",
"    The nonchemical methods of treating individual mounds, such as the use of hot water (190 to 212 degrees F) and nest removal, may work if colonies are small, but usually are not successful with large, mature colonies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Combination treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Broadcast baiting can be combined with individual mound treatments. Baits should always be broadcast first to efficiently reduce fire ant populations. After one or two days, the worker ants have spread the bait through the colony, which can then be treated with an individual contact insecticide to quickly eliminate the stinging worker ants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Barrier and spot treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Barrier and spot treatments contain active ingredients that kill ants on contact and are usually sold as sprays or dusts, while some are mixed into latex paint. They may be applied in wide bands on and around building foundations, equipment, and other areas to create ant barriers. Barrier and spot treatments do not eliminate colonies, but can prevent fire ants from foraging indoors or infesting electrical and electronic equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/7\">",
"     7",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_table graphicRef53647 \" href=\"UTD.htm?1/43/1725\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     INDOOR TREATMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A few bait-formulated insecticides and some sprays, dusts, and aerosols are registered for use indoors. On occasion, colonies can be located indoors by following foraging ant trails back to nesting areas. If an entire colony is found indoors, it should be exterminated as soon as possible by applying a spray or dust onto the colony. Use of a bait alone is too slow for this situation; however, if baits are used in conjunction with spot treatments, then the bait should be applied one or two days before. If the entire colony is not located, then spot treating infested areas or spraying ant trails with registered products may not eliminate the colonies, but can at least kill foraging ants, thus keeping them from attacking. If ants are entering the home from outdoor colonies, apply barrier insecticides to the outside, around the base of the structure, and chemically treat nearby mounds using individual mound treatments. In addition, bait applications should be made when needed, usually two to three times per year around the perimeter to maintain control (",
"    <a class=\"graphic graphic_table graphicRef53647 \" href=\"UTD.htm?1/43/1725\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Fire ants are attracted to electrical equipment, as discussed previously (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Indoor infestations'",
"    </a>",
"    above). Thus, indoor equipment with wires, contact points, fuses, or switches should be inspected if a fire ant infestation is suspected.",
"   </p>",
"   <p>",
"    Another approach for controlling fire ants inside buildings is the use of an \"inside &ndash; outside\" treatment. This is being used more frequently in homes and also may be useful for some medical facilities. The treatment consists of using nonrepellent residual insecticides that can be transferred by ants that walk across treated areas. Treatments are applied indoors where foraging trails are located and applying a spray band outdoors one foot up and one foot out from the base of the building. Ants that cross this band will not die immediately, but will take the insecticide back to the nest on their bodies and spread the insecticide around, causing in many cases, complete elimination of the nest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     BIOLOGICAL CONTROL AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fire ant population densities are more than five times greater in the US than in their native South America where competition with many parasites, pathogens, and predators controls their numbers [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/14\">",
"     14",
"    </a>",
"    ]. Successful fire ant biological control agents could potentially reduce the dominance of fire ants, allowing native ants to better compete. Fire ant populations in the United States could then be reduced to lower density levels similar to those found in South America, thus minimizing their contact with humans and animals. Therefore, an integrated approach of biological control agents for long term suppression combined with specific chemicals for immediate relief would be both more effective and also reduce human exposure to pesticides.",
"   </p>",
"   <p>",
"    Research on natural enemies of fire ants is presently being conducted by the US Department of Agriculture, Agricultural Research Service (USDA-ARS) in Florida and Mississippi and in some universities in the United States (",
"    <a class=\"external\" href=\"file://www.ars.usda.gov/sites/fireants/\">",
"     www.ars.usda.gov/sites/fireants/",
"    </a>",
"    ). Two biological control agents that have been developed against IFAs are small decapitating flies belonging to the genus Pseudacteon and a protozoan pathogen, Thelohania solenopsae. A more in-depth review has been published [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/15\">",
"     15",
"    </a>",
"    ]. Decapitating flies have been released in the US. Thelohania solenopsae is being used in field studies in several areas. Other biological control agents are in various stages of development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Decapitating flies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are about 20 species of decapitating flies that prey on fire ants in South America. These flies are host specific, attacking only imported fire ants, and pose no known threat to other organisms.",
"   </p>",
"   <p>",
"    The decapitating fly hovers over a fire ant worker (",
"    <a class=\"graphic graphic_picture graphicRef73506 \" href=\"UTD.htm?23/42/24225\">",
"     picture 2",
"    </a>",
"    ) and then quickly dives down to deposit an egg in the ant's thorax. In a few days, the larva hatches and moves towards the head region. Once reaching the head of the ant, the larva eats the ant's glands and muscles, and releases an enzyme that causes the head to fall off (",
"    <a class=\"graphic graphic_picture graphicRef60731 \" href=\"UTD.htm?4/38/4705\">",
"     picture 3",
"    </a>",
"    ). The larva then pushes the mouthparts out of the way and seals itself into the head capsule for pupation. Depending on temperature, the total developmental time from egg to adult is between 30 and 90 days. Once the adult fly emerges, it has only a few days to look for a mate and repeat the attack cycle again.",
"   </p>",
"   <p>",
"    IFAs quickly learn to avoid the attacking flies and will hide under any available object or leave the area. Therefore, a single fly can stop the foraging of many workers, and a few flies in and around an IFA mound are sufficient to stop foraging by an entire colony of fire ants. If enough flies are established in a large area, decreased foraging by IFAs could cause a major shift in the use of food resources in favor of other ant species, reducing the total fire ant density.",
"   </p>",
"   <p>",
"    The decapitating flies, P. tricuspis and P curvatus, have been released in several states (Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas) and have successfully reproduced and expanded in most of these (Alabama, Florida, Louisiana, Mississippi, South Carolina, Tennessee, Oklahoma, Georgia, and Texas).",
"   </p>",
"   <p>",
"    Decapitating flies offer promise as a biological control agent of fire ants because of their:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Specificity for only IFA",
"     </li>",
"     <li>",
"      Ability to adapt to the climate and geography of the affected areas",
"     </li>",
"     <li>",
"      Disruptive effects on fire ant behavior",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The total impact that decapitating flies will have on IFA populations in the US over time remains to be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Pathogenic protozoa",
"    </span>",
"    &nbsp;&mdash;&nbsp;The microsporidium, T. solenopsae (Microsporidia: Thelohaniidae), is a pathogen that causes the slow demise of a fire ant colony. It is one of the most common pathogens of fire ants in Brazil and Argentina.",
"   </p>",
"   <p>",
"    During a survey in the US in 1996 for pathogens in IFA colonies, T. solenopsae was discovered in IFA workers in Florida, Mississippi, and Texas. A field study in Florida showed a 63 percent reduction in IFA populations infected with T. solenopsae, and the pathogen had spread to over 85 percent of fire ant nests. The true field impact of this disease on IFA populations may be difficult to study because healthy, uninfected ants may move in and colonize areas as infected colonies decline [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    T. solenopsae is transmitted transovarially (vertically) from the queen to her offspring. Horizontal transmission (colony to colony) also occurs and has been accomplished both in the laboratory and field by inoculating uninfected colonies of IFA with brood from infected colonies. The major effect of this disease on fire ant colonies is weakening of the queens so that they slow or stop production of offspring. Infected queens weigh 50 percent less than uninfected ones. The advantages of T. solenopsae as a biological control agent include (1) debilitation of queens (2) specificity for IFA (3) self-sustaining infections and (4) lower relative tolerance to chemical pesticides.",
"   </p>",
"   <p>",
"    IFA colonies have been inoculated with T. solenopsae in 10 states (Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, Oklahoma, South Carolina, and Tennessee). The widespread utilization of T. solenopsae could result in a long-term suppression and environmentally safer control of IFA populations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Yellow head disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another naturally occurring disease of IFA was discovered in 2002 while examining IFA colonies in Florida. The disease is caused by a protozoan, Mattesia sp., and was named Yellow Head Disease (YHD) due to the yellow-orange color of the heads of infected ants. The disease was identified in 8 percent of the IFA colonies surveyed and was found throughout Florida in both multiple-queen and single-queen fire ant colonies.",
"   </p>",
"   <p>",
"    YHD probably occurs in other states, but to date has been observed only in Florida and Mississippi. Although the actual impact on IFA has not been determined, there have been cases where demise of infected ants has been observed. Therefore, this disease has promise as a biological control agent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Parasitic ants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solenopsis daguerrei (Santschi) is a small ant that parasitizes IFA colonies in South America and does not sting or interact with humans. This ant produces no worker caste, only reproductive males and females, and therefore is totally reliant on its fire ant host colony for its care and survival.",
"   </p>",
"   <p>",
"    Solenopsis daguerrei enter IFA colonies, attach themselves to fire ant queen(s), and divert resources from the IFA colony. The IFA workers mistakenly feed and maintain the immature stages of S. daguerrei.",
"   </p>",
"   <p>",
"    Field studies of the impact of S. daguerrei on IFA have been conducted in Argentina and have shown that S. daguerrei reduces fire ant colony growth, the number of sexual reproductives produced by the colony, and the number of host queens in multiple queen colonies. However, a major problem still exists with trying to utilize this parasite as a biological control agent for fire ants because attempts to propagate it have been unsuccessful [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viruses have been shown to be effective against several insect populations, and a picorna-like virus has been identified that can infect the fire ant. In cases where colonies with the virus were collected in the field and returned to the laboratory, all of the immature stages for the colony died within three months, although it is too early to determine the virus's potential for use as a control agent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7752/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/44/19138?source=see_link\">",
"       \"Patient information: Fire ants (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The imported fire ant (IFA) is an aggressive, stinging ant originally native to South America that has become a formidable pest to humans and livestock in the Southeastern United States, Australia, and some of the Caribbean islands. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Impact of fire ants on humans'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The red imported fire ant (RIFA) is the most widespread and damaging species in the United States. Regularly updated maps of IFA territory are available online at",
"      <a class=\"external\" href=\"file://www.aphis.usda.gov/plant_health/plant_pest_info/fireants/downloads/fireant.pdf\">",
"       file://www.aphis.usda.gov/plant_health/plant_pest_info/fireants/downloads/fireant.pdf",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Territory'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The various clinical sequelae that can result from fire ant stings are discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=see_link\">",
"       \"Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      IFAs live within earthen mounds, each of which may contain up to 500,000 ants plus one or more queens (",
"      <a class=\"graphic graphic_picture graphicRef69747 \" href=\"UTD.htm?25/43/26292\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef57987 \" href=\"UTD.htm?16/1/16403\">",
"       figure 2",
"      </a>",
"      ). The worker ants are highly aggressive, and will sting anything they encounter as they forage for food. IFAs feed on a variety of food sources, including insects, small animals, and plant tissues. Workers find food and take it back to the colony to feed the rest of the colony. This behavior is exploited in different control strategies. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Medical entomology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indoor infestation of homes and medical facilities is a significant problem. Aside from the obvious risk to residents from stings, IFAs are attracted to electrical equipment and can cause mechanical failures and fires as a result of short circuits.",
"     </li>",
"     <li>",
"      In parallel with professional pest control services, clinicians in endemic areas may be asked to assist with institutional management plans for fire ant control. Some suggestions for prevention of outdoor and indoor fire ant infestations have been developed (",
"      <a class=\"graphic graphic_table graphicRef51581 \" href=\"UTD.htm?19/36/20043\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef72595 \" href=\"UTD.htm?17/48/18187\">",
"       table 2",
"      </a>",
"      ), as well as an algorithm for responding to the sighting of ants indoors (",
"      <a class=\"graphic graphic_algorithm graphicRef77768 \" href=\"UTD.htm?0/10/175\">",
"       algorithm 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Clinicians can also help devise a medically-oriented plan for how to proceed when ants are encountered in rooms or on patients. Our approach for patient assessment is designed for facilities serving debilitated residents (",
"      <a class=\"graphic graphic_algorithm graphicRef65915 \" href=\"UTD.htm?36/13/37086\">",
"       algorithm 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Invasion of health care facilities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      At present, chemical pesticides are the only effective method for control of fire ants (",
"      <a class=\"graphic graphic_table graphicRef53647 \" href=\"UTD.htm?1/43/1725\">",
"       table 3",
"      </a>",
"      ). There are no methods that permanently control IFAs in an area and none that can eradicate them. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Control of imported fire ants'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Outdoor pesticides &mdash;Broadcast baiting is the best approach for treating a large outdoor area. Individual mound treatments are designed to eradicate a colony that is posing an immediate threat. Barrier and spot treatments contain pesticides that kill ants on contact and are applied in wide bands on and around building foundations and equipment. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Outdoor treatments'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indoor pesticides &mdash; Indoor pesticides contain low levels of active ingredients and require regular applications to be effective. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Indoor treatments'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A variety of biologic control organisms may be used in the future to curtail further spread of IFAs and reduce the current dependence on pesticides. Promising agents include several species of predatory flies, protozoa that either cause impaired fertility or death, and other ant species that parasitize IFA colonies and compete for resources, but do not interact negatively with humans or livestock. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Biological control agents'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/1\">",
"      Lofgren CS, Banks WA, Glancey BM. Biology and control of imported fire ants. Annu Rev Entomol 1975; 20:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/2\">",
"      Vinson SB. Invasion of the red imported fire ant (Hymenoptera: formicidae): Spread, biology, and impact. Am Entomologist 1997; 43:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/3\">",
"      Kemp SF, deShazo RD, Moffitt JE, et al. Expanding habitat of the imported fire ant (Solenopsis invicta): a public health concern. J Allergy Clin Immunol 2000; 105:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/4\">",
"      McCubbin KI, Weiner JM. Fire ants in Australia: a new medical and ecological hazard. Med J Aust 2002; 176:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/5\">",
"      Korzukhin MD, Porter SD, Thompson LC, Wiley S. Modeling temperature-dependent range limits for the fire ant, Solenopsis invicta (Hymenoptera: Formicidae) in the United States. Environ Entomol 2001; 30:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/6\">",
"      Wojcik DP, Allen CR, Brenner RJ, Forys Ea. Red imported fire ants: Impact on biodiversity. Am Entomol 2001; 47:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/7\">",
"      Williams DF, Collins HL, Oi DH. The red imported fire ant (Hymenoptera: Formicidae): An historical perspective of treatment programs and the development of chemical baits for control. Am Entomol 2001; 47:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/8\">",
"      Lard C, Willis D, Salin V, Robison S. Economic assessments of fire ants on Texas urban and agricultural sectors. Southwest Entomol 2002; 25:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/9\">",
"      Pereira RM, Williams DF, Becnel JJ, Oi DH. Yellow-head disease caused by a newly discovered Mattesia sp. in populations of the red imported fire ant, Solenopsis invicta. J Invertebr Pathol 2002; 81:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/10\">",
"      deShazo RD, Williams DF, Moak ES. Fire ant attacks on residents in health care facilities: a report of two cases. Ann Intern Med 1999; 131:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/11\">",
"      Goddard J, Jarratt J, deShazo RD. Recommendations for prevention and management of fire ant infestation of health care facilities. South Med J 2002; 95:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/12\">",
"      Oi DH, Oi FM. Speed of efficacy and delayed toxicity characteristics of fast-acting fire ant (Hymenoptera: Formicidae) baits. J Econ Entomol 2006; 99:1739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/13\">",
"      Oi DH, Williams DF, Pereira RM. Combining biological and chemical controls for the management of red imported fire ants (Hymenoptera: Formicidae). Am Entomologist 2008; 54:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/14\">",
"      Oi DH, Williams DF. Impact of Thelohania solenopsae (Microsporidia: Thelohaniidae) on polygyne colonies of red imported fire ants (Hymenoptera: Formicidae). J Econ Entomol 2002; 95:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/15\">",
"      Williams DF, Oi DH, Porter SD. Biological control of imported fire ants. Amer Entomol 2003; 49:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/16\">",
"      Briano JA, Calcaterra LA, Williams DF, Oi DH. Attempts to artificially propagate the fire ant parasite, Solenopsis daguerrei, (Hymenoptera: Formicidae) in Argentina. Fla Entomol 2002; 85:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7752/abstract/17\">",
"      Valles SM, Strong CA, Dang PM, et al. A picorna-like virus from the red imported fire ant, Solenopsis invicta: initial discovery, genome sequence, and characterization. Virology 2004; 328:151.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4086 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-07C1274D5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7752=[""].join("\n");
var outline_f7_36_7752=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MEDICAL ENTOMOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Species",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Territory",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Mounds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Ant identification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Feeding behavior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mating behavior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Implications of polygyne colonies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      IMPACT OF FIRE ANTS ON HUMANS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Environmental impact",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Agricultural damage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Indoor infestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      General medical impact",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      INVASION OF HEALTH CARE FACILITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CONTROL OF IMPORTED FIRE ANTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OUTDOOR TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Broadcast bait and granular applications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Individual mound treatments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Combination treatments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Barrier and spot treatments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      INDOOR TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      BIOLOGICAL CONTROL AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Decapitating flies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Pathogenic protozoa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Yellow head disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Parasitic ants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Viruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/4086\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/4086|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?0/10/175\" title=\"algorithm 1\">",
"      Protocol prevention of stings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?36/13/37086\" title=\"algorithm 2\">",
"      Protocol ants on patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/4086|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/48/30472\" title=\"figure 1\">",
"      Red imported fire ant in US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/1/16403\" title=\"figure 2\">",
"      Fire ant mound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/44/7873\" title=\"figure 3\">",
"      Mature fire ant colonies size",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/4086|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/43/26292\" title=\"picture 1\">",
"      Fire ant mounds in field",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/42/24225\" title=\"picture 2\">",
"      A decapitating fly with IFA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/38/4705\" title=\"picture 3\">",
"      Decapitated head IFA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/4086|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/36/20043\" title=\"table 1\">",
"      Prevention outdoor infestation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/48/18187\" title=\"table 2\">",
"      Prevention indoor infestation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/43/1725\" title=\"table 3\">",
"      Common insecticides",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/44/19138?source=related_link\">",
"      Patient information: Fire ants (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=related_link\">",
"      Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_36_7753="Congenital and infantile nephrotic syndrome";
var content_f7_36_7753=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Congenital and infantile nephrotic syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7753/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7753/contributors\">",
"     Patrick Niaudet, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7753/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7753/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/36/7753/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/36/7753/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/36/7753/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term congenital nephrotic syndrome refers to disease, which is present at birth or within the three first months of life. Later onset, between three months and one year of age, is called infantile nephrotic syndrome. Most of these children have a genetic basis for the renal disease and a poor outcome. The precise diagnosis of the glomerular lesion is based on clinical, laboratory and histological criteria.",
"   </p>",
"   <p>",
"    The causes of congenital and infantile nephrotic syndrome will be discussed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a review of 89 Central European and Turkish children (from 80 families) who presented with nephrotic syndrome in the first year of life, two-thirds overall and as many as 85 percent of cases that occurred during the first three months of life could be explained by mutations in the following four genes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/1\">",
"     1",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      NPHS1, which encodes nephrin (a key component of the podocyte slit diaphragm) and is responsible for the Finnish-type congenital nephrotic syndrome. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'CNS of Finnish type'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      NPHS2, which encodes podocin (a protein that interacts with nephrin at the slit diaphragm) and is responsible for familial focal segmental glomerulosclerosis. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'CNS and NPHS2 mutations'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      WT1, which encodes the transcription tumor suppressor (a protein involved in kidney and gonad development) and is responsible for the Denys-Drash syndrome. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diffuse mesangial sclerosis with Drash syndrome'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      LAMB2, which encodes laminin beta 2 (a component of the glomerular basement membrane) and is responsible for the Pierson syndrome. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Pierson syndrome'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    NPHS2 and NPHS1 were the most common, accounting for approximately 95 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/1\">",
"     1",
"    </a>",
"    ]. None of 28 patients with a mutation who were treated with glucocorticoids responded.",
"   </p>",
"   <p>",
"    In addition to the above defects, mutations in the PLCE1 gene, which encodes phospholipase C epsilon, are responsible for the early-onset of isolated diffuse mesangial sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Diffuse mesangial sclerosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Nongenetic causes are often secondary and possibly curable disorders. They include infections, such as congenital nephrotic syndrome induced by syphilis or toxoplasmosis (",
"    <a class=\"graphic graphic_table graphicRef80781 \" href=\"UTD.htm?4/54/4971\">",
"     table 1",
"    </a>",
"    ), and toxins such as mercury exposure. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Infectious causes'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H23\">",
"     'Other causes'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CNS OF FINNISH TYPE",
"    </span>",
"    &nbsp;&mdash;&nbsp;CNF is most frequent in Finland, with initial studies suggesting an incidence of 1.2 per 10,000 births [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. With prenatal screening, the incidence has fallen to 0.9 per 10,000 births [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/5\">",
"     5",
"    </a>",
"    ]. CNF has also been described in various ethnic groups throughout the world [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CNF is inherited as an autosomal recessive trait, with both sexes being involved equally. There are no manifestations of the disease in heterozygous individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Light microscopic studies of renal biopsy specimens obtained early in the course of the disease show mild mesangial hypercellularity and increased mesangial matrix in the glomeruli [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/6,9\">",
"     6,9",
"    </a>",
"    ]. No immune deposits are detected by immunofluorescence studies. Over time, there is an increase in mesangial matrix accompanied by progressive glomerulosclerosis.",
"   </p>",
"   <p>",
"    Tubulointerstitial changes are also prominent in CNF. Irregular microcystic dilatation of proximal tubules is the most striking feature (",
"    <a class=\"graphic graphic_picture graphicRef69624 \" href=\"UTD.htm?37/36/38470\">",
"     picture 1",
"    </a>",
"    ); however, this change is not specific and is not seen in all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/10\">",
"     10",
"    </a>",
"    ]. Later in the course, interstitial fibrosis, lymphocytic and plasma cell infiltration, tubular atrophy, and periglomerular fibrosis develop in parallel with sclerosis of the glomeruli.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;It had been proposed that proteinuria in CNF results from an inherited error in the structure of the glomerular capillary filter. The abnormal gene was subsequently localized to the long arm of chromosome 19 in both Finnish and non-Finnish families [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The defective gene in CNF has been cloned and is named NPHS1 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The gene encodes for a transmembrane protein, named",
"    <strong>",
"     nephrin",
"    </strong>",
"    , which is a member of the immunoglobulin family of cell adhesion molecules and is phosphorylated by Src family kinases [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/16\">",
"     16",
"    </a>",
"    ]. Nephrin is specifically located at the slit diaphragm of the glomerular podocytes; this could explain the absence of slit diaphragms and foot processes in patients with CNF who have a mutant nephrin protein [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/17,18\">",
"     17,18",
"    </a>",
"    ] and in mice with nephrin gene disruption [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the original report, four different mutations in this gene were found to segregate with the disorder in affected Finnish families [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/14\">",
"     14",
"    </a>",
"    ]. However, the two most common mutations, Fin-major (nt121delCT) and Fin-minor (R1109X), account for nearly 90 percent of all affected Finnish patients and is associated with severe early-onset of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/14,20,21\">",
"     14,20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In another study, 32 novel mutations in the nephrin gene were discovered in patients elsewhere in Europe and North America, but no abnormalities were found in seven affected individuals (including the 5' flanking region) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/12\">",
"     12",
"    </a>",
"    ]. These patients may have mutations elsewhere in the promoter or in intron areas, or in a gene encoding another protein that interacts with nephrin [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link\">",
"     \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A case report of two siblings with a milder form of CNF (ie, alternating periods of proteinuria and remission) showed that the two children were compound heterozygotes for two novel, nonconserved missense mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/23\">",
"     23",
"    </a>",
"    ]. Additional studies from renal biopsy samples demonstrated expression of nephrin but with impaired function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most infants with the CNF are born prematurely (35 to 38 weeks), with a low birth weight for gestational age. The placenta is enlarged, being more than 25 percent of the total birth weight. Fetal distress is common and the cranial sutures are widely separated due to delayed ossification. Infants often have a small nose and low ears. Flexion deformities of the hips, knees, and elbows are thought to be secondary to the large placenta.",
"   </p>",
"   <p>",
"    Edema is present at birth or appears during the first week of life in one-half of cases. Severe nephrotic syndrome with marked ascites is always present by three months. The proteinuria is highly selective early in the course of the disease and hematuria is uncommon, reflecting the lack of inflammation in the glomeruli. The urinary protein losses are accompanied by profound hypoalbuminemia and severe hypogammaglobulinemia due in part to loss of selectivity as the disease progresses. As a result of these changes, nutritional status and statural growth are poor, and affected infants are highly susceptible to bacterial infections (peritonitis, respiratory infections) and to thromboembolic complications due to the severity of the nephrotic syndrome. Hypothyroidism because of urinary losses of thyroxine-binding proteins is also common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/12/3273?source=see_link\">",
"     \"Renal vein thrombosis and hypercoagulable state in nephrotic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The blood urea nitrogen and creatinine concentrations are initially normal. Renal ultrasonography shows enlarged, hyperechogenic kidneys without normal corticomedullary differentiation.",
"   </p>",
"   <p>",
"    End-stage renal failure usually occurs between three and eight years of age. Several studies, however, have reported that some NPHS1 mutations are associated with end-stage renal failure occurring after the age of 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/20,24,25\">",
"     20,24,25",
"    </a>",
"    ]. Prolonged survival is possible with aggressive supportive treatment, including dialysis and renal transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nephrotic syndrome in CNF is always resistant to glucocorticoids and immunosuppressive drugs, since this is not an immunologic disease. Furthermore these drugs may be harmful due to the already high susceptibility to infection. A retrospective study of 21 infants with CNF, for example, found that 63 verified and 62 suspected septic episodes occurred over a mean follow-up period of one year [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Standard conservative treatment includes daily or every other day albumin infusion, gamma globulin replacement, nutrition with a high-protein, low-salt diet, vitamin and thyroxine substitution, and prevention of infections and thrombotic complications. The diet is provided by tube feeding or by parenteral alimentation.",
"   </p>",
"   <p>",
"    However, the rate of intercurrent complications remains high and growth and development are usually retarded. As a result, some patients may require bilateral nephrectomy to prevent continued massive protein losses before the development of renal failure.",
"   </p>",
"   <p>",
"    A possible medical alternative to nephrectomy has been described in three children. The combination of an angiotensin converting enzyme inhibitor and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17848?source=see_link\">",
"     indomethacin",
"    </a>",
"    therapy, both of which should lower intraglomerular pressure, led to a marked fall in protein excretion and striking improvement in nutritional status and growth [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If nephrectomy is performed, dialysis is provided until the patient reaches a weight of 8 to 9 kg. At this stage, renal transplantation can be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nephrotic syndrome can develop in the transplanted kidney. In one case series of 65 patients who received 77 kidney transplants, 23 episodes of recurrent nephrotic syndrome occurred in 13 patients with 19 grafts [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/31\">",
"     31",
"    </a>",
"    ]. All 13 affected patients had the",
"    <span class=\"nowrap\">",
"     Fin-major/Fin-major",
"    </span>",
"    genotype, which is associated with the absence of nephrin. Eight (of 11 patients tested) had circulating anti-nephrin antibodies. Recurrence of disease is associated with graft loss. In this series, the addition of plasmapheresis to oral",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/62/38886?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and increased doses of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/63/17401?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    appeared to improve the remission and graft survival rates of patients with recurrent disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Antenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CNF becomes manifest during early fetal life, beginning at the gestation age of 15 to 16 weeks. The initial symptom is fetal proteinuria, which leads to a more than 10-fold increase in the amniotic fluid alpha-fetoprotein (AFP) concentration. A parallel, but less important increase in the maternal plasma AFP level is observed. These changes are not specific, but they may permit the antenatal diagnosis of CNF in high risk families in which termination of the pregnancy might be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, false positive results do occur, often leading to abortion of healthy fetuses. In one study of 21 pregnancies that had been terminated because of increased AFP levels in amniotic fluid, only 12 fetuses were homozygous for nephrin gene mutations as determined by DNA sequencing [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/33\">",
"     33",
"    </a>",
"    ]. The remaining nine were heterozygous carriers and would therefore not have developed CNF. The kidneys of both groups had a similar reduction in podocyte foot processes and slit pores.",
"   </p>",
"   <p>",
"    Genetic linkage and haplotype analyses may diminish the risk of false positive results in informative families [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/34\">",
"     34",
"    </a>",
"    ]. The four major haplotypes, which cover 90 percent of the CNF alleles in Finland, have been identified, resulting in a test with up to 95 percent accuracy. Commercial tests are also available to detect NPHS1 mutations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CNS AND NPHS2 MUTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;NPHS2 encodes an integral membrane protein, podocin, which is found exclusively in glomerular podocytes and is the causative gene for an autosomal recessive form of familial focal segmental glomerulosclerosis (FSGS). A few patients with the typical clinical picture of congenital nephrotic syndrome were found to lack NPHS1 mutations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study found homozygous NPHS2 mutations in two of five such patients [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      These findings were confirmed in a second report that described 11 patients with two recessive NPHS2 mutations who presented initially with congenital nephrotic syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Two additional cases with similar findings in terms of mutations in NPHS2, but not NPHS1, were also reported in a study of 13 unrelated patients from Japan [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some patients also have both NPHS1 and NPHS2 mutations, resulting in a triallelic abnormality (homozygous mutations in one gene and a heterozygous mutation in the other) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/24,25,36\">",
"     24,25,36",
"    </a>",
"    ]. These findings demonstrate the genetic heterogeneity of congenital nephrotic syndrome and the absence of clear",
"    <span class=\"nowrap\">",
"     genotype/phenotype",
"    </span>",
"    correlations.",
"   </p>",
"   <p>",
"    Although affected individuals typically present in early childhood, some have milder disease and present in adolescence or young adulthood. Issues related to treatment of FSGS associated with NPHS2 mutations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link&amp;anchor=H27#H27\">",
"     \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\", section on 'NPHS2 gene'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/54/21354?source=see_link&amp;anchor=H631397722#H631397722\">",
"     \"Steroid-resistant idiopathic nephrotic syndrome in children\", section on 'NPHS2 mutations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFUSE MESANGIAL SCLEROSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse mesangial sclerosis is a second hereditary cause of infantile nephrotic syndrome associated with glomerular injury and rapid progression to end-stage renal failure. The same glomerular lesions are observed in the Denys-Drash syndrome, which is characterized by the combination of nephropathy, male pseudohermaphroditism, and Wilms' tumor.",
"   </p>",
"   <p>",
"    Diffuse mesangial sclerosis is seen exclusively in infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/6,37-41\">",
"     6,37-41",
"    </a>",
"    ] and appears to be transmitted in some families as an autosomal recessive trait [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/42\">",
"     42",
"    </a>",
"    ]. The defective gene has not been identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The glomerular lesions are characterized in the early stages by a fibrillar increase in mesangial matrix without mesangial cell proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. The capillary walls are lined by hypertrophied podocytes (",
"    <a class=\"graphic graphic_picture graphicRef77219 \" href=\"UTD.htm?6/5/6230\">",
"     picture 2",
"    </a>",
"    ). The fully developed lesion consists of the combination of thickening of the glomerular basement membranes and massive enlargement of mesangial areas, leading to reduction of the capillary lumens. The mesangial sclerosis eventually contracts the glomerular tuft into a sclerotic mass within a dilated urinary space (",
"    <a class=\"graphic graphic_picture graphicRef56256 \" href=\"UTD.htm?40/2/40999\">",
"     picture 3",
"    </a>",
"    ). There is usually a corticomedullary gradient of involvement, with the deepest glomeruli being less affected. Tubules are severely damaged, especially in the deeper cortex where they are markedly dilated and often contain hyaline casts.",
"   </p>",
"   <p>",
"    Electron microscopy reveals hypertrophic mesangial cells surrounded by an abundant mesangial matrix, which often contains collagen fibrils. The podocytes are hypertrophied and contain many vacuoles. There is also irregular effacement of foot processes with focal detachment of the epithelial cell from the glomerular basement membrane.",
"   </p>",
"   <p>",
"    Immunofluorescence shows mesangial deposits of IgM, C3, and C1q in the least affected glomeruli, while deposits of IgM and C3 outline the periphery of the sclerosed glomeruli. These immune deposits are probably nonspecific, occurring in areas of previous injury.",
"   </p>",
"   <p>",
"    The same glomerular lesion is observed in the Denys-Drash syndrome. As a result, all patients with diffuse mesangial sclerosis should be screened for the Denys-Drash syndrome. This consists of karyotyping in phenotypic females, looking for male pseudohermaphroditism with a 46 XY genotype, and ultrasonography should be performed in all patients, looking for Wilms' tumor and abnormal gonadal development. Some investigators also suggest that an assessment for mutations in the Wilms' tumor predisposing gene, WT1, should be performed to help identify individuals at risk for the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. As an example, among 10 patients presenting with isolated diffuse mesangial sclerosis, four had mutations in the WT1 gene [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Diffuse mesangial sclerosis with Drash syndrome'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in the PLCE1 gene, which encodes phospholipase C epsilon, appear to cause isolated diffuse mesangial sclerosis. In one study of 12 children from 6 families with the disease, homozygous truncating gene mutations in PLCE1 were found in eight children [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/2\">",
"     2",
"    </a>",
"    ]. By comparison, missense mutations found in two siblings were only associated with focal segmental changes.",
"   </p>",
"   <p>",
"    Phospholipase C epsilon is a member of the phospholipase family of enzymes that catalyzes the hydrolysis of polyphosphoinositides resulting in generation of second messengers (eg, inositol-1,4,5-triphosphate), which are involved in cell growth and differentiation. A pathogenetic role for PLCE1 in glomerular development was supported by findings of disruption of the glomerular filtration barrier and edema in a PLCE1 knockout zebrafish model.",
"   </p>",
"   <p>",
"    How a PLCE1 gene defect results in changes in the glomerular nephrotic syndrome is unknown. One possible explanation is that phospholipase C epsilon interacts with GTPase-activating protein, which is known to interact with the slit diaphragm protein, nephrin. Perturbations of this normal interaction would have a downstream effect including the subsequent interaction of GTPase-activating protein with nephrin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Clinical and laboratory features",
"    </span>",
"    &nbsp;&mdash;&nbsp;As opposed to the CNF, children with diffuse mesangial sclerosis appear normal at birth, with a normal birth weight and without placental enlargement. The nephrotic syndrome may be present at birth or even suspected in utero by the finding of an elevated plasma alpha-fetoprotein level in the mother or the discovery of large hyperechogenic kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/45\">",
"     45",
"    </a>",
"    ]. More commonly, however, proteinuria with a bland urine sediment develops postnatally, increasing progressively during the first or the second year of life. Various types of extrarenal signs have been reported in isolated patients including nystagmus, cataract, intellectual disability (mental retardation), microcephaly, severe myopia, and muscular dystrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22761?source=see_link\">",
"     \"Cataract in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All children progress to end-stage renal failure, frequently in association with hypertension. This usually occurs before age three, within a few months after the discovery of renal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse mesangial sclerosis is reportedly resistant to corticosteroids and immunosuppressive drugs. In the previously mentioned report, however, there was a clinical response to immunosuppressive therapy in two of the eight children with diffuse mesangial sclerosis due to a genetic mutation in PLCE1 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/2\">",
"     2",
"    </a>",
"    ]. In one child, remission was achieved with steroids, and the second patient responded to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/24/34176?source=see_link\">",
"     cyclosporine",
"    </a>",
"    therapy after failing initial steroid therapy. These cases are the first reported cases of successful remission in patients with congenital nephrotic syndrome due to genetic defect.",
"   </p>",
"   <p>",
"    The degree of proteinuria is typically less severe than in the CNF and specific supplemental therapy is usually not required.",
"   </p>",
"   <p>",
"    Treatment is supportive and consists of maintenance of electrolyte and water balance and adequate nutrition, prevention and treatment of infectious complications, and management of renal failure. Bilateral nephrectomy has been considered at the time of transplantation because of the theoretical risk of developing a Wilms' tumor. This issue remains unresolved, although some investigators have not found Wilms' tumor in the kidneys from 14 children with renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/41\">",
"     41",
"    </a>",
"    ]. Recurrent disease does not develop in the transplant.",
"   </p>",
"   <p>",
"    The combination of an angiotensin converting enzyme inhibitor and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/27/17848?source=see_link\">",
"     indomethacin",
"    </a>",
"    therapy was used to treat one child with diffuse mesangial sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/28\">",
"     28",
"    </a>",
"    ]. The child had a sustained clinical response, normal growth pattern, and suffered no adverse effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIFFUSE MESANGIAL SCLEROSIS WITH DRASH SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Denys and Drash first reported the triad of progressive renal disease, male pseudohermaphroditism, and Wilms' tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. All of the patients were infants with heavy proteinuria progressing rapidly to renal failure. Incomplete forms of the syndrome were described and the glomerulopathy was identified as diffuse mesangial sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Epidemiology and genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of cases of Denys-Drash syndrome have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/46-50\">",
"     46-50",
"    </a>",
"    ]. The Denys-Drash syndrome is usually sporadic, although occurrence in two kindreds has been reported. However, constitutional mutations occur in the Wilms' tumor predisposing gene, WT1 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Wilms' tumor is an embryonic kidney tumor thought to arise from aberrant mesenchymal stem cell differentiation secondary to the loss of a tumor suppressor gene or genes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. The WT1 gene lies at chromosomal position 11p13; it appears to encode a zinc finger protein, which is probably a transcription factor [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/54-57\">",
"     54-57",
"    </a>",
"    ]. WT1 is also expressed in the gonads, suggesting that the genital abnormalities in the Denys-Drash syndrome may result from pleiotropic effects of mutations in the WT1 gene itself. This hypothesis was first confirmed in a report, which identified constitutional heterozygous mutations within the WT1 gene in some individuals with the Denys-Drash syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequently, mutations of WT1 have been found in most patients with this syndrome. Most abnormalities are missense changes either in exon 9, which encodes for zinc finger 3 (with a mutational hot spot at an arginine residue thought to interact with the consensus DNA sequence), or in exon 8, which encodes for zinc finger 2 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse mesangial sclerosis is a constant feature of the Denys-Drash syndrome. It is associated with the two other components of the triad in the complete form, but with only one of the two in the incomplete forms.",
"   </p>",
"   <p>",
"    The clinical course of the nephropathy is not different from that described above in isolated diffuse mesangial sclerosis. However, Wilms' tumor may be the first clinical manifestation of the syndrome. Thus, careful renal ultrasonography should be performed, looking for nephroblastoma, in any patient found to have diffuse mesangial sclerosis. The tumor may be unilateral or bilateral and is associated in a few cases with nodules of nephroblastomatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/42,51\">",
"     42,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Male pseudohermaphroditism, characterized by ambiguous genitalia or female phenotype with dysgenetic testis or streak gonads, is observed in all 46 XY patients. In contrast, all 46 XX children appear to have a normal female phenotype, with normal ovaries, when the information was available. The finding of a normal male phenotype seems to exclude the diagnosis of Denys-Drash syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=see_link\">",
"     \"Evaluation of the infant with ambiguous genitalia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     IDIOPATHIC NEPHROTIC SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic nephrosis rarely occurs at birth, more commonly presenting during the first year of life. All the morphological variants of idiopathic nephrotic syndrome seen in older children can occur at this time including minimal change disease, diffuse mesangial proliferation, and focal segmental glomerulosclerosis.",
"   </p>",
"   <p>",
"    Establishing the diagnosis of one of these disorders may be important clinically, since steroid-responsiveness with a favorable course can be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/8,60\">",
"     8,60",
"    </a>",
"    ]. However, most affected infants are resistant to therapy and many progress to end-stage renal disease.",
"   </p>",
"   <p>",
"    In some cases, particularly those with familial disease, NPHS2 mutations have been detected [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/21\">",
"     21",
"    </a>",
"    ]. NPHS2 encodes for an integral membrane protein, podocin, which is found exclusively in glomerular podocytes. In several case series, NPHS2 mutations have also been detected in infants who present with congenital nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/24,25,35\">",
"     24,25,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, there are individuals with both NPHS1 and NPHS2 mutations resulting in a triallelic abnormality (homozygous mutations in one gene and a heterozygous mutation in the other).",
"   </p>",
"   <p>",
"    Other genetic defects associated with infantile nephrotic syndrome include mutations for alpha-actinin-4 gene and mutation at the locus of chromosome 2p. The latter appears to be responsible for some forms of steroid-sensitive idiopathic nephrosis, which is inherited in an autosomal recessive fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/61\">",
"     61",
"    </a>",
"    ]. Some affected families, however, do not display linkage to this locus, suggesting additional genetic heterogeneity.",
"   </p>",
"   <p>",
"    These findings demonstrate the genetic heterogeneity of congenital and infantile nephrotic syndrome and the absence of specific",
"    <span class=\"nowrap\">",
"     genotype/phenotype",
"    </span>",
"    correlations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MISCELLANEOUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other disorders are infrequent causes of congenital or infantile nephrotic syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Pierson syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pierson syndrome, (also referred to as microcoria-congenital nephrosis syndrome, MIM #6090409) is an autosomal recessive syndrome with congenital nephrotic syndrome with histologic lesions of diffuse mesangial sclerosis and ocular malformations (microcoria, abnormal lens with cataracts, and retinal abnormalities) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. This autosomal recessive disorder is due to mutations in the LAMB2 gene, which encodes laminin beta 2 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. Laminin beta 2 is abundantly expressed in the glomerular basement membrane where it plays a role in anchoring and in the development of podocyte foot processes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/65\">",
"     65",
"    </a>",
"    ]. LAMB2 knockout mice exhibit congenital nephrotic syndrome in association with anomalies of the retina and neuromuscular junction. LAMB2 mutations have also been found in patients with congenital nephrotic syndrome and either no or less severe ocular abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Galloway-Mowat syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Galloway-Mowat syndrome is characterized by microcephaly, mental retardation, hiatus hernia, and the nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/67\">",
"     67",
"    </a>",
"    ]. It appears to be transmitted as an autosomal recessive trait. The nephrotic syndrome presents early with a mean age of onset of three months and is usually severe and resistant to steroid therapy. Renal biopsy reveals minimal changes or focal segmental glomerulosclerosis. The underlying genetic defect is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Infectious causes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital syphilis &mdash; Congenital syphilis can cause membranous nephropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/68,69\">",
"       68,69",
"      </a>",
"      ]. Histological examination often shows a mixed pattern with membranous nephropathy and mesangial proliferation. Penicillin treatment leads to the resolution of the syphilis and the renal abnormalities.",
"     </li>",
"     <li>",
"      Congenital toxoplasmosis &mdash; The nephrotic syndrome may be induced by congenital toxoplasmosis [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/70\">",
"       70",
"      </a>",
"      ]. Proteinuria may be present at birth or may develop during the first three months, in association with ocular or neurologic symptoms. Histological examination often shows mesangial proliferation with or without focal segmental glomerulosclerosis. Treatment of toxoplasmosis or steroid therapy usually leads to remission of the proteinuria.",
"     </li>",
"     <li>",
"      Other organisms &mdash; Congenital or infantile nephrotic syndrome has been reported in association with cytomegalovirus, rubeola virus, and human immunodeficiency virus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nail-patella syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1973?source=see_link\">",
"       \"Nail-patella syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mercury exposure",
"     </li>",
"     <li>",
"      Neonatal nephrotic syndrome due to membranous nephropathy has been diagnosed antenatally in infants with mothers who have mutations in the metallomembrane endopeptidase gene, which encodes the podocyte protein neutral endopeptidase (NEP) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/71\">",
"       71",
"      </a>",
"      ]. During pregnancy, the presence of fetal NEP protein induces a maternal alloimmune response. Maternal antibody to NEP fetal protein results in fetal podocyte injury, which may lead to chronic renal failure. The mothers' IgG response to the expression of fetal NEP determined the severity of the neonatal disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Congenital nephrotic syndrome have been observed in case reports of mitochondrial cytopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/72\">",
"     72",
"    </a>",
"    ], type I carbohydrate-deficient glycoprotein syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/73\">",
"     73",
"    </a>",
"    ], and Herlitz junctional epidermolysis bullosa [",
"    <a class=\"abstract\" href=\"UTD.htm?7/36/7753/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because most cases of congenital and infantile nephrotic syndrome are caused by genetic mutations and fail to respond to immunosuppressive therapy, genetic screening should be performed before starting treatment. In addition, extrarenal manifestations can be helpful in the diagnosis. As an example, genital abnormalities in an affected male infant suggest a WT1 mutation and the diagnosis of Denys Drash syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nephrotic syndrome that presents at birth or within the three first months of life is defined as congenital nephrotic syndrome. Later onset, between three months and one year of age, is called infantile nephrotic syndrome. Most of children with congenital or infantile nephrotic syndrome have a genetic basis for the renal disease and a poor outcome.",
"   </p>",
"   <p>",
"    Mutations of the following genes are responsible for the majority of cases of congenital and infantile nephrotic syndrome.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      NPHS1, which encodes nephrin (a key component of the podocyte slit diaphragm) and is responsible for the Finnish-type congenital nephrotic syndrome. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'CNS of Finnish type'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NPHS2, which encodes podocin (a protein that interacts with nephrin at the slit diaphragm) and is responsible for familial focal segmental glomerulosclerosis. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'CNS and NPHS2 mutations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      WT1, which encodes the transcription tumor suppressor (a protein involved in kidney and gonad development) and is responsible for the Denys-Drash syndrome. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diffuse mesangial sclerosis with Drash syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      LAMB2, which encodes laminin beta 2 (a component of the glomerular basement membrane) and is responsible for the Pierson syndrome. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Pierson syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PLCE1 gene, which encodes phospholipase C epsilon, is responsible for the early-onset of isolated diffuse mesangial sclerosis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diffuse mesangial sclerosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other etiologies of congenital or infantile nephrotic syndrome include secondary causes such as infections (eg, syphilis or toxoplasmosis) (",
"    <a class=\"graphic graphic_table graphicRef80781 \" href=\"UTD.htm?4/54/4971\">",
"     table 1",
"    </a>",
"    ), toxins such as mercury exposure, and genetic disorders. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Infectious causes'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H23\">",
"     'Other causes'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Because most cases of congenital and infantile nephrotic syndrome are caused by genetic mutations and fail to respond to immunosuppressive therapy, we suggest genetic screening be performed before starting such treatment (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/1\">",
"      Hinkes BG, Mucha B, Vlangos CN, et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 2007; 119:e907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/2\">",
"      Hinkes B, Wiggins RC, Gbadegesin R, et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006; 38:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/3\">",
"      HALLMAN N, HJELT L. Congenital nephrotic syndrome. J Pediatr 1959; 55:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/4\">",
"      Hallman N, Norio R, Rapola J. Congenital nephrotic syndrome. Nephron 1973; 11:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/5\">",
"      Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000; 58:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/6\">",
"      Habib R, Bois E. [Heterogeneity of early onset nephrotic syndromes in infants (nephrotic syndrome \"in infants\"). Anatomical, clinical and genetic study of 37 cases]. Helv Paediatr Acta 1973; 28:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/7\">",
"      Kaplan BS, Bureau MA, Drummond KN. The nephrotic syndrome in the first year of life: is a pathologic classification possible? J Pediatr 1974; 85:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/8\">",
"      Sibley RK, Mahan J, Mauer SM, Vernier RL. A clinicopathologic study of forty-eight infants with nephrotic syndrome. Kidney Int 1985; 27:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/9\">",
"      Huttunen NP, Rapola J, Vilska J, Hallman N. Renal pathology in congenital nephrotic syndrome of Finnish type: a quantitative light microscopic study on 50 patients. Int J Pediatr Nephrol 1980; 1:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/10\">",
"      Rapola J, Sariola H, Ekblom P. Pathology of fetal congenital nephrosis: immunohistochemical and ultrastructural studies. Kidney Int 1984; 25:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/11\">",
"      Kestil&auml; M, M&auml;nnikk&ouml; M, Holmberg C, et al. Congenital nephrotic syndrome of the Finnish type maps to the long arm of chromosome 19. Am J Hum Genet 1994; 54:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/12\">",
"      Lenkkeri U, M&auml;nnikk&ouml; M, McCready P, et al. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999; 64:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/13\">",
"      Savage JM, Jefferson JA, Maxwell AP, et al. Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families. Arch Dis Child 1999; 80:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/14\">",
"      Kestil&auml; M, Lenkkeri U, M&auml;nnikk&ouml; M, et al. Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/15\">",
"      Pollak MR. Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol 2002; 13:3016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/16\">",
"      Lahdenper&auml; J, Kilpel&auml;inen P, Liu XL, et al. Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. Kidney Int 2003; 64:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/17\">",
"      Ruotsalainen V, Ljungberg P, Wartiovaara J, et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A 1999; 96:7962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/18\">",
"      Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 1999; 10:2440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/19\">",
"      Rantanen M, Palm&eacute;n T, P&auml;t&auml;ri A, et al. Nephrin TRAP mice lack slit diaphragms and show fibrotic glomeruli and cystic tubular lesions. J Am Soc Nephrol 2002; 13:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/20\">",
"      Patrakka J, Kestil&auml; M, Wartiovaara J, et al. Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int 2000; 58:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/21\">",
"      Niaudet P. Genetic forms of nephrotic syndrome. Pediatr Nephrol 2004; 19:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/22\">",
"      Shih NY, Li J, Karpitskii V, et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999; 286:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/23\">",
"      Kitamura A, Tsukaguchi H, Hiramoto R, et al. A familial childhood-onset relapsing nephrotic syndrome. Kidney Int 2007; 71:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/24\">",
"      Koziell A, Grech V, Hussain S, et al. Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet 2002; 11:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/25\">",
"      Schultheiss M, Ruf RG, Mucha BE, et al. No evidence for genotype/phenotype correlation in NPHS1 and NPHS2 mutations. Pediatr Nephrol 2004; 19:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/26\">",
"      Ljungberg P, Holmberg C, Jalanko H. Infections in infants with congenital nephrosis of the Finnish type. Pediatr Nephrol 1997; 11:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/27\">",
"      Pomeranz A, Wolach B, Bernheim J, et al. Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. J Pediatr 1995; 126:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/28\">",
"      Heaton PA, Smales O, Wong W. Congenital nephrotic syndrome responsive to captopril and indometacin. Arch Dis Child 1999; 81:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/29\">",
"      Mahan JD, Mauer SM, Sibley RK, Vernier RL. Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation. J Pediatr 1984; 105:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/30\">",
"      Holmberg C, Jalanko H, Koskimies O, et al. Renal transplantation in small children with congenital nephrotic syndrome of the Finnish type. Transplant Proc 1991; 23:1378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/31\">",
"      Kuusniemi AM, Qvist E, Sun Y, et al. Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1). Transplantation 2007; 83:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/32\">",
"      Ryyn&auml;nen M, Sepp&auml;l&auml; M, Kuusela P, et al. Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein. Br J Obstet Gynaecol 1983; 90:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/33\">",
"      Patrakka J, Martin P, Salonen R, et al. Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations. Lancet 2002; 359:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/34\">",
"      M&auml;nnikk&ouml; M, Kestil&auml; M, Lenkkeri U, et al. Improved prenatal diagnosis of the congenital nephrotic syndrome of the Finnish type based on DNA analysis. Kidney Int 1997; 51:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/35\">",
"      Sako M, Nakanishi K, Obana M, et al. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int 2005; 67:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/36\">",
"      Weber S, Gribouval O, Esquivel EL, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004; 66:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/37\">",
"      Beale MG, Strayer DS, Kissane JM, Robson AM. Congenital glomerulosclerosis and nephrotic syndrome in two infants. Speculations and pathogenesis. Am J Dis Child 1979; 133:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/38\">",
"      Rumpelt HJ, Bachmann HJ. Infantile nephrotic syndrome with diffuse mesangial sclerosis: a disturbance of glomerular basement membrane development? Clin Nephrol 1980; 13:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/39\">",
"      Kikuta Y, Yoshimura Y, Saito T, et al. Nephrotic syndrome with diffuse mesangial sclerosis in identical twins. J Pediatr 1983; 102:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/40\">",
"      Urbach J, Drukker A, Rosenmann E. Diffuse mesangial sclerosis--light, immunofluorescent and electronmicroscopy findings. Int J Pediatr Nephrol 1985; 6:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/41\">",
"      Habib R. Nephrotic syndrome in the 1st year of life. Pediatr Nephrol 1993; 7:347.",
"     </a>",
"    </li>",
"    <li>",
"     Habib, R, Gubler, MC, Antignac, C, Gagnadoux, MF. Diffuse mesangial sclerosis: A congenital glomerulopathy with nephrotic syndrome. In: Advances in Nephrology, Grunfeld, JP (Ed), Year Book, Chicago 1993. p.43.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/43\">",
"      Schumacher V, Sch&auml;rer K, W&uuml;hl E, et al. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 1998; 53:1594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/44\">",
"      Jeanpierre C, Denamur E, Henry I, et al. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 1998; 62:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/45\">",
"      Spear GS, Steinhaus KA, Quddusi A. Diffuse mesangial sclerosis in a fetus. Clin Nephrol 1991; 36:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/46\">",
"      Denys P, Malvaux P, Van Den Berghe H, et al. [Association of an anatomo-pathological syndrome of male pseudohermaphroditism, Wilms' tumor, parenchymatous nephropathy and XX/XY mosaicism]. Arch Fr Pediatr 1967; 24:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/47\">",
"      Drash A, Sherman F, Hartmann WH, Blizzard RM. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 1970; 76:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/48\">",
"      Habib R, Loirat C, Gubler MC, et al. The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): a distinctive glomerular lesion--report of 10 cases. Clin Nephrol 1985; 24:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/49\">",
"      Gallo GE, Chemes HE. The association of Wilms' tumor, male pseudohermaphroditism and diffuse glomerular disease (Drash syndrome): report of eight cases with clinical and morphologic findings and review of the literature. Pediatr Pathol 1987; 7:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/50\">",
"      Jadresic L, Leake J, Gordon I, et al. Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome). J Pediatr 1990; 117:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/51\">",
"      Coppes MJ, Campbell CE, Williams BR. The role of WT1 in Wilms tumorigenesis. FASEB J 1993; 7:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/52\">",
"      Weinberg RA. Tumor suppressor genes. Science 1991; 254:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/53\">",
"      Huff V. Wilms tumor genetics. Am J Med Genet 1998; 79:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/54\">",
"      Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/55\">",
"      Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/56\">",
"      Haber DA, Buckler AJ, Glaser T, et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 1990; 61:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/57\">",
"      Lee SB, Huang K, Palmer R, et al. The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 1999; 98:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/58\">",
"      Pelletier J, Bruening W, Li FP, et al. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 1991; 353:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/59\">",
"      Little M, Wells C. A clinical overview of WT1 gene mutations. Hum Mutat 1997; 9:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/60\">",
"      Fuchshuber A, Gribouval O, Ronner V, et al. Clinical and genetic evaluation of familial steroid-responsive nephrotic syndrome in childhood. J Am Soc Nephrol 2001; 12:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/61\">",
"      Ruf RG, Fuchshuber A, Karle SM, et al. Identification of the first gene locus (SSNS1) for steroid-sensitive nephrotic syndrome on chromosome 2p. J Am Soc Nephrol 2003; 14:1897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/62\">",
"      Zenker M, Tralau T, Lennert T, et al. Congenital nephrosis, mesangial sclerosis, and distinct eye abnormalities with microcoria: an autosomal recessive syndrome. Am J Med Genet A 2004; 130A:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/63\">",
"      VanDeVoorde R, Witte D, Kogan J, Goebel J. Pierson syndrome: a novel cause of congenital nephrotic syndrome. Pediatrics 2006; 118:e501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/64\">",
"      Bredrup C, Matejas V, Barrow M, et al. Ophthalmological aspects of Pierson syndrome. Am J Ophthalmol 2008; 146:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/65\">",
"      Zenker M, Aigner T, Wendler O, et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004; 13:2625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/66\">",
"      Hasselbacher K, Wiggins RC, Matejas V, et al. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int 2006; 70:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/67\">",
"      Galloway WH, Mowat AP. Congenital microcephaly with hiatus hernia and nephrotic syndrome in two sibs. J Med Genet 1968; 5:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/68\">",
"      Kaplan BS, Wiglesworth FW, Marks MI, Drummond KN. The glomerulopathy of congenital syphilis--an immune deposit disease. J Pediatr 1972; 81:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/69\">",
"      Losito A, Bucciarelli E, Massi-Benedetti F, Lato M. Membranous glomerulonephritis in congenital syphilis. Clin Nephrol 1979; 12:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/70\">",
"      Shahin B, Papadopoulou ZL, Jenis EH. Congenital nephrotic syndrome associated with congenital toxoplasmosis. J Pediatr 1974; 85:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/71\">",
"      Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 2004; 364:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/72\">",
"      Goldenberg A, Ngoc LH, Thouret MC, et al. Respiratory chain deficiency presenting as congenital nephrotic syndrome. Pediatr Nephrol 2005; 20:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/73\">",
"      van der Knaap MS, Wevers RA, Monnens L, et al. Congenital nephrotic syndrome: a novel phenotype of type I carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 1996; 19:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/36/7753/abstract/74\">",
"      Hata D, Miyazaki M, Seto S, et al. Nephrotic syndrome and aberrant expression of laminin isoforms in glomerular basement membranes for an infant with Herlitz junctional epidermolysis bullosa. Pediatrics 2005; 116:e601.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6137 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-60.18.131.125-8B92F8E3C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7753=[""].join("\n");
var outline_f7_36_7753=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CNS OF FINNISH TYPE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Antenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CNS AND NPHS2 MUTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFUSE MESANGIAL SCLEROSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Clinical and laboratory features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIFFUSE MESANGIAL SCLEROSIS WITH DRASH SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Epidemiology and genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      IDIOPATHIC NEPHROTIC SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MISCELLANEOUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Pierson syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Galloway-Mowat syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Infectious causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6137\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6137|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/36/38470\" title=\"picture 1\">",
"      Renal Bx - congenital NS of the Finnish type",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/5/6230\" title=\"picture 2\">",
"      Renal pathology of early diffuse mesangial sclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/2/40999\" title=\"picture 3\">",
"      Renal pathology of late diffuse mesangial sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6137|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/54/4971\" title=\"table 1\">",
"      Causes congenital NS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22761?source=related_link\">",
"      Cataract in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=related_link\">",
"      Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24506?source=related_link\">",
"      Evaluation of the infant with ambiguous genitalia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/59/1973?source=related_link\">",
"      Nail-patella syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/12/3273?source=related_link\">",
"      Renal vein thrombosis and hypercoagulable state in nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/54/21354?source=related_link\">",
"      Steroid-resistant idiopathic nephrotic syndrome in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_36_7754="VF complete HH";
var content_f7_36_7754=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F68768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F68768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Visual fields: Complete Homonymous Hemianopia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 454px; background-image: url(data:image/gif;base64,R0lGODlhCQLGAfcAAP39/f////7+/vz8/Pr6+vv7+/n5+SIiIvj4+CEhIR8fH/f39yMjIyAgICUlJSQkJPb29iYmJvX19R4eHvT09CcnJx0dHSgoKPPz8xwcHCkpKfLy8hsbG/Hx8SoqKisrK/Dw8O/v7xoaGhkZGSwsLO7u7u3t7S0tLezs7Ovr6+rq6i4uLunp6RgYGC8vL+fn5+Tk5DAwMOLi4uPj4+Xl5eHh4ejo6ODg4Obm5tvb29/f3xcXF97e3t3d3TExMdfX1zU1NTIyMtXV1dzc3Nra2tHR0TQ0NNLS0tjY2NPT0zMzM9DQ0MzMzDY2NsnJydbW1sLCwtnZ2c/Pz8vLy83NzRUVFdTU1MTExM7Ozri4uLW1tcrKysHBwRYWFsjIyDc3N7+/v5ubm8fHx7u7u8XFxcbGxqKiojg4OMPDw76+vrKysqGhobe3tzk5OcDAwKysrHZ2dr29vbOzs5CQkIGBgby8vJKSkpWVlTs7O6ampnl5eW9vb25ubq2traWlpZOTk4iIiJeXl5mZmbS0tK+vr7CwsHFxcZiYmKurq5+fn5GRkaCgoKqqqpaWloCAgHx8fG1tbbq6uo6OjnR0dIeHh4+Pj2lpaXV1dba2tnJycn19fRQUFK6urmhoaJ6enqOjo3d3d4yMjLm5uY2NjXh4eGpqanNzc3t7e4uLi3p6eqenp4WFhbGxsTo6OomJiX5+flZWVmZmZmVlZWNjY4aGhnBwcDw8PKSkpKmpqWBgYJSUlF5eXpycnGdnZ2tra19fX4KCglpaWoSEhF1dXWxsbGFhYU1NTT09PUJCQpqamkBAQIqKip2dnVFRUUVFRaioqFdXV2JiYmRkZElJSYODg1RUVE9PT1NTUxMTE0tLSz8/P1xcXFVVVVJSUkFBQX9/f1lZWVtbWz4+PkdHR0pKSkRERENDQ0hISFhYWE5OThISElBQUExMTEZGRhERERAQEA8PDw4ODgwMDA0NDQkJCQoKCgICAgsLCwYGBgUFBQcHBwAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAJAsYBAAj/AAMIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1agAAWLNq3cq1q9esAnQK+Kp1wNiwA9EKQNtyLNm3cOPKnUu3rt27c93ifXs26wAAf7EG3trTrd69iAlDTEyXbc21c/8GdhzzMOPLmDNrZvxXwODNWPVOLnB2wGcAhbuO7QwabsTWXinLtBxZa4CwslFChs27t2+8on8DOAvZLGC/tlMPPy6c7OvmuV/S3ss2OsnpzbNr39568GSww08D/x3OtrNxznDXWkeYff3K1XbHBhi8lqB7kNi569/POH9mz4KF5txPZt2GGoC/qXcfe9DN5N9bpgFQAHnz4XYbSw/yp+GGZAlgAAanbWYca3p5ZtlPog0woW/1YdTebIgBiAABBpgwRwkDwMThjjx2iFUABuCYIWcFLFAAAcedl5xYBBFQgGkEnDdkYws69CJMU75lAAEIADCDJRAAdiFLzPVoZo/nhZllXd4hIIAaXlwlGVdBAbYBBcupGCJ1VT6kXZ8hrcnVWVxKEEAJoQg0XFtnNnombru15hYBBASgByNXJUknT2gVEEAIIQw0gAEr/phWbYD6eaVLgm4VoQEIFP9QgyCdMJOFAWOq1KqjvEo6Jm/1IYArKoXUJ+BWqbqUo4oGAkaffVR+9CeWjBVgwF9YmNJOLWYgkON7vYa73569CQDBAigIcwsGsHbIpEAWHhfWcoKZRm5sIW0n3a5amehZABBkcpuFKolr8MEQ3jscAoF4M04pPAwQJb4+AYBAANYWiKCElE4cV7KLTctojMcGoMIelV4F8kX8Iuwyj5EGFoIBKRxihgoQIAABAdOtfBJbEs5ZZr0RfjzSdj5n1HKA8gbwwh4aJ03R0i9XHZt2gZEawCKqeIaABKUi+xO9Ck8pdUPcuSRiADAYglqmZz8UqdV0u+yWaRiAMIAdbxz/igFqX8WNH0GgCa5Q2i2BFoAMk8zHc2gmHaZw3ZSP23HYP1Zyx3y3KVwxcqEFRt/khh+OeEpUg5dVADVcMh+uk5X04JPkVR5uaakn1rGTWjkZwB3JzO3uTpqVbjrSuoqYY+trkUbek2l9lCHvzdq+I2sCKsnf7k+6tWUAjayhstHE/2fSfsYzNDRmAegwiaefuYWf6l5Rn7v1l4kHAJJF78c9WAXw1CjER68Hpa8jxTvffnTjqyG8r3aCsZanOnIY/9gPf2fCGAWQ5JfDGOh+ZPlfhEYVAFTwonrkuwkID8gg/bDQIP5ZWgB+kAmJ0cY0HBFUAA+EwcQoCCHCcw4E/2AAATmVZX+3Ic3kGLM7GlHqSRgAXxjgdqzh2QSEKNHQCwfimwAIoRYSwk5nWMav4vTwLqm6IdkEsqWe8WxUQdxMEynVxiLq4oSuSiFN7rdFg2xoiyD0SgCSQIwoVVA1yYrjGRM0tdisRmje2Z/EFrDExEhsjkeSGADsMMV+VZJCNDHfSTgUKLLY65SolEsAlmAJCfTPMKqRG2Kwt8jGYESNAqDdvPxilglpcmmoDCZg5khHJxFAEcygYl36KJHMpARmFHzLkYhJTY8RxgmlMMDd8tKitCiylizaSCDvMs1qVnNLFgPAHxqxFmvSZYyVYV8Woak0U2KlnObc3Z4CIP+GWkjmm+C8XekA6ht85vNyHRvAxRShi9tMbGNxiR+rnDlPmEmNoGMx6EFDFJYymMJe8AlojxTUs/npR6MHpaMBkBiKzeXyk3xJHEVH+ahEElQrKDUnRwNABlJkUqSNKsigRDJOueT0oBJEDSUC4VDn9QdcM1Ugr7p5kDWpKIBHreYpbQMFUugJqBk8FViYWdQIBtBJWE1rSi+3JVINZxTJuEr3LsNMGG7mmVWL2VwMuqW1bmmapQoAFzKhRPqBlT/QglzkYJPVtTZxSxILwC14IQAkZSo+Q/2Z4irKH5gmprHm7OsTAxMAN1wiR5jrir0O+5vELmqxrQGtY534JFz/JSKZSCqNJV8ru83StHIZWg0xZYvQCckHDKnoJWtFBq8CqgcsqPvPcqYp2tliklKR5YUnAsBBofkQtv1iDF7ppqdgntJTlT1SWrGqp7NiVaXV5d2P0vAKKPXMQvShV3hVu9wloTCzBcOMW9xbzCPBKlbvpZEB/mpMazkxsoLY7pPiZ8qNwXJ1gAQWZ+02zHNSqgQd6ICKhLXgEmO3SAtwkgEgAIESk2qSW1rAxeJgCm9VNoyrmxGpuiSZKBnyLAG0jGfP6NpYriQzpnEvqZYcJZ1FyQALWLCRaCSxLhkJAh1wMK7CkAgPSagsAGpupuZTNLMsWL9vM6mvfmu1S1JT/7RFJDF8pSyBv9Y2Z35Z8JMKoDNcjQESlJwwBWIVnv15i8eAgZVZIPC3IpW1bkUWG5mIlDHRXuuJFOiABJ581kSfq60ESHGRWnwxO8Q10HSSzLWAFJoSRXkBG+iSidIcTQ2z+WC7cXM1F4ABFujgBjKAAQ5soAIUmCAEHcBAnRm9AQxQINMoKAEINlACUKUABMLKUSQyQaPKFrFZ7eSujCXkqQJQ4FqLEkAJbspaklIMQzHKJQLmHWXAOpEALEari2FdKSMBwJUCcLYBBs0zSWwOwaIzDMaM67sFLGCb5zrSZY2bw0dD99YIS/JB3VSIGLRCHLbQBjKcMY5psCMd1v+AxS/CYY10rGMdzTBGO6aRDWNkgxznaAIgwswGOHApgAMYAhEylSMMSIECAkDAArAihB6oiACG6oEVIGDxWtY1IVZFVi4d7nDoNQQtHITAAKKMgA1CQAIbvNghGiFuTwGOtAQxjaE2NgAIeGrFy6ks0mltEXZ/F+PhenpKpxmASBzgAQloQAMScIADNGACE+BABhTQAA5MQAEc6IIIJmCBDGSAAREgwQQcMeYsPKIALP5LLuggJxU5wRs0kCSSTMH2UiUCFhsAd3/RSK2IopTBA/DCNsKxi07sYQ+9iEYsiAEJPpRCFqXYwyUmQQw+QCIWlihGL2IBi2KMYxVLj2L/Ik7I5y3VAAOEGgAMhkD1/RHgBVfowJgNEAkvfNksSXeSiqgqkar3a8Piomv59Fel5QIRcAAM8AAVoAEf4AEV4AARcAEVEAEa4IAH+AAS+IAecAIxkADCkEuVIgrfAAALJixHAAU88CEBkGlJgAY68C0QkAM1cAMtVlkhkAQ5EALstXvxgTp2FVEDGABjQAIHwHgTwAAHYAFKyHmX1wAJmAEcIAJSuAMj0AIjwAAJ4A6+EAALUESCsAijAgIFUAdGIAQYAysFkAmk1wEsJgBTwA1DEABuAhigMApcuCJJB4LXwn9f53cCBni9IoDGZE4BEAcVcHgH4AAL2IAXEAEV/3ABGqABjRgBDoCBHuABJHCJJOACDUAL3FUphFBIBGADKbABAlAJjQMCrGACQJIOWRAAT0AEF9MIeiAANiAFRfQEeCAFEhBlQ8aDVxc9BTElo5JPAQAGRuABjlgBE+gAihgBEegBH0ACJyCJkTiJingBHtAArNeFAaALfyCHGIAAMxAHTiAEE7QBLyAGY3AuAdABG2ADojADqKF0BiAFXKAnuJFfoLQQCsIdfAgSuCYYdlZMTEYqHeNnDKAADwB6CyiBD3B4EOiMCeiIEngBF6kBJzABgHCGAUAIcCCH1EALBIAEQjAIRbAF06ADJsAFTzAGIaAHtUAAZbAEb/AChP8ADiDAA04gBV4AAgCwM8gyNP7HTfoSE3DxF+VEKmf1RJUSBz5AjUHwBSRQiY94kQ6AhBIJgZTojJR4ARMgDFxYRHaACp+yBCawUt0gCjxVBEWECLEQADZACDAwH7FABgEABUwQJnlwCiv1LSWCSOrhTRxydQZzVbUVapCFerCyYILHJQGQBQlgAQzAAA6AkY6nABmgeIvXAIcXAR/wAJzZABH4ARmQKFozCB8oATegAhIgC4dQC64Adfy0C5FgDFdQJCXQC6pgCMyggmFADHkADTCwAeh2GkWJMDACOhKyUtciLB3ThYm5YIXXAB6wAi7gAo1YAZcojQ04gaK5eAn/YJle6Ygc0I1FNAdTtATt8AMSAAVSUAgmoAnAEAByIApxkAU9wAdFUANhIANhAAOhYAcBkAdXEAeYADllgiDaE1IjVRJTlRXlZDGoN3f+GJnOmKHO6HgWIAKUJwKfFwEKIIGPNwJVwAFZ+QAiUAlyyDODYAgYEwUyICsw0AEGIAOS8AILYAIboAILoAVxQAAdUAIpgAJRUAcUgAEyVgIbYChB9lLGQXTGZSbf0RvLSTRPonSjci0TtgE/wAIsJixdggYOcAIPsAIfwIwRiJEaEAFIWJkJkHgN8ACimQCV2ABV8AoAYyiSwFQdQAQFkAbmwAmzIAS5BACnUAmLQAkH/0IFvjAFloAFAIMBy8AJwhAKODQ+SZZkCLIWvygcdWUw+JSlgVoIrEAIamAGecAIfcAKWpAFdZAGZaAIH9AAkPgAlAeNjncACmABCpAAiAeN45kBO9AADjCeHDAHAbBpAcAGxOAZtfAIA7EAhZgNZigAFBAAGAAHr0CtQVkAt5AOOCAQOWJ3bQQAMjYAg5YjvQg2NTUorXGlHANZAyABCGCKEzYWNNABCBYlAYAFbeAADfAB3/kA0AiNlViJD+ABGoCrCfirjsgAIyCWoRYAinAIAIMDzYYCIcACBpAGUGCvTsQCjcAEPCN/A+AJuHAxE7Qzduc71jJlYZJiN5Ynyf+ZFyQhUIJIreEgAg2weRwwAlU4AXHKAD97AXHqiEk4eROQASA6AY/3q0Y7pyKKooh3ABmgCABDGm5wCnL4Ai8QACBrJCDQAQCQA4uAAkpnYIuACahHARsAAW5gBjkDJAo1CFsQK1yyADKgBTaQYp/xqZvxXII7F1c6Kl3YhXO4ACDgcFxSAnAbAhgQAhxrAHHgAgzggB+gARXwABp6sNDoAitwiJWZq8qYAaOQS7giCGEgAD9AAmJwIXaXCaDAMxgjAFbgDU6AK/tTAHTwB6gBZXsnf+SaFbhCZvOxdDfLey8UeE2ZMTJWAMNQASQAmhB5ABWwudPYgBHQBZSnAOD/mwC9ygEcwJAJkAET4AAWMAER+LOeO54W8AdJlyN1AKMEQAFG0gkYiwAlIBBQMAwlAABIJwEYYAjPADAmQBrCEJKIu6PG4AcYI2ICwArHUAPYSjs9wmcaY6XxJBh7uwAEV4jdsAu5MAvR8AuwAA3dcA3TgAzkgA7m8AEYeQGb+4CVWZmKuIAPOYEVwABEGwGn21AOJwC8oKwdcAQpUAJpcAN1FgI6UAC8sAYFUGeNCwOPYAPN2SWHkAVfJhAyMAc6sIJ1FwB+YAogIACiViKFCyzNyysxK1rWIgHoCg0J4AEXoIAO4HgG+5XH2qu9CnkN8ICTeXm9unkHIHngawEc/8B4caoAkoDGOYIFYokrUBcCrKAIgRFlGwAMZUCCXEgAWcBOApFiFNAIKRAWY4cAouAJxwvCHfAJsuhU64M0+7Mz8yI6viUdOOVEMSYAXFABPvABCZC+CcgA4OmMA9uIFXgBldh4jecAkoiR5Yl4CpCIlMgBywAw2eoJ7GQoADAG5CADAKPJlRAI7ketZADAHhICTkIHZvBSAmEFehCH+4MBBcAGioAn+2NYjdLGjvLGozVvJAgOB8DMzoh4hNwAlFeEUfu9CRABkzkCvmoBVdgAUEiFLVC+vXp4HCCWaosFjwALYWAFfSAKniIKgUAAQrAHORAAOAAHYPA7h5Ajgf/AVG7wDdn6BJPAAr+jBrjiB8mEBaOAAqhhCUzAalWkIRJTIPulGfJqYHRURGjwAUCgBD4QAyuQ1StwAidAjSSwuRGwx3nMeM6sgNvZeIzXq074mSJwCfMGAgHADJiSeyCwk6kwBRMG11tAChRgGs9ZClhQKQAQRYNAC12CGqSxDH3DJRfTAaQgqYQ2y2biz43yxtayUnxGGr9QzAedeJ3XeRywAyBK1gg4mUGreZ7neQoQeUI7Apb3qwgoAoAQlAMwCLvADnswBoDAomugBatwBz9ACTAwBaZwBHrgBLjADARACs9AC2wgBqggAZ5AC0lQCSHwDYiAAI+ABn6AC0z/EAs24AaAoAOjAKirIWRotkjBOIzQAhmAtWBFBAYM8AEcGANeTQLRzKY2jISPZwHOPJ43zABKqITo+6sPXQEZoAkBVwBUIAuPoApIYAYtDQKmELuHUAmeUgaSEABIUAxOEHDJkAMLoAhzcC1QkAcAkAKlgAYCwQlXEACIAAkSIAA44Ansx0F9cTvSwiGTUTTWUrfRkyOyMLWUiIUNMOCKvAmibXmcOQGtLbQgur7gmwGtXeCVeQAtIJYQsAEA4AasdzEpRgtZIAdmMAAhAAA/MAdWMApJMBYLkAxv4AmiIEl1sAZQ4AgqIBAgMAlsIAl5cCFpAApX0AlL0CzaIxjL/4s8OmIWSrk7K1adDKuN3fkBYZ2hE4iFCHjkFsB4DanQ4KuZqW0Bi9eQlnmeQQIBgYAM7FAKWgALTDAEy3AFk3AEh9BQmhAIz7AMKDAKLHAEskAFuYAEiEAIAOAIz5AIhpACqpADPLANUOALqsADXOwH4QAF0/ADKfYy6QMzanVWSscDM5ACKkBsKRACuxCRoBenibfanGcBLdAFVdAFGYDkoB2FIzB54svaQou+pCmaVRAKAFC2hWcKcigMngA2SxcAdWAOOTAvAiEJsZAyYcEIwzADt/FwG7AHYYDYYSEGl3DK71gAemMqX7HG4YIlaBVAOtOuG2AkmMAA2akBXP8JiW6qlXRahIeHhQDeeKs94OALecAagSLaAF3wDQOAATuTDCdErQPgBpZwBavAAwJBAKrwBpzgCTwDAVEACF4gCTRwGyDQB3UABYOAFQiAAs/wA7dABQEXAFIgB0TQCHoDP5CR6HYBTxqRwcRUr9KgBNzgDGcgDubQCitwxxgp5b9ayOjbAlWQ0anNkFiomb7aeAPueZIn5Z+3A3+wpQIABXtgLokwCARApF0oBH3AAhgwAytGAFAwBup3A3y2BJwAAiVgAzX4BoTALHI4BcCQAn1WABiQW7uE3gGlIyrmJN82L2GBCQrwAfbdlQ3puVPrzLz6q557rKFdvgmNea7/DbXAGqebYAkBn61/kCg58ApJwJRFAgq0QBpXEQA50AxQMDACUQrCwCy4ogPOYNJiAhABkg3DEECAgQAEChgAECAAAAEDAEAUIGDiRYwZNW7k2NHjxIoCHI4kWdJkyY8pVa4cUIDAS5gMBxRT0OTBgwkMMmRIwOBCBQsKhCZoMIGDhQYtuojIYGGnhQdELViYMCHB1QZZJ+xsaoHDgRF2AhQomIZYAAoOTXQaFbHAwzLdbARYYBBBLEoBJBg4aCYWgBIq0A4gYKMGAcIB6pSrIQABhLdzTj2EAGDAQ5ArNW/m3FnkSdChRY8OQNhAgQIDQmDyQ4hVljFgJPW84OGD/4cKCr5GYNBAAdYEE5Ae6J1hRBcOCqpS3TqC6e8Ev7FJA7Chg8A7AYT4khIAwYICABiFAYABAwEBKvzoCFHDxAABbMAMqEGjA4IOfp4YMIFhAYItskAghR4oQMCABRK04QYACjjIAIky62zCCUMiTTQKM+TIooVg6rAlYjj4AIgVKvhAAwUOcMCBAxTwLcUDimrgAA5aOOopC2I0yiqhJjjgxwO2yuAor8BCJSEJAkijFscgQAwNMbD4riIU6kAjBQQgAgGMK6LoIMkCcIACBgkIyAOZDQKgBBIA0ipAB1aS6OAtl9DAhIYFJACAoYss0vBPQD367EJCC3VIAJc63P9zlwxOcCACEm5KwAEGIvCAN6NUfMC3qoQa0sUGLBBBhBZG4ODUU3HMALrf3LEEARleEGCNOwSQoC4q2NmCLocQ0MOUAAxAwCEhpqFiAfQCCKGZR/SCwKEezvAiWAhECqOZNCmgwKVaMqloLAcDFTclCw0dadwJWxpAItQQSA218AqwpAISLiDhgAoucOCCC4JULrqbYjzggQxEEPKpoowjTgGnhBLKKxw5eKAFQOhKMpJaxoKBBYOeuSQAHgbBoTRyIgkAiSQICOCOXAKQIYsSAqjBmB8keCGJiYZ4ggAVhKDAInKKCACFGhDiYpqREZtoXXSbBnRQc6MGDVEDqn7/KQBLHtDgAwY0CCKGFTRg4FGhshq7NyGnGmGEVUMVkoO11y41qIYTIM6BHWpBAIYSZpUkgPsWQMKVHhYw4FkE0qjjhdQAkMCEMaI4760OmHgCCYSodAILFQCoywAcvCgDhG0TsqIILzoQCSKnW+fIXNdXcumlAiSQoAMIIEgQgsNlOeCDSQ+IoMQHWrzKAgdmnMDUrDbZwQHdPr1KOYeFq6pTDkQg8qsugBEg9wBEmeQhPhwBIIckxigDi26KoIGRJUQpAZhUDBDDjTR4IMQaAqEggwy0EGEB9EGCAJ6BhxmUQAxOcAICHNEMEEigB1pgAgRMsLQIxU6DK5FaB08C/wACCCtBCCnFBDygAR9cQBzH0MAFIvAABjwAeg2QYW9CVbAdcGArcEPOVkTVAhGIqinKmYCL8HUBEUxCABi4zBpeEQAI0AADb+lFFgIAg5EpaRjfy4EKDECBdMRhAEPIgcrWwAe6SAEHIkHHHArAgigkCQfimFYSioAQNIzjBQZBTAb9tMFxwQ6QHTGNAULoJAjc6jvf6cQEKrCpDEzAAcXzTag4EJxQ7UAEO6hCT1K1k5ww4EdTyUqLqNcADmjSR1aBxylsNaw6TMJzL2BPMBTxCGAESwBgsAYUqtGHDRguF4AwxDJUE4A5WGMQ7NgAG5ChgwDAYRbaokEA2PCFN/9kIwkyOIIBVpGKPGSjBBiEz4YGOUioebBQn2lQCBNkuAAQQwQaOMBPPBADDVTghWOLwARoyKKs+MYrRcQhNo4yAoZpb1Ki1NFQIlCBDIwPns9YRQCekA4tGEAKZchDCPjgiwB4QQuc4IIO0oGJDcQhC58oAR0uIQApuEELW6hBNvqwAEYIQQ43MMM0ULAEM5RhDSiQhBKvQIYyFIKJkMHMH88JKEE+dWlLMyRMEEAACSBqXSJxhBEtMLerCIdITUlABoA4gh3YTXtNaUolGzDE6TmsYEdRAAMmtQnzGUgAaTDEABAwhRQYgAUqYEEJePCHHhTgBQuYwS0KIYcF+Af/BRRYwi2CiYIQECEEFEgBBiCAAxgAgAZqUAEOlvCCI2DgCVeAwBOogAIpJHKAEIJQRiySQal+BLeaSac6DbWnhTwGnqbYQQUYQAISVKBEFZikii5QlRqW8kdE2QqpOLATHRLRbtN9kYt6MgI9+HVYqnBFADYgBRPEARlpgEQdSkADCFDiFX+oRRQlcIRqjAEdS0gkAL4RikTQYgB8ecIw3GAIViwABBt4QynQMIslGAADvnIEI4jRAcuYxjK5hepvOXwRwlh1AGOQRS1MAQo9aIIUyEiRP0dQhUv6Jns/uiTBbKSbpTDgYF1J24yiU0QFdAGhLiqeAzZBjVcKwA3E/3gJHQJxVQpAxAvBEMIAIPCYDaCCFARQMHrqsI0bEAACaUFAlq48EQJgwhlRcAgILAKIdGAYAeU8DXwQ9cfbfjglCwlPRTBILt9GTQAKqQhiEBMATYzgNlxbgQf29cIEPKACRYxuJQcWHONkQCeRnJFdjTOq7Mo1ASN4RAHyFIBnLGOJTLABCIZQghIMIA5cQIB/MCCBHwjjCQMI5oQHgYvc3QcCLBiFEAgQggFIoABuEEYIVGYgAujCDmWSgLvcBYA5hbC2ep5QVD8c4tO8RRRI+UAEYtSCHeykBUMaQQtKJQJTMUAnDcB09oIYxCGNFUfDiY7DNtGC6RXlAO+gBf8U6wIFSyRy0J4jAAIocDgMQHsBFtxT7iYewtrB5zQiWZdDCECBuhRgWBOhgASS/awBIIsAKXjGDfyU59s6ldsYCQ9FOBNoc6GGAjTALAg60IENaCIBEXhUAur1ABfehLm/ieEBgmMwFUXHrMiDW1OEFyThTAXIDGtBA6pAB7+miRFPZMIx1GAQA8QMErF4iGMKoAJjqKJXJSCAJkCBAESVoAA8gAYmRjInLuRiBiKhAAQGsAY63GcDBHCcu56VENbN/OYe5jZMFKKkCpwgCI2ugNNT2YUWTGUH7nDeupUDt0v2Zt0ZgMcmRFAFGMs41JziSt1ClaMDuMMV1anLFfj/MGc3TEIwvICD5/YgCcD84g0CmMI1khAAQeiBLtHABQGkEI0jFCAOcEBBADwh4BIAog4GCAEdqCCAGcwBCQTAwipU4FcBROEcU8AMiHd7zvuD5DO9PZTMNcJ/nPugECgAJDgHduiGbmiGZiCHD9An5KkADSCBF4qACKgNuyoeu2EABRgBC4g0p1sensiAHdiEpSgif/qN7nqYBLAAUBCADgiBAGAEOKgdHlABGgiFH0AAEMCAznmDRXiML1oAHlCEITAAG2gIAEgGsbCd0qCBb9gCLvsPAyADYnC5gvieEFAdBzGIBnE4P5O8zfC2p4qQAVOIqgmAQUiARtMACkQb/+PggKLYpB1Ym+siFeQgohaogi54B3VQCk26iqNoER5jq1XxoapwOmxAhTYZFjQwhQUAACcwhRdAADdIhgVjhTFYABMwAyo4n0O4AQQgA1z4ojVAgw0QglEgggCQAkBIgQ5AhEQoABRoBDIogA4IhSMQABjQgyUQACo4BRZIlgEbBSgYiwwDMcnzM5IAwJH4wo1gxgA8lAKYAQnggSAot+RpAEd7ACMwgkmpDeIYmBX5DRZpKAUYkhwRJd+IpCKquh6hnuqpigjIgFJwQRAIAFxIBbQIIS+whBoYmnVBgECwg4XYAAdZAlBAAlObsALwBESQAAhANgJgATo4goRIjf+9ogMbSIspSAcxUBJw4AEB+ARQoIABqARUWB0w1AwxRKdyQg1tQwhG0MZJkiGnOx6eiJ6CASKjcDfjWLcWcAd16IIucJ5RcRGFagC0iqTaUwBSYUfl2ISK+Y4AAINMSJDLGKwQKIEF6AD/yBOQEzOHgJA8KScuOwiXKI3KCAAQeIuDYLw+oou6GAsWMAUquIxVUAMBADmVjAj/eypoHA1nxIhvicaTQJSXQIAZOIYK8IAT0gAN8AAScACiEB5zu4ofCRUFYJGnWxWiPMGeSAqecABSoQoXcZiyYRgLuIAWKAa0SBNCeAUAGBbDWQBLwATERAgo+AUYAAEUGJZoGoT/oXFFa9KEhUABDGiIV2iEAFCBFHgLEAiHNAiAKPgDHcCAH2gEFhCAMXiD03CDKyinleQgytugdWEadjkNLkOAJLkFNewJ4sjAB1AOTzu9HejAczwVpTgVPvwqdeBAe+sCGEuALnCH5BiSnWiAPRyBGGmKLkAyCCiIMTAFvmADcJCBAWiEYAgADKgGV5CwasiDAHCCbGAzV4iGATGGRAiAK1AGAMIEdJiBAKAFUiiPaEAEAAgBSOCEAKABUHACADgwGUiBWCgDjxICYFADy/iPPPuwwvStvwxMKNW2gpABbWCACsiXC3ABn3CAHOmJ5EFNdCS6t/LDd6gCnNChFgGi/6Z4yu5KQephgE04C/BRg4pKAVIAg7rwAzcIgGUohduRgkUIgSGwKQBAgUIggwFwhV5IuykoBBuwAWdABAF4gTHQAhQwg3AoAQxIAlyAAm1hgduBABkAgQHoABmoCCxivPEkz0IZpNlpuGpjiJJ4izxQAEfrDRgZGCCZrqc8x6c4Dg7ogjdkmDtkN+fZihEEouuaCq/QJE+zgB3QBPOCQVGgUAQogkOYAQIQA0yoNS7AggKgADaIgr0jBBMwACaIAwOQADl4gg1IAVaogRJ4gk9AAQDQgjwQgAW4AygwABAYBSwYABgABCuwvlXQAYQYGl2YAmrgAg4doMj7y9bBM//DrD/CjMb9s4iqsUUDoAEjGIET4pd8kreiKximwK6jmJQNxAZsGEF34MN4MKjaUxuucBGx8ifh+I0J2IQ9mM1neQN9pAFAkAIbKNJZGAM04AQB+IZHuIM9kIA6QAIkaAdMGAYy4IEiGIBe+AZFyIUtSQEZ4IZI8IVQoAAyWIBFyAY2aIUtEIM26IMAyIITQIMACAV0wLtegAMuJMxnzD8Oa8nWidUQGjQeYAMmOIIiEIIeoAFduAB5s6tIY6heDRJ4c4pScY5244Aq8KcGiCGkaIDXAz2DuS5/+qp1K4pIY5ib3IRHqI4kiYOoNUkAGLMsMZy3MIA0cYxhEYA00Yv/t8CqhpidYMEAkQDYYEkQ7yiT0khOh3iBYbiCkJiIW3mL85wqm9OgJ9XYDcvYABSJeBEWAigBCbgBIJC0R6FA3piRTfGK68KuIUKlFtiEKlhWdIMHbFir6zEKVLo3tHKOmw2VLgCHqimIQpgE8NiLw8oBQrACGBiCAaCCIsCCNIAANeqAMZABUaiBGYgjJ9iCIWAtIZgBCNgCGSADGtABL0AAFjiCF7CCFFABKmCBnfMCFCCAGngCCaCAKCACCCmN89yqVs0IwXWa2WGIL2FRCFQCEriUE7gAyOw09DUeu/oRfENZzc3cdmMbz9XALogHdbiuKnhZGBmBd+gCBtC6/1V5Ibx5Bd/Nqjior4jknevgV4QYsLrYEz2JsrG8DMKgEwpQmXE1OQjYgLfkWL6oTT++AWEgAt67qnBbnaxCRoug2Ke52Gb0v+31oOltRoMIABtQBgV4AAqkFLsaCuVwivflCv10DhHYhNYzGABmmLUZlRHo3xFwhyowlfrNgIF5qyrYBVNLE1bYA5fRhjA4FIRIBXTovoQIgBkoh0CAGjqQhcdDiBxohjUYFAEQhG2QAYdYAN+tiKq542HBgA4IZKzCgA2oNsM7EKUZ4oko4qZxCUM61crwAhI4Azz4AAUAgnLzgCIamAhgw7eqq+lCKBpJDoLiZQvYBPoFq6RQh/9NYJsdgIfWY5sugIcqYJgaEQEauokRALsNeBYwiNoFSIEj0BMvQANTGwQymE1MIAL0iwQ384JBmM1IsIEBcQIVWADU2gADeIKVXoAowIECgAAhKAH2HILn7IAk2AuH2AJnwII94ZBRmIQswbs+eTlxsVhMXsZnlFIMsZXZ9ANHCIVRoAVhsINVOAMa+hFRio6pSE33fd8aIUqQngBsAOMcEhW2EQGiLMpbzh4OwAYhO450C00L6IJcELm0kINUGIAUGIQakAAH9iwY8OEfoAIQ+A8VoIAhYIZgJIB4JQA2YIMug4EQAAFOeILa7YDF2gJJYIHaURl+NQjHGIsBdBD/rLIIk+QjPbFkbqNndInV1OALLIgBcWgDfRGlFRHHR2FDG2KoBGhW5wjpc7QAtjGVIPqqVWG3pRg1tOIkbKhfU+Ekg9muTRAwzwIAKOCDNHkDPNABAbiDUuhKWFA1FZgGXBAAJxCHIQiAPygGQ+oGvcSCcpgWVeiGkYEDkFoAcvCDAMABa0CEADgCPCADAeiDcgBnvUABKBCCFAiBYSmAKygEGOCdyNNesobSsX7xZrSM8CgzAPgFd9gBinZKOJyRGeHVH0NNIU+oHQg9qSsVh2mB/8zlTTjvEZgAeFMO48ihfLMKC6gC6ojQAPiEU2iJhhOCVogDtNBtOrCGh2hX/wOYAjywgoTgHQSQhU5IiIkbgChwBi34ng1YlzdIBxtADRgIhScoACtYBUdOA0EYlj5QBZf4BCYAABighh7YKuLWM+Mel9lJlLpYAiXAg8n8gBW5iRWhFPSFofjMTMAegQS4jZs8x3M0FafUXFXi7jj0bh2q5SJflR+RSr3IKi+4hATpgBrogBAqPJCjgM9Wga+0jwUIgf7YgGKHtjKhGgyoGgkoLASpgQ2otQLhLCT47NHhV2JYhAB4ASp4liRoByR4RIpoUnSRcSgl7pDY5P67LW0DIYYghtqojQb0gH4BkqGjJCEnjsjNTM/1jesGuOJ4B6Z42fw9lcv1DVKhN//dYIoEqIJt0J20yINv2AATeAgTSIJbiIQ+kwAVKINPMNXXTIE14IK3oAsDuAI7sIHPOJA+6AMResQUoASrRgLpLAAwaIbuuIU9SJNXeIUBMIFtYAQBuIFqkN60aPHxrHRxuXRkqYsnaAMfEB4PcDoYGvizMZ5ehaHgsAAGOJG5Nopz1J7lQSvtmd8SZLdNGgENvE90owqi2wHvkYCCoAI9MCQd4AQUgIA6sEQK8INIYE8/KIMFOAI7oIECcIJkMBBmwJkUEIQCqawUIAA56APViBOArQMeKIAQYAIMnYEpGAAbMAYp6AAsOAIvMIFGyAZXWyAZYDx6l4iIaPewnpr/PvmIeM/edqoqGg+AWrCX2vAA9M1A6LYrOA1HIEkY1JyAHegCpxCBFpmK7CFBexsV7aEKp/NoEUiAFoCFW6kWTjDOEFAFIXiWSRDRLHiGuhCDWGDPUKA/AQAGuX0DXdgjNACISSwQABO1IYCuNQK8nMIRAAAoNAYMPDQxIMACBAYILJg4oISEAAMwDCAAYeOABQQKFADg8iXMmDJn0qwpMwDOnDp34rTp8yeAAQOCAhAgoAABAAGGNKnw4MKBBlEbUE1glUECBRakHjjAwMGDrBMSPHDg4EACCxYUTGghYsKIuCM47HCHjUOGvBZG3H1wgIMCDiIUJLigoYUeAxIg/whgAoqAgCzjfhQQdIoAhli6ApSQpiUAl2E5BATKhGABODUBkMASM+CNsRkBQu0ZAIJbI9vVzATYcixOADXTeCCgUABHM0TQ2CB4IeAPJDnBOhQAYXwoUaDaBfDs7v07+AACtNssSYCAUAAEAsD5cMIDCagRDhBGewBsg6wK9ivw2rVrAxZkoEAD+7U1ggVdxMMBB+p0ESA2VWQgYAYiuEVYgQVqdcAm4ECwAGOFvAIAEdlgEsIaVAhjxRq/GJDHIWysokIvXDxhyRWATMGMIwbc8gwirhggzBoY1CKGJJwkkYoJnJSCRSxIJBEMGgGk8YsUArxhCAgCzPEIACjksv+IADmMwwUABhSwQFHYjUcenHCGx1OccY4nAAEbdEABAhwF8EMrFXjwwX5VWdXABA34FSBXXWHFll71JTDBgBns8JZcI7TQAoMWirBVWxwckNeoA04QgQNdXLYABQRMAcoAEIBQQgkIhIABAotRsIEEfUKAAAIplTDAYgYEK8FEFAAggQkLgGDAAiBSQIEBzyJQgg4agQADAiaY8QMBMoBABAZJyJHCCzC8wAQGR6lkVJ0/zTkvvTq9GSdLLJ0mFAETIRDAJRGcQMIJ8zFA1X8HRPCofgUykHBUAk7AH1tUbYKNCDtEyIEFLaw1AcgUZoBXomg1wIA64IDImBavQLD/wXk1gONGKlkQYNwYzHACiAkSYHCDI5FkAoZ4AwTiCSfLQCASC65sYccgATzLhCBLLGNFDo9QMUASdDwRgCijsMnGGwGEEAoZCKigymgLcCfAAi3BdG+8db9Ub092bxdCLd5UM0w4xsCizAo+xOcXAxUIWgEDE5b1wAOIJvCwAgx0UQXIIPfHwQgZ+NfVBGqNXHkGm3CaaAOaWvDpAZlPwAADm9ARQHEIUAHKsi9jsAEEAGyAQAEDINA7eusVcJRxmKU5vLEFSEBArwukJJIEQwUAbQASFEBRBzRU4wVFzwdwSC4hcLemRh1w95BLdOu9Pt7xf1eneRtRhBP8AZAy/8EH/UcQ1lgcxYAIaKVyEfOco6yCH6scijAOCMzISBa6BEwlP/SJy+lgJxV1DONDIZGDJQCggj3UAQMAIIkAEuELE+gEB+D4xE5oEQ0b4CRuLwjGGo4ngQUEABPT0IF4uiS+AnQAJwXAwPEo0IHzIDEAyoMbSzbyEOy0r4oDcJ/egBK/LNpEAFcMAAZgUQElMMAvO4jABzTAuIPdJwJOoQ+G8iOVB6CqPy3ogqlAloG4WOArZnkAxazSsS4IRlMcuJiAOEDB0EnFAS14hQAgYBwrGOI8kAFWmkAAgQJAYCUYMBYEMCAB9WAgbiboEwJKCa2hrAQBAPhXUAawPZZcBP8CFwEBCFaCAzgsAQMQkEAutSAIn3VyAThQhA3ghcV4GUV+zuzOMn2ykmnOgBWRqIMb0OAGLEQjARpQ4wMeRsH/MOACYQGQVizAwKgkoAIOaFQCEGYWtagFdfvpCgUfhigOuGUCkEtUFXZxkiLKYQ8BYMEe0HCzECwGCqFAwAZe8CEE+OEIBBhCB2z5Bj9QQAUskIAENsAGJwCgBJ+UwA9ukQIQLCEECyiBswxggyP8CimvpIgAcMWnFBBBfcEKyhFkIJ6g3IuKXJQT3o7qEwGA4BoriEEQTgDVCkSgqmcJIFj8ciiqSKWMF6hA60TQhbngxVMWmIBXYAfH/TBAAV3/2MFadqAOeOygC5tIpFX4qUgNTIAaAaDA85JgigIEoA6nKOIfYnGeXqAiACroRiEAwIRsvCAAZjDEAExgjUEIgAi/+IEAwNAJ2QRiFcXxRdkwwIcq8aAWWYpDJ3TAkQLIoBM/0AirINCI2R2xJEnYhgqyp5Kj5u+Zxo0mTYSykZUMAA0eiMpTMuABDXzAnPb5XForcAHKFUpD/Elc5BKGsLJQjED8iSeBqMKW0PUHLBPbxCyGRwEBMKI2agLADK5BhgCcRCl3GIZiKIATIZgDCgLYAAq4A4dZlISwAUBBOxbBXx4GYBDecAi15isIcqBAeDVAAmOWYNGNCKAP2njB/wB4tyZS5OFecitKdpSqxaTKeCYXwUA6jBAEDZwgCBf4sXbdOaBGwa7IsCsUHRnwqSpcSgQj2IGE8sNAsUwMUnMhzCbesQkOVOGueQlQFQjpTQXQInvVk0ImikIGPdAAAFAohApC0Ict2CYRRSBAFAJhAgNsQQ4F2AAieiAAHHgiuD/4wycJMYhf/mELBlCBLrAwAB1QIwkD2IIhYECtkwzgD3lISgCKaAVL1MCIzCIFcIRHXOOyOifIfYlQhsKS8xxvCkBoggekmoAguOAD89kPWRzwMAH+b3Vr8Qo9M/C6hTVqKgcoy6HQy596pnMsWbFgWxtQhVgMDwMBKAQpDP/woQKoIBlcuAFFAAABJKhiCRsAgXhQUAZR6ICwAChADrRAU8jwdwtQOIL0AlCAFDxBDTrQXlFY4IQx0FAX60BBACYxCTbFLQVLAEMPbJm9IThhCsXsHd2MWmOabHHkLjFPFGHhAVyf4AO51oBZsLKVMoazyON8tloPxgG4tGAEIshAC6qgTvaml2J4QZSyu3zWTQhdcxxwRwusEoERjEIAIC0AFS4h8JxAjwCnGZ66J/Ir4W1gIxLoQFEQYJQCIIAFOAEBsTZwEQKYgHh8cmLPuPOCYWxBapS4QgD8MImLDMEOG1DBJZwgAAOgQgq0m9ura1LcVjsz8ve2JObXM4T/VkxXCTFYgQtI8AGqRk4Bf8SKXqSCqEIpIC4c6084m30VByys5tfeD4MmxKAAskUtGeqCL0zibUSEewNDMEEJAtCJOwSgCGkLwBKyUYIO+CEHajcEIqCPiYNcoRjQUoUQkq+JxvLADDDAySz2KwZG8LAG3OgBEW9QFBvMYAA/8IPbN1ANIQAADF4oii6sAttJz72dnMnJC42ZnHkkBQJUAwOsgAcMSgR+1aLkx1eURVZRUARcgAegyqNMgGDQRQYkwOi0XgtkTltVzMRkiAIAXQtA2Vu1wMi0ADbAlaKMgCtEUu8wgSngBC78Ag2tQjhw0jSQQgD0gDiwgpVoQw0U/8A39EIA0IA5uMEALEEz8IAAEMIueJsjSAJngEMfRKE2sIEAYEE3HEEAEMI6yMALmF8SzIIWZIIYuIEdDEAoAEMd/AENZAIT5AAoiEEpGJjIxQvlFeJPbA+tLRdk5EAbtNzAVBdVoQXlnMVXJADn4EV/AMjquIWy3RzEeIUDaJdZxNx/6Md+eApgNNDDPMAOBN8CtAsbvEIAyAA5IMIAUEEUcMIPJEI6SAAVREIayMECwMIiEIAZHEEezIAucBsbcAEYEAIGlIInQIAuLIEZYEIZFIMQFAEtSMEc3MAnlIIEYMEzZMEcdIAYMAO8gUEfCIAc5AIPUIEkbAEo3AA1CP/CAvwBGIwCGRjAtIzHIB7gTJScAlpSrHDDASiOBvzYQnogPnUFBj6A4rwTWp0FWsSTBTCIDJLgCJxiC7CFIhkI6/FH6ITgDlzMJjjIDvgcYXDAKkzYADCB1g0AGYzCEk0BGHzIGCQBgnFCDSAADywCDAyAE7DBR+QBDwCADfRBCRBAEuSB2wCjAHSAGRTBAHSAHMiAANSAINxAADhBIHTAABjAAMzAHByBLgBRAGxAMnxCHejB0gRADrhCGdDBD7zSydFSnRQi5S3VAk7Ecv0JEJwAkAnbRZ4VfVikA1CQyKhTxJzVWkgKgExZsP0P5PhFwlSZVihbffxHWDDADsT/Aid5Wx2YAlMlAQsQwTHcQi4MAgGwAABUAjF4QicIGAXwADTEQTdgwvlkwiSMgiUQlm2sAyJcQihoXB+kAxlswxVwBwAkQjDgAjqgCB9AHDBcgoMFgBv4AhpIg2w8mCGkwSrcghf1jkBqB0GOXEmQ2AIEAx1dQFUpTlhoRQMYphzF0weIgxFowKRg23xSClz9xWC03gg0AF1QDFVopmayxQh0ATa8wzy4gwhg4l9QQvbY0qtYHSwFy1TykLgR1s3gxPCYGu34UhQJmHVwR0mIBL85UbrhVAAcgTd4AXfMlx3GQgjgxNJEwTR4wb/gj76sBwHKREC+xOTxZfwsk1Fg/wdLKAWMcYcQBMEKqJFFamLlmB7sgAXsjIymVE6ADMhmNpvrrMXkaNVD/odIAptZXFdVtEAwEMt8gQEfwE0RxBkSmAAOLAAYqMLvgIDagAAdkEFKAFYBaAEvdIABdMACAFMolAEB2MBiLEASUEMIrKdicMIhUIAkKYsJqRsFlERjuAIOFAVOlIAmqML55M15kkd61s0VEel5GIDVQYMDcKAawadYDAh+ZA5nClsZceazCVs8WcpWCAZbiMBb0OCArt607cDrWQjHTIAIwAM8/NxgHMAIUEJOxc0WpAJ/HY+alGoJGEUkicT2HIW9oQeeoAd/GcBBZARO9Ev2rCi79v/K23RACPCCDNwmJsWBKkDPrQhACqzCDdhKB/QJS2REdQSP5c0NkrIaFslS8JgESHWASQGW9iABHnwA7XlgOF1bYsIOBjKAtAadOm2mgDxZJqJeXkQKBXEVwqApSSZKGTlKVziFCFwDJ21AaMElDJzDGwgY8BSAKnRCET1EAZhANEgYGPVOIliCCnCHrJpALLxBURhHAIhBJlQWAZQAUjyDI+hUUmBAq0BGTgnAIPjCDHDHAnSABKwCM3iR9MBLFbXJqg5kAuoNFb2JLNHaAqTDAWgAfHgAfNrs5CDdWWmOWAAGSY5MXjjrz9GHsskR0L1FokxKPVnKXGTA5QAGfXT/gTq4xVswwAjQwgm5khekAp50AGwSABagASdBQRIQQAegQf2xAE0VwA9QBgRgAQ0cERLwCQgIwWLMwO8SQA7gSgFEwRJJwAysRwjUgD/iBBUgQxIcBU4YAC14KwYkhQR4ATQEF+0MDxwkwhTZycMeF5EiBUd0bwBwQjnAAiwMwzZ0QzcoiiRuYOwV0OTQ3qJUGVU06FvtwJANxrDF05Rhm+tkYldQzAqSRThdpOI0QDWwHdqNgS/Qzg0QAQw0whGsyS8FAC40QicdxFaCgkUlH0Y0whyEWrvwlyutCUlcT0gtxkpQAAjcW7ScBAoEQx6AkYABWjHAgBcFTwj4Ai7c/0vDrmqrvk+MLdeyGIMDdOD/nOk4TcoIUpAWrxd/IF2DYsMmZMyDNMCE5gdIZoAFOkDoJJtevCAn4kVerCArasJadpIQGJQA3IIzOAQt5ML2NMMoBMAMZANngYE2fI0eWEIAEIEttOMVBIEVDMAamIOslsIkCIAJsAMhHKE11EEAkME5iEEAhAE5mMDNGAALZIEQyJ2+XAEa/E7x8MAt6IBYPgQCZAEZdJgXLTGppm/lEakiCk8B/EEGnMUFOACXcex4VRXlTEz/GmY8JQw/ORmCLNLJDNsn/gfMjpM+VcV40d5itmAGREAC/AIOdxIbGEL2oMAWzIA5YMFaqgQCLP8DKQhAcUiAAPzAJViBsczwH5jB4r0GNeCzJDADRmQCJwAADJQDKwjAE/QoAFBBNqAhZNjAMoyB2WBAKXnBKsDAxNKuH8AzjL3q3dpEE9vNFXnRvc0SAFBANjyAB/xRND9kPIXOQ67eWJRXx6jDPGBMFWCDsiErpIwMWn3FBZgipbSs64FpPDWAYSxM6RrAsNxAIPBBFhxfDkBAClBACpSdCbAAtIgSLokLtSyqBNgABEAArWi0CbzAntiADWwABVjBCwAACyQBEoXAFJiyDCRBCIAAGITAKx3DJuPAvgZAHJBDCawbC4QAAaADSaGADPAQIsSC9nASeRypL89JxMb/ap6Q5SFcgMvFwAn4gD+1IGGQRVVFToH0r32UUZG1zllx5np5YilCzGUaJsS8bH6MYligFwH9QrewkBjQsb2FgAoIwiAYy18JgBXQgQkIp1JoQkJzBwtBgSNAHCeYgkoEQiUAEx3EwUcoAp3pADCgYQ3QggzYUpoEgCC4Ake4RACkQC6IwbJ4XQDQAqwAC5uUtEnnbd3scgHmpU11gDM8ACQK65lGRVJnTkaOxcE0Lj9dygSALl7sgMecFVcQBh3hU1ZwTF4wyFld8QHAxzG3wDIgQAoEQBZoAx4YgyrQQBpIAAXgwhoMQAhc9ADggCRQQQFIQSjggAHIgS3aQDJE/4EgPwMNLAUYmAAGTAEU+AwUJGUIBBoBpAAm1IAEFAEbLAARdMMVUIAckIEWhEAYVBIRRIIo7C47pAEIlIEclAEGkEIqGMAQHMGaB0XwbMdmy0/EBg+IJG0ArMEInIAGxIDokUADkMADrIVUgBPlUNA7tZc7xSc7xRNdVIEInAx2Xdd/jOLCJAzkgEU0lxE3H0wFcEAunAYB6MAorIMZ1AAbWIGAjQInBICM8OwQHAK+GoIqXE8oVMkauELvlAEgVMfbhcRUblIqbQ8AdIRI/ApGmAAlsMIViQJv9AE0JEEBwIAqeCUkCAMAgIA1aXT11K1/x8RJ14kXxcp6bJ0sLf/eOkTACsAnVngiV4FMNPeetU1Zx2zKpeAeg6zkVjxbsZXMzYkzXryeVFgFdLmRB3BADh4sBCxBnQMAJ1SDbAACLdAdJDBCAMCALBgYGAyDDgjAI9DxEXDDFgjAFcDC1xCCLCDLKwCDALxAMRTCgxVDGQQAFYQDFwhAGEBDWp8SFqADGJwDF1CAY3+DLDRCLxCAChAAK2xDHRxDFqgADSDANSQDIARntKT0T2h2n38HFi2eskzLQSTDCMCHy33TWWjxsCXOVx3AVsS9V0COyaApl1VBR07Fzc30Rc79VbQRHU36fZDsyaBKO4lALki1AayBLZzDL2RBJzzDBsxBGpj/AhioAR0MACOsQiQ8Ag04AhnwgCz8AB3IASE0AorQAifMgjFadgFUQi3QbjjwggDMgDFEzQ9ww+xuQRuIAQSEgRcQQC4kAiWggg5QggmkAdC3RhZEwgL4QjIQA/PJTZH697rHyRUVAGDRAA6ggAmEwK24UAcmfsx6BVwgq6iUYnlx1V6cpDvgEWHAxYRk4uRgBccAxIEECgg2SNDgwAGCExQgTJjgwQMHEUa8CiCBggAymQxgILABQQgAAxCYQACgwIIAAhAUCNBhQ4AAFCDMhEAgAIISECQgWOATgk4EBAyEkHCTQgEMHRfwOHQDgoEFGxZg8oOhxAYaIGr8sUJh/0aJGx0IpSHwA0aNHgYKCBggQAAAuXPpyhUgE29evXv59vWrN27dAQQ6FMC4QMChBBo0XGBcIcKDBAkfHmBQ4YGILi0yLFSQIAKDBBMeThBRRQRogQcQOmDQYMJk2BYIErQQm0EED6EPOHB9kIFvBwkjKOBmQOqANJIESCUQRQ+ZUFfw9jkERRiCuzgaOflT5OICN2bGmBHg5dOCAVneEIAgyAuEEnmYFKARZsgAGodeIOhgIgRVnIhkjAAM2KAHRqbwpIajQGCjBjekGGCBmuyqC8MMNdxQw7/44hBEDAcogIBJmjCGHGvI6QYWElyIIQLXGlCAMtEmuLEhykZrSP8BCyzIwMcJfMzgNGxGsIAD2g5iLYGDOmuoAdoMavKgGxliQMcmG9hEDwEooCCAKwwpoCMKMEBggAAMGxHNABYwAM0DCyhgAwB8gsmAAUIYYAAIVBoAAwngpMAAAZRyKaW4CpBCDyIAJZOCRS5xyU0BfgBnC5kQCAAAR07BKYA04ZTgLU4DA+DUkeLykNVWW01VLgLuuguvPDio4IJcNYjxgdUos8zGDIT10ccGYnTNgV4bmFGBGyXyjVcHEmBAtBl9RZK2Ayr4LaLXpmzys9CqIWCBN7kwBAAcVokDg5XisgOcFPAqIIRdmJGJVmZKASFUWSmFYICRhirAp3YNIDT/APdkosCEcPIoAAC8cDlHCpVUMsCSaCLmNFQ+ZXorxJBFpstVvEYGMa4QCoDjBCVIUEIDDxI4IQgXYnwttocYiCiiXweqTcgMcMwxgyrc2UQEKRmorVkoGZoANqZ75EBYqJeNUtgM1NEkgEDDBEWABUJwj+EXBjDgBRQEwAAFqkJ4gSYVUggKhRDiNMA9DJpLYQMQSqKg3AVMIgAFCkCQYAMJ2hogiV2EGJslAA7RRAACJJCJjE5eYAsACEAABBGbCBgACUdkCGCDgAOGdeOSXXcdVi/D0IWZPvwopJBJGhDOAVwjs2w1LEcj7YIKFLLyM8t6j4zKA26EKFlqc5vo/zeIsMT5R9J+Teg1DqgW+oAIGoDGAEEFiEQWAFT4JhIDcECBRC7+2IACHKTCQEEMtorLCUQWkEEFEKgcTlhylwFsgC1nkgnBAGCADqAgYiHIwhEGYAMTlAADW2AFDiTwAxWAgAJQ2AIEkJADgoGggSxAAolYdzIXzuV1L9TQW9ryiAi4QAlGiEEMPgCj4lUAS73pFZaWdZDJUKk2RUxIjyawMxF4DxtdmNHOJpA1oWFJaAVRAJCEJIIWjGAESSIWkDLAAXXQYSZgQgMo0kSGYOAgAHqoBQA6kA1qCGALrWAFAPoAhBsEoBemCMATmqCGAqShHEQIACO4kRFDXCIALP/IBicAUINueEEASziHEAKwBnPIi1M8qAQN8FaoAeTBDETRVA7uwAIChAA5FHCFKjq3AAAs4AilGIKbIIaquayuda8TpofmMqe2mKANI6AWY0DzAcY4Zleh2ZloJqOQMjbgAUur5tI6M63GDOdq2RQIuDKAkMtcIALKS9ZvYFM1iCyrNwfgYrbEBw6MbAoMesAAmAhgg24MIgCwlEkgLBEU7UAAB80o0AIWBww+cGoAN5iCemrwAwpIYApCOJgcdrmBK8xAACgQRRRcIgAT9CIUANABCwcBDhXcMgDy2UUyDPQRAEgCFqaS4U5h6Dqe0iUuIxJAJhIQgxN4AJ0agEz/bh7QAAY0JjQGYUhTefSZnXXreq+5zQGGVIUqdNN5twmabBCCEAU88XscQKsVrbYlYAhAAhIQQBzgwKcoeCIFCChCEaYyhRdghQkmMEAP2DADAjiBCgdKww0wMANWoCAATmBESrSAhrURAgkBKIEZZhCAGSQCBwP4QRb29FcJLCAabgAABjqAKlHEAgUDIBXqYMEFAiAAAZdTAyjQxMIByOIOIKsLXOwyTOP6ZS4EUC7qynGBNsQACD6IgQtOQAISnMCZS5WIt5bIxdpMczhV3dZBsBmRCFQAiLBhSEMm4q1pVcADmFEIkrrZNGpByVoVUEAwFoAwNNRinwQoAAqg/yCFJ6gqAENIgxZQsKkCdCAJkUgsXFVwAy4wQW+NKMfYLBELAoCgG40IwAuuwYgAHKEdYAgAE87BhTyxjQdcGEMJ3BIAFTxBDkiIGJxyoIU0FCBNC5jBFfJAg5X8VIYxRDJd2kIKDwBhhyT4AAl244DiTaQCWvoM1RKQASOOc0oRELOYGwAk2QRNSay5WtMaUkYrYotH7czababVhW8UgAKbwsQkBkABFSxhKEe4gpnAYAUMhCAONzBACpjQkxtEYQEYOMIGCBeFEiAgBTwISg56QAAK/KAEff6B3iiQg6WkYAYFYEIxjmAAHvDCCwCYAyiATIYwQIAHwzhCAGTQiP8pBMARlCDJIMLQgRzsAjwqqMQYZBWwkfwyLrQ67rRNFqvldgAZEThDE4zggxVY97ofOOrNDpDNJVlzvQwxiBLHud3WPAueogFaRKpUTgfsKpuzydoEONACDjhkiQzwQAaCoRRbkoEUBoAAEWqgkkygQgBS6AO/lrALE0DAE0nAySVoagVGdCAAcfAFCJqT5w2YoAMdoEAHEBAoEEoAACagSecSxgkxuMQMjwhADphxOgzAIQ4ByAIX2vUHEQthDSoIwA988UfhLllkSv5pqgTgiCC04gxAMIISpitlEqwgCD4gwYyatK0HeMA10iPvsnCVqwqUWXvc81nUENJUInH/YAQiGEEGxvkzZjVLSEL6TBUe8eCaZKGuAZCDNlIAAFKUQrPIkMQgxYGLACDiGH/MBTEEcAQf9EEAWjgDEwJwCHTAwACl6EUAeFAOTgQACeYgfR3OgQUBjILxKoBCB8hADjV0gwxREAMB4IAKO3SCBYRAARN6IQp0WAEKWpDAHvJgB2KkQBAzIMIunjCMPqjpQnJxNqqoXX7iKldWGyBHBbTedQ94QMrYbQxmlmRua0qpIFebFrWaCqwgWqaMrGe9FIBauotG/o81gMZ5koRKtMQBPIADoMFyIAAAyuAVCGAGmiEQDIALsOAZjkAQ2AEExOAT4iARVKAb1gABGiEJ/wRBDDhhEiAADfygDDwBA5zgFvYkC26BUBABCjqnElihAHrgEaQAAKyAEmoAATLhGQJgEVgBEdJgDMChB4RAF6DgD2RAE+gAAOxADTxBFERBGkqAFQBhCxyBX6DuZKQOyUKlXUjhA7jOBVbgAyBjiC4AuxygISIgV4LDA3hmIrKpAHlHD8GHIIQIXAYw/3pkmgqQe5hGy4xFA8RtAh6BAEqAAgCArgoAAmagDEqAAExABaSCBQQlFI9iA3RgAQiABmiAADCgB1KgBEBgBiSgBLQvKnqACBAAAqSABfoMCygNBZzAI2DgBwxABchAAjrACmZgCVQABWBgAaJAB7ygDv8MgAUwgAWgYAjYQAVmEQPAoAi4gAwIZwBKgA14oA56IKbMROHyhE+Kq/yOCx4HAzkAxRjw0Ae8DbvATcogIzLIrr1mBEiYRnp25lgeoCGYqoiaBFgGYr2WZZqqaZwso6kcsqmgxnmsJHw8YAS4oSdgLhJKgRNrAAOeQBwYoRMOIVQAYBFIIRlyobNsbBYKwRBCJ2BQIRXCwKXeIBhqIABMYQ+UYg8UwcY6wQ4CIAmsQQoKAAu4YQuag0L4YBRCIRQ+5r+0QBY4ycZogRH+4F74BBGEgRVSoV1aSA0zhA1/ytkCABgaIAiCAMou4GqsJSAtsqmypTeEI4iuR80g8jP/hmZGTGMEBtACRAA3godKDAISK+MCPOADVuAAXkEAOgBguOASfmIoyodUyMUAAAAnyOUV88SWDMOBokIllCJg/EQmzgQ0g4IkLscwQAIltkAZwCBiSkoTYMEE8oIKmiANIkY4LWEX4CJhMkkcqMNkaAJiwI+hAkPa5lGYQAWilAsCmmExgmDKToA7SWBXrCwvLWDdqgk4wEkBboaagiOdDrBpbiRmlCWJruQBeIVaJHIidEZatCet7s0ju2FsWosNYmEqymAIOsAGHqgA2OAWEIB+voQC8oANTtNN0gAQQMAAOAZVWKInLtEAQCDA/GRODsZv3EQCHoER0iRUAkAM/3phCdxEwAAAEAQByORqAEQBEmYgTUAlLUdmLZcM2BLAB05gBeJLONIpfPpPIBgASaxqnaonIXqFqwxCZxRgBDZhBJqlWIrIiz7DArqgMLEpqoAmNiTCeXqDDzPAIvZJAMZgD1ouYjDABO7CTwgAJTZltdLkbO5CKtwEA1QCYBDlckIlz0aCUnwiqCJmAP5jAVTAJW6iwgDACZyAXFIgDmDABjDhBQQMCbCgA8DgCIICBNCgbZwAFMuHTmGADAAGAT5T/KQtOqUTL4xT2lbxBaJABl7ABnDgBXLAGjxACXYDvRwju3TjAtyLvPqyd5QlRtSsNXDFqRJAPGekAXJFWf+gZmf6jnuw5Lzg6wE6o9ySRSCuplj40B3SoU8FCAyiwX3IwQxCReEKgBFKAQZWSzswoBYSIWwWQAIIYA0ugV+Qo089zW48wid6YkRHhyX85CYOSBJU7MHQhAxq4QlCJbdkDRVQogMwAACgAA5ugCWmYkd51KfSUiY0AUiRSswcowI0QCJ241cYoIoW0jeeRTjQyzWUp1tGgwN2gO8a0CHxbjImoAUQs9zMLXnCyXjKaWcuYAe4ZgP0hg0gQcBuABFeQAAwIbgkwBPSQABeYBQ0qgd4QSRwgQ0CgAb8IAcGgAgKofGEgA0ogAAiAQy8hBGEAABAIAx+IKQGAQYiThD/EIML4uAcsyAHDKA3DQAUZiEnLlTxxgEG3EQlKCAadG4ZOUUK8KAMBKBO2qIPmoECAuYkSAZWYccANKEVzkEZjqEVjMAbgEAcwm4FhNQF6vD9YgaqeoUiKWM+k+UBiqdXaPYCSMDK0ikiXAO9usUyzitGxAxKnxRamko955M1GMJMm+gC3MEapEIloEAaMAACUoAlzpLk4ILSEjZiBAU0c2tEQECAOLFd/EQuJEBjUYc5EcBCX7FP/GMkUEAT8mAAQABFr0AWdCBsDGUB+KARAGBf70INfAFuny1kQaRHd8ot7iIVEuBX+VCpcAXtIuCokBRmuyk4+BIvtyVJ+U8h/8voSF72qpAkIpiIRlij3PxPeDCDIKYlAnbAIo4iANgADgqFEcYBpAKBGGaCD1hSBs7BsqbgGtKWGiQBAWjgF0RBANjgGgg4GcAhtvYgFSKpGhBhAISgFTAhAKRAGUiPGdZBsKIBGAZABaqhD/A0BFSACtwAA1CUAm6AFZSQTzeACpgATmwiB6DgBzYAUViACpzABsxkLqJtJUb3L4hrFffgA8oBD9rgC5oAMoEgdrvzBDTg3j6gDlcW357FV+aTDz/g/UIDvi5gIkiglWmWV85LWnqn7RzDSBPiW0aYd1jjNgTuBCajArrgGva1JqBgD/Z1Cw6hXCqBFAQgBIihEP8EAAu2gR1V4RRShxIWwcZKYQwKQAuaLgC0IBZUQACE4RIApxMAAQBC4BcCQQBkYBjKNgdk4QpA8ygCAQ0WoAMqRAKOwA9SAAMMmSYWwQsEBUwGoAj8YAYK5STGL4IxZIJlyC1qKAKawAeASANI4AIiAldUGYggQiHFczKEA3evhojSbEaoJnuQp0hvxDeqaVkOsUl9o1nuc6sYYBO+4SIudBA0AQAIRYFToif4+U1CgkxuK9JWIiNWYgPAFwLybCYwwCX6RCk6QBYBRQJQoAMsJ3VKgFQggBNhDgqyQLfWAQLI4o9MABqkIAAGQQs2ZRVKIQTIMIAAIBwm7wecQCX/TAAZyqBSiGtVHhmS+2IAYIDkSOECWuELzmDreMgDqusyVFlanuoEriebJGKIHmI+4Qu74isCNhqUH2BXTPiqJENb0K6ceiNXHGM4gAfNQEPewJVZcBiHLUCNEQBMpgASaoIReqHB8sAPBoAFqKEO1HYUbKAAwOAOFMcO5KAD7oMKBoAHmKEHEMAJeAHk4uANpKIPssBwVeEKBsAEPuEJEMAGFgEJ0DsoAiAQOoETpdoEtsEJ7jZxAmAO9CCmbEAlimAaFIlzIrpDRnbJ3EJWXsEDvuALNKABNCAIxk7gWntXGmA3dgZZlKpXIuN5nIfvekRo6KtqrKSJ+K9JsOr//7ApvgBxWbarIaYFGyziTUKPGi7iCmghBQwgD1KBXIrhD1jvGsYAALJAGiDrFCpBPyChvsXgRhWPDlprFBjhwy4hDrr2G+xWCCaBBQAADADBBDDgDgrEBOwgCQKgEgxhA54hCwaBEXQgGLxAB8KgCBqBBTQhEwaADUQhDbggB8TBC1CAEYog0UKBGxAACcDgCZ7BBmQFVgrbL+5CuQZgEhgACM4g64DAO79uBc7uAy4gAYN3pg8xnbBJ3sLnAkQ5WOnvauQudy/DwhsySnaHSRiT354IaoT2IVrciKZFD8kBBjJWRS3hTVYCYQEgcd7UT9XjltDkoiznTUAAJxKnfP+SogBS4KgF5WwQgAUMhSj8BAFKYQ4AIAW8QA02oAhyYQgwMA+OoETAZgG8oBA6ABPaQQf+LBIALcAFXKIJnKecbTAA4BQ+ILpAWQNmFzS+7e2M5QG2hQ+DFZ1+NwFoHTRcQ0iIheKlpgE1m3eLN8sqwAU0oDJeVrMjoAV0jkQCAA1e4Wy2YBJwoACoABP09Q1IDwV4QQcIYAgOAWAQARcgIARWodWkgBZoYLkpQV7uYBEKAAf2gAsiaRSOQACi4BKSQAAGIRQuLRQszwROgRVeESMeYQ38QBMOTQDcoBfUYB2cICcoIBXMQBAu4SQCoAi2wQ2CIQ5ojhm2YQxg4Qf/EENVfInRAUMm7hHIDGECYiAug0AJXAD+RHnKKkDdJoC0K2MPJSM0BiIBeocxUJj/UBh5HwI0CIKaDkIBqIZanoZHiGRoowQxgaY1QsPKOMAZVKBCVJQPgEwNluFyHsEQEnUa1iAAyCCRAiAZ2MGV+KBLdMAatCAAOCEdwCMRjkEGBIAUfkFvwOEUZgIdupgHrIEVBGAK2mEQCKAQIqEDwEEXqIEUUqAQQMAN2uANlAELiOAIACATGsEUXOEGyAABwiAWAMKPtRkCCgwYACChwoUMGzp8mDCAxIkUK0qEiPHhAIOkPnwhceGDBhIeDozU8GDChAgXHji4ABNmhQgO/xg0yDAig4IEGko2UNAg6E8FRIsCDaqAwQOXDhwwjRChgoYKBxgcuGr1KlMHXTQFILAgABc9BCAUAACCQoEAEChI3CDgosQFYQMYACAAgAGJBuIGWEBhQMECcTfaNYDg74K9BBBsRLAXAwBdmvYSDgADXRazEBz/EbagAOICNS6hIQygw4Axo0IQ2FAghAHECQUIxjvAou7dvC0KRrA4wCQLKz6s8OEjxgoPIns6ELHTQgOnSh2odBDBJYMEO5VGrcogPHaXUMdfPcCdwYSdRhNYENHggNGfKrsn4E70Z4MESxs8qCCCMyVAsIAAV/CxliCdpDAAIn0QQEEYUAhwQ/8jKARQxh0oDMDJFQNIcMsTBAyxxgwDEIGLCQVAgYhBXJQxAASEbAEBDqoksQAObMAAAAYQciFEEkgYoCIOTLzghAklwIAAFkmIMQUISGzwAhM/iIECXgYdlFGXXvamm5de2kbAAHB4YEQFF6yggQYXJOBBBOA1EMEHCWDnlEtT1dSABRnQiV4C4aF31X33KVCfShaolMB54IX3wAUOCHqfo+fR1FQVrwiwAAQBjJGJQaohsBYCCBAgEQZrBQAAqhhIIBgEnhogQViAUSBBAQUsIEFjAQxAQLBfSTTAqV9JAEAAFHiKAARMFHIqqpiFscQGMd51SyACUAACsiwsU0T/AS90oKocgKgqGKpl6WpAaAgVCGa8YPpFETARBHGBBye4cAIJIlFFkwX3WWDBA+VFkEEGDsz0wHZENWpwVOUZekBMKDVaaARALaXUUgpwMMFQRmFlU1VBWZDfAS4dEIEGImRTAl0BuEHMQaHNJgABEmxgFwHJFuApW0GHcBYBIEgkAQYSGSQRCHsFQGpcHUjA11wUpKNHspwKMMYHXhDrcyfDJBsAYYxcsEVcCCQrZttfyjuR2xghhJcpByx3QU8aMODBBQeIULF3KycgFFAMTLpxS4hW5aih+B01AcEi1IcywYxq4EAGjTNeVVPYbeLIh1RnYYoABlBwAwQCLFEG/wAIXCGFBCpkkYIAKaSxlxdiCIABGigUkMIREBjQwbghDIECp0O8UBYSr1JQBAgA2HAEAQYgMUNZQuiAAQUobGDABjd0sBgKPrIga2GywCGsRFGYw0SPq97SiwyswkbAHcsIAH5eeNELN7ht4RWokIQkKlEJYFjjJW5yk8E84IHqiIcBCqiAcUggp8jdCSoREFxQquMS7sTnAW3q2wW2c4AJhJABMZHJx0I2FP0wgCYJAJl8ihIylWHHOA2wRghkVodSnGUBpjIABABAAaVBxmrt6l+wKECqUw2gLwIQgFlyA5hWSWAvpjMAWGCQBMkgQAo/kIAYfsArHGDCBClgQv/MEMCGKwjACkuAgARw4LwajAEEkvlfQuhGN7mJKYAXEaRDqmiAAtSiAW0IwkxI0AAO2EIJ7mFZx5oiMgu0IAP8IVx1nHKAGIqMKItqFHYasAN1dEEBIxABn3CigIbFRyj7Oc8M89SCUGwrMVnQQwAEcIt2mEAAdpAFBEAgizUIAAnniEQAvEAO+71CFgDQwRmygIBCmCMHBshDO1QwgF7oYQAzWIcWAvADaFAhAFRwBhcC4IlrvCAAnbhEAECwDj+IpQ0zCEAibCEDAMyCfTTwBiYgtDM3gKEErmOVCVhBBBVIpIpe4AQGgDWYMRCCaAA4S20IaREA/jIuctAcdi7/cIIEfMAIU2lgvj4wk5jOBD0RIAEJNCCnoxBMZVLxgHUmQKhGfRA7zPmATR1QFQ444CeRapMGPuABBQAuOzZRicnutBSOidA7eVvBCSxgDPL1hQyh0gsIBrCAJSQBAihIAg0I8AIupIAANljCRnIwA6AJIQUIoAAPKGAAFdSRADQoglnKgIRmlQFHywrAHcxBA6jxDwPOEEYAMPA0N/ggCQAowVcI0AtdsMU2AnjDOCRqyNQuBKSqdUiBMnGAYwABpwcYQSs50CirCCo8NsFhKSnYgMNRhzuWW5RRMgAy/UwgYSNoQRV20KcMiKAFE6jU43ZiKca1YA4B2EBiROGV/xKgQAdTAw4RKcA7VXnxmBtoTAfIh9kFbEAFUNwADkwAARjU4HRTwIHRhKCiEEghZi+IgkGeQATwDWFqJUjSAFhQBBRIoAdRWEAIyCCDBdCACGsxgyVqJYMQSKQZjQhACXKQGx40I20swIGnREGMrxikiv8DKW+myE5xGKEJXzhDEJqgBAg6tU0riMAE1HSBCigZPRakScNCaYEdjEBQeatAAqr7gPNgzCoP+EC/SJKdB2D1cC5t000OQJ2fJOA7KsuqU0ToEjWNhAQZyAYIIOCzJZxiLYlohgoAAIk9GGAGzfCEANCgjXV+AhkmGEAt6DAAFYwDEQEgAzI4GwlrsP8gAKGQRQcEAA7uYsAaqChTalTwBDkgQVoLKAEWsnC0vHQgCnk4wgKSFYIbcMENgD2WDjjBg4LYBgCB9F9rIcLaY/8RrQGAgwZWEAMfXGAnDqDuSw5ggUAdapTrkSFTttOAyFkOKEThgAiM2+0DcOAd7mgBB1ow3RGgjNztwUoohbKJUFyWauCFGg2gEILVLOLWdpADAGrwiCgEIAl2gIsqFlEAEzBDBwUYghmIZgU2LGAAcnCCAEowiBpE/A08IIAKnqGCBYChRQWIxBV0FgceAAAFXAgBBWwQYQLUQAcQ2AAWTGCAWMAhAFNYwjOKoANnQKEDUxDDIDZgh190oAf/VIiDFzYAiUdQCAuJ0EGuCmRskdqY2IgJgBhaYYtWGAE5LsjXTT3QpgqQYAJdEG545JSACpRkUPkJWZKtUlUGWPk8aTaJU6VSAYM5wE1KHrKc9oMdm8RHTSgkvJh3EucL1BSS0wgBcAhwBDgArQdIuDMFKPBDFlCABVM0AAZKwAIMbMDCbTHfBjZggtXnbAMY6IBjFhM+Xv0ZDXbwLAU6sQV/xkEirHhEAWggiCiUoACxAEMAwIALT6kBFAGwwihwcE9IICEAuYLAbZTdpWQf23+JAUWb+LVUd0Ml730inFEQ1W38d4cpl3ecyMKdQ0/WKBbwDpsgXbe1Hn5CMPWm/22EkwBV4Aps4RZj4BUCwAq2UAMBYAeQkBqlcAgAgATT4AaVxg0wEACPwAcB8ALtsHxyMA09EAB+sA5ZAg2usEy2cE5WMA1TYCDegAYB8AewUAIGsAt6IAAzQA6sIABT4AJEMADPoAQmCAmzEABS0ARjMAA1QAMFsAufAAylYAAvsAFOsA51MA7PUAI4AABzwA1OoAw9UAM9EE50QAu9oCyowRBVBFLGpheJ4QYhEQQxgEFaESkyoSYJkAEusTENw0J7kxUfxBJxcmX5cW2MAxW9lVVL8QEf8AA+ZVMs4VSS0jBJwSfrYTBXJhRrdnk6pGRwcgIMMA4moDMDYAWQUP8AEnADg3BRZmAGALAByzAGEJAEgHADA+AFldABBVAIWgA8rrAFFBAFl/ADAyAGfCBRuOAK4BMKZhAYqKBMhMAHIHAEkjAFtJAEtBAGAkAJfaAFofAE0iAFL5AJUNALUXAIcGAAp0AIjXALQpAJKSAGqJAGdHADyuIzxBZI6OcQ6qdszAYHDnACPmBlKYFd91FLUFZdV8YBOiEUjxJKRAFUvCVCguIog3IfE7ADO8ABI1Bd2+EnCTNvD2MpLvEALTAKrIJekeAVFKACL3BnNmcqIMAroXFr5ld+5zUbySgBCIACrncXfCUrOkABALAAN2A94gVFACABw9NzweJ5JdD/AbjHk2BpADAAA8vCPWJBBpgxAzCAAyVQCDMgASWwAUQQAqiGADgQBXWJAVJQAwOgAzogA1GAZ3fxEFWkh7qBmMOGF3hRdnHgAB8QBEpwAlnWMPwXZqHEMk7RQSeleVkWFIJSAQ5gXIiyf56zMNnhOPcxQ0uhd31jMEkmE3iXVQ4THhwZmg1TKRGTeCPxALGIABe1BNIwRWYgTwHgCIAgACwwDG8QAEwwCz8QAJwADaxHCYDgi6dwBQHwBJlABDNjCeC0BuFIAI6wBoRBC59wa6wSB6ZwBYAwftvCC3mgBWEgGAGgA69ABq5gBXkBAWGgBYcQBj+TBGYQB47QAwSg/yu3kZAKyRAMmVrG9loV4AIkUAFWsRP8wZnawR0qsVwioDkYgx1RMSn74X8/oUNahjGFogDSJQJY1ScEs4BF0TgoEx8jAAh/sRdx8A3d1SsbsEW9YhauY2qmMjyNgQEIIAECcCoGECMItTaQoRaOQSsFASsdoKCrBxY6UwA+AxwlECyYBaSOQX4IYDoFIA2WoDW3lgQrcE6/QjXAcA65UTaLYQmg4BeoYkcNepiLiZgNEUjN8ikQGYgnQFX7ASnnoQCLEgH9glQGoyYzYROLEh8UtB6LijKCgpo10aEeGjKNwh+fuWZ5k2Q0sR1bsaF/wjkUwx9RcQH+cgET0AwgMP97BBAFhoArC9ABP6QXBUAB1iOoANAZSLQqBeAYhoEYtwYWGxKWICA1SzobibAL4PQXplMLf+AXcWEFs4AEyeIWASAJp2ACc/Ep5JADv9QXBIBZDcqHDhoRhIR+7BcAfFABMdAmEYCo43GZUCFm4TZukMJCMDEVvFUxQoav/lGiaoZCoHqSKpRTnsqA6AEUgjIC+jYbAaAFq3BProIsBDAqRnMWxPMhQzkAKHBErvczKTAXyNJdYdEsntIWOdMuyWIqv9QBe8FsEnGzvxIaf6E0VJkCNlBaYxAYGzADGJACfiADomEDOmAANxAHJWAqP4AEBbAEXlAswOGuC1GzaQD/QUHgAyRwAh/QQWiWJ0shH3TSJo8aFT0hKZZKkkbBKMLlOaC5qOI2bwqbZWhGE1HxZArwKFahJoSiqEUxQkl2Ah5QAbLaKXehA6awAMGilTcrADvDKpHLF2thROpCAALgeWCxRTzjGHHhi3zhRcaaBqjwKkAqAR2wCHfgegugIktwCeO3lPjFCI3QASWgAkP4BHdgAxjAJBAgGTGiEO26tWQTQA2BvGJirAFQChXgA4tnZCoTFWrmHziFoaQYZkuBJ3XrFEVloZhnHYuyKIQbFFVRQ/+BVEJ1XVuWQhrKAZIANWthLr+SBaQQGMsACDtTC3IQAEVgCVgQAFAQDeMK/wquAAAzsAfdygXEYAMBwAiUECyoIAgBwAK1gAVZCAfBhgV0IHN1IAnLwgtsMAAhIAlUIAAvkAg2IIy80C2s4Ew3sAxSgFZ0gQ6ihaUXhQW2MATA8UsD8AkCYjq/AgDB0KO1MkULEXZtg7yiEQBpcAIrALYnEIgoIVwx1UH8UQFBQR2uKhI0gR40aRSH0zKY4zmman/1wZrbER5qkh1O4QB9UxPg9pELs7eFom061DJQdQE9NDy3NgS9gAG31qUQcLMKupVSK4tI+qu8Bxjk06WIMXuFDBYsoCsb0AGu8wJzlRgB8AzOYJWeglbQsAqcshcGwATZQAZ91SoFIAuOYP9iwmIG3jCu/oPLXYIQ/sOnGkFsygs3tXFIDNHLC4Eqe/ABQNBlFToTJ3ChLBFuYmZdh4NCkoKij8IdlRIeEGMdGeAnJuof9fEACrADByCp9kZvgWJLUcEBdgA1YaEFwFA2XDAHssIGfVAAMJAHhmUFycAjWKAItfMJlDYDqACDUiAMF+IHlOAjlWAGAYACk1AEAAADptADAIAG0kADAtAHhhBYqbAIKjgLBkcEvzB+iCANYKkHvIAZ3QAGXZo0G4ALnjAbokMBySAGqhMAISABNhAIUYBe5JcCbvAJUzmEVYQQ58eYxMaHu9yYwqwle1EHK6AEShADLhAELqAB8Rv/MYrLANl2An5zZG0SEisAqyjRZKypqSWDmjCxxa3aMDQxE1EBQRSkFUYFE9gWHX+CVCU5EzBxmVJBEm8yDRQgXwaQA9EAG07gCCogAdQgDAOQArCQBQXMDgr3B+Nws6TAfSWADIUAAFhgDSZoWhIVCrAgGZAQgSqwDq9QNqxiBYQwBBuQqxQABU5QAl9HToUwBKjXLhJwBUzgewRCADBQBkRwa6rFrn/UxMcLzPLi3NFdzIfkKd/wATHQFE62eC+RAV0QkrwVAYKyiSGjuCkUAT6hQxMrKBwzKcQlZtbhADuRMAeQARHQBG/SQelrkVeRvjUxmhkQCLsiGZHwCORX/yAbAAE3MAOdQgMskEg5sAG+yDwFgAIs0FHFmyu/MrMHwSl4Zkekglm70hllARemoitJhCucoqCzodMEAjQIIAiqsBdhoAgVtwdFMAAYYAlZIACDsAy5gQK1UAQIwAtckBu4ME600heNmRd8Slq/zMvGxiUyGwBZcAJGYNUuEANhXRVS4WWKu1RrxkEN9FT+0jeYY0FZlhWgtDGek2R8kgCv6jeHI3ce0GXPoUKnmt1rHB+M0zGHo3k1ga8s9ABm/gDO4BqzFwXGpIx7kFeekAcPRgsq3AOJoAIFwAR+kCVjUAcAkAJmkAQIIASHkAKqrAuFjAl9gGeIUAeXhQmrhv8AO2sCbTDRMuDYAbAGv/B5vRIAytAHqcHTAcALvcApP+BZJbAOSRDEysaYS03Mzx0vgEQ2/5MXIwUR5xcWj/ABLuACcKcxgLIwKCMnTWFBFcBJiXfekmLOnBhcXJwnlIIeTvETVcAAHFAB57s4GcAALmA5K5mIWqZb/UEVI+AKp+OkdVDgAsAIzlDqwBALAoAD1ZAMAYAFQVAIVe4NOgAAk+ALIHgGdWAAiGALNrAAilAM3RMNdAAAMqB0ABAF1aBwkTAOKqwLsCABEjALuoQDsOBMU3ANPyAAYYAOPgIHoTAAP1ANZKDwWkAAxFAIhxAINQAMUYAEhkAFkFAGfSD/DAbwBpowBY9AA45wCwMADITwBndQNnvRmIIh5bw8zH/01FAsByegBEbA7f1yQovnASvAJjPBqf/BHGQd+DFVMVaWFdZbE4xYFRxzKXkdXFCBEkjFSU3RZoq4HjmEQmaMJ7KEVCzEMpqXAMigsmHxA50gAd/ae0pqrEm0lDKQFgYQAohsRzrTLMEOIQjhsc3iOigwVwRwA7/zDNYwLjewBtw0C6RgFleACBBABuwwBJjBBVRgAKTgCwEgA1yQBS8wBUCwBSFwBGCwBI4hSHlBY4dE/kyOkCClK0/uUbfR5E8N1QrRpQCwDvAADyOwA5vQAu7gDgCx4907EermqXu3/2kEhxYHsMl7p64Kth3w6Knrom7TO3jy5MFzpw6byE1VEGLD1oLBuyolOezYMaJkRXjqQmLcIcJClyotMmRoMSJBA3iTAmAwIEDUqQASiHCiUCLJjw4UsLwAEAINjQIzwGwQsKQIhA5oZBSQwWZDAR5MJGBQI4XABjNRCuBYk0IAkUUqCDgpBAECIjcAJHyyIuCGIhQGoPyhQMBPoQA4XCEZgMAABEGM3lAOIACJJCfCmIQG0EfXEmE2AgAwoAgRok8FILweAEB3gQIEBAgYQED3bwACdAMoUPw4gNwCCBgIQOgDECNBYpDQcKFChQsaSJy4EKF7hAMOxGvw8MGDhv/sDtwneED+wPwDDeBHcJBgaAIFChIwOECBCQ6IQEAFGHCAAQYUsCADBRx4oAEGEqCvv/4OUBBDBB9IkD8LCDRPvAsuYOCcDQKAAIAeIIFAAFZ2qaEAQ1IRAId01AiAimOuAGAObVIo4Bc+AtDBCFYCcOOMHgrgpBwZBJDkGhYA6OWRADZoh44ApHiGAkK0IUQZJ4pYwoBoACFFDwy4KKEMZbTohhUroBDAklWAIWaBLTbAxZs+xrmBgOSMW67Q5YATwAAJEBigAEIBSJFRAoQbILfiAsA0U003xdQA3wgIABErAlgAgeNsQ6CAAX7DFDjmmAsAgU9CCUWROSSZYxn/WmhxZJVUyunkFD742AMSPoB5xRQ49AAFkkwgicWSTqKRxpc9apkllk588aUTWXLZpRputonmmgugmcaYdM05phxllNFGmyB8iCEGI1qxRRlvbDlGHGXM0UaZccxx4RQDNBMgEqYKwBSEBYJDYIMOAFgAABQrFgCBBRiuOICJQZXAABA2mBQ6DASIFWEIVn1tgdCE6zQ4AiiADgEUGJYgBEHBaooASFIhIEXoyjhji1hDC2CZbpBiDgEBUnHEYoudCyGp4ShYIFHDHCUgN69Jdm64V4cjIFVcSPhCiRg++ECDCiJ4gIEHKvBAO/bchvCAtyPgjrwJLBDwgAc4mECB//ossGCCBhZvoD8OCB9qhJj4K5xyh0TYpIUJHjewvwkKl5DCA/TTj0EORqgigwMmEKEB+jgYh4ICNjBgRQQCAMORFABghYsCJFikDAFkiAOFAIrAhGQuhAgBhEhuQEAGTEqAQIY0ZIeij+fY+AEBCZb4gQAUiCggBzR6YMWEJ2ZYQIsttnACgxoWwAATFdzIQYUSBtiihx+WSAEWKKACIehAChoDgG8MtUDmDMBjIOCN03QzAAosCgKawQDNHGUxTnUwUyhzIABq4QWKda1RBUCAZgygKhbyhje5YdimUBYalFHAF0TgINKA48LnGGABEFjAAiRQgMjABgG3EUBvAv/AG+MIoAa96MAGpJiCDqBABTZQARVZgAMY3EAGOKABDGSQRRWwAAUhCAEGNjCEGnRAiAHAxCmAoxkEZLCOXcMac4hYlUWtUAIrG4AbUySAW/zBNhSQnQQ64BsJVJCJ3gvZAp5zqRUOQALBgc3GEACHKxQgBEFcABm8gAAKeG8ANlDFDVCYKgxcgRAL6EAB/PgGLWTmjhAABhlwQwAJBEA4GDBBADxVqTmqAAKDWlVxmlM239yiBS74QN4alwEOJO5CChhBSiYwgi5goyWbGMk73OFNeFggATrRCFBGkAHUdWEHXeBJS0bijnfE4yLvmEc8QrKJHWwEc1VYCX9eQk3/DmADHhRxxw5achCJbAIe88AG4ibgAAw5IAPHgMEPBZCDUlyyOEgxjgRKIMwUksoADhTAWwiAgdsUoAMYQNEAUAACAJwsAJkh1R8xBYBFIAMFFjOBACAQDEpAJ4ZgCAIVLMYwBPDBEr5sUQDUkI0jaGoBBqCYpRhYqOQccwinIVSjfNnLmxJAkpfyoAcB6UBNSCFWTayULJ+TzEbVVVXIEZQPL8jMg1EABesQgmAkMNgUmCAEGwBBB0DQPKwtgAKCeYIMMICCH4AgBVJ4Sw1AMNisEQEdGUwBZakYxQxKQGIbwEAHRIoEKUBgswP4ISJpRkopIgAXlxgAEH9YgIcl/5Fif3wY2TQTNMc6FgIUsBgq5iCA4v5OAkE0QAdOeLsBRPeHuVmiAQyAFJJBAI8L6AQaUvowCmBKkc994+wwEJwSMKy9k3pOdlO6FgjE4jQTVMEkqjEFHYBiD6pw1XBWxSjlFCoAURiFBIqwhkKwYhByUAMnEOEHRMiBEH2YzRv60IdB1IENaiAEId6ACz/4ARdvUIMcONwIbmjBwoRAhBYGoQUtqAERn2FFFjARYUJkgRWM4MQiFvGMPhRiECB+hhpYIYcxQIISkXgDIsaQBjAQAhd9YIMZgFyIW3Cix5FIMSbYMGU3cIELYhiDHEyw0gDkYBclSFV15UpE2iWnbP/addoKZYlCl2XMN2agRG4wgIGS7dV7BJBBFAi9gcEOQAc5gEAIBgsBE1BluxQEgBwgQcSDwZIFgl1hcIVTqEct8ISLAMZOHXiEUeCAAmL4gxQGAILX5DCtmxLUEGnwhzKY4KWPRUDXfrPDV7Fshi8rFVkOW0rNgGAYWJjgDJPoqbsiCmUAQEAUg1gCNaoAtSqQZKUCIIRSnEySLgMV0jxom53eNTgbo2sBprCKVqlbhse+9aYW4Qd8a6rft/430gCwByrYO+Cv+WCmJhjDTYUQElF4DcpwEQ5BoKIPlHDFOaw24Kx5VDmPCsAQduHGfG8qgZrBrgwz5cAyoCOumqr/btd4Y1bdHvGq0MFUcGLIcAGcYhGxqimjyEJr6iYFBS7DNqN4+1yk4QxIBLDCLOB8zOpqjFIvBM7BSGlnQcHXVMnxAy2EKZzkNGpSvemaL1WF5yQGW7vOmTbNAcAEUtT0pGm/NKt4I8xVeSqBlSpbMofDKkYI46YoQ0ExYoEKIuSiFqWA8wZLviklosAUPijHNNJxDWhAIxjDKMYuhpGLXAxjG8FABzfQEYxt5OIXluBDMYbxC3BkwxnnOEc21lGMXChhHcG4xurDYQxysMsZ1mhGNToPC24Efx3mUEY6tqEMa5BDHE3Agze0cXtyWMMYFyhGMIyRjV/0gh3WkIW2/yxhCWIY4hJ60MQrviEMYFBCD5mAAxxS8Yj5u0K5ulgDUJiFT0CFSrCDRrgDXaEGSniF/COFV3AEYaCEZZgDRcCVZViF//OERBCETzCEVyiENwiFQOAFZjCDZ1CFPFiDREgEM1AFXMiDRfiEFyQEOWCDOnCDK/CCKVgCKpCCJTgCLPACWTCDKZiCMoCCOhgDKCgDJ6ACIHwCIsiBIjiCJDiCI4jCIegBHuABHdCBKIiCHOgBHeABGrABUsAEFrgqEBgCGIgEYbiFONAEc7iNZPKh4Bi2CSoOlHmBaFCBWBE33KgUH/INYeqN2JIk3gKiCxouAoglLugGjakYRXSsx/9aFFISLMEwlccqFb1qmgpyoFNIhEQZLEEBgA7ogUGjgOYhABqQgMC7q93QLkfJGLLiAV9wmfVSuYA7OIQLgCxQhHpTOYAzOH9DmiVgioQTRmL0IJSZITc4hCWalBz4hAWAhDfwBCYQh83qGlubvEo5JiTIBDVwAjFwAidAQigggzoQhTjgAjeIA1FgAzawsDe4hUQoBEwQhUIghA8LQVwQMjNYhGn4A0LwA0G4gwNshEYQhEBoBF2oBAoMBWo4hUeghTkIhW8gBUBYBT24g0QIg0b4g1WgBeWiA29IBU3wrz2IPT7IBJYkhmLYBnSAhdWDhWZYB2MYBmjgBmnwFln/mIVwAAdoqIZ1kIZrcAb2KwVpiIZOuIRaMIQ9uIRMuIRTEAYMdARNcAVaoAM90INveIVHOAVmMQRNuAZpgIRhuAQ6gAOoNIVa8AVZiIZYkMvQ+wW0NAU+KIVOiAVp8MtoyIVO6IRZ+IVisARygARiEMxeiIVZmAXe24VggAZYqIZqmAZ2SAdjQIfTA4dwiIZh4IZ0WAecXAfka4ZMcAZusAQWsBkCKIF00IJPGIVOIAUJspQA0ypnFCYxkIYtyIEcmAEYmAEZ2EIemAEcsAEbmIEZeIESKAEVQIEXaM4UgAEuTM4XwAEZmAEamAEuGAYioAEZ+CIZuIEyxIEbUAEc/yCCKPiBIYiCIUCCHpCBGkCC/JGBNnRPIWjPG5gBQ6AFG+iBG/iBKNABFqABIaiBIfiBGpgBLPBBIaCCKeCCNOACNNDBLSgDUXADL9iCJRACKFCDS6gDJhADLGACNECESmDIEkwGQZgDO7gFM2CGMAgDFgyDQFAEhjTBP7CDTJCGZEiGQLCDUXCFWpkDV8CVhJyDOziEQKAFV6gERWAEVkgGatADanjSUKCFb0gFUNAEQ2gGO6ADWpAESQCGNNGEb6CDVDAFUiCFU+BSODgFCKQGQOCVP0CF+gOGPRWGb3AFQ7CGS4iDBMKUCtSCQFgFWUABkJu8TGmR5AgAX0CCo//5oH77N93cKZQRlGNDAGlwDU0pxMPLOXVjlZyDmYQLDgfKgViggLDpjUZBoEoCvHB7jhTCqgQalI05qzQAhN9wIEGxt3rTzSRiFUsNAE/whLeStlYZNhrKtwQ6Kd7CACGahIJ7IT0yq9hqJAwYLNQqFdMCARMwgec0ARVQgReggReQAR2YhEjAgeeCgB9IAkwYBTMwgiK4BFo7DkJBlH3dqR6ohjOQhXQIhqJkh2kYh3Iwh3a4BnBohmloB3QIB2twhmwYh3ZIh3aYhmxgB3LoBlhYh2kgh3UQzQgIBmtABmQ4h3HAAyXAA2SwBVvIPnIoB2QwAlsQh2N4l3bwBmf/QAZn6AZlwJc20IZ2WAcGqABnOAYX0IB5sQUgcIE2aAOX1QZ8kVk8UIZjaIIzaAUgwL4zOAMfOAMXwFogyIYLuAZlaAdywD1omAXSy4VikAZZ2EtpiIVS8AXYg4NJeL9LMIWohINQmIR0MIVM6IRwwL+9JQVXcAVq+AbHfYVTSMlHIAU4UJZXoASOFAZHeAU9cAVdWIVLmARYUARKyMBl2Mo70IU7+INAAFJBOASIHAVJYEhdUARUoAReqARaCAQ/MAMzEAQ7UIM7MAVCQALY6A05QIU0aIJBAAQq0KpG/SCvgYA9kAKhKpsUEgzmCKKSUaGDWQsDCIESUJRgkxgM/wCBFHkBS6CBDXgYA2A0lOFW4xC3a/NXSAkOUBvEDhi3ckuihHPGZV3GTFU3ClqAqhEALTA8CqoaWzoYVYQArJKlCnosA7BEzcAaB6IFQVgi1VqhUjo78AWAtcgN7xKOoLmzrMMqUpKAYPCCJWoU5Ig4wIvWujqpValfYtUUixkAYqACASiBXvqEWZiDV1CFalAFaECiwdvDUsOUmUECOPgBGMjO4dxOGKiBGiBDHhiCHHjPJ/iB8syBIRCCJ+gBIjgCKfiBHyCCH4gsRKiGHLiBHtjCISCCO56BKCgCKSACHiACIZiCH8gBIWCtIkiCMriCJxQCKUQCKnwBUpAEG/8YAizQQisQgiT4zSewAiaQgh+UAiZIAvmUgRdITxh4ARYIAejcThxAgSO4hBu4ARt4gRp4gUI8Nvut1Bzqt0IQuwAIASfglEtxoCViuGC9KWMMACa4BHsb5kstuWvzNzTQEhm2gUq4AT4YA2Sggli43uaQXkwpIo1BAhvgDayKqxdytwnymkGkA9WMhl4gBnCQzHWAhT2YhRXYBnAYyuZLB3QAh24IB8LMBVkgBmKpBT5gzGgoBmLAW0sIBm4IB0sgBcPNBWLYhQ/gg0uIBUPQg1PQBGBwBGDgSDpYwALUhUPgBU/ghYa8gzDwBF0YhUqohDKApdvg5QAAAbOC3zr/wlWryy1F2a4hyl5IUSz4wgU14K2DGYAMkqQNCDaz6gAMZimvORhP8SE9i4znmgQuqJSrsqRJaqQ/QjnY+p1UFRQUajvgOKsUMIY4CA0JUIxr8IEiGIJxMAI7sJTcSDvcOJVifYFryAEADtYA5ruG26lNSREr6ATkoDbtAhXYUjiUuuVjLlaDu4Q+IOBhHWyFE8ZbFoBSKgAhMAWYCoESThWriRWc+Q2GCZqTgiXYMCtaS4ReCAAU2IBZi+AfEqLGephIQ6GVmSFsMy2LASJWwQRYeK3UogDVygrv2qFK2Q1Vge66YhQa+h0B8ANSCA1HMYBYuABqMIF1qIBOOGvd//jmJdoNDtI5RIkr6M7D3Yi7XDgAF+gODxiKCfgJEeCACKgCAREB1dmcakqQFuiCFmiQFtiBkdgEd3IAJdgJEYgHfJCHKuCJHaCmLsgAeFCIERgBEegCeXAH1OHwEW+BElcobHCHediBBtDvCbiHUTCrVn0DetMYUinEFzoY2HDs7DprVUEAnXGO21kiuKYYnFvu6sqaumIOCIApUhGriUER7yIVRou0VvUhizGr0HDfGhpmSRImKfcuB8I0odoAHQALHkYAGqgB73qBGyCZ4QgALpwt+s3NAKABX6iBDegBIWCCI4gCJADDKDiCIniC+syBGugBG2ABE0AB4RROK/+AAQpIAR2wAiwgAyZQBWJAgyacAia4gktngiKgQibYAhItgzQgAzEQgy24AkxgAidAg/cBAzCAAjCgMjGIhkcYAzXAAkzIgjgQAy7IAhpjA07QsA0TsZTeN0ZQhTVYAzNYg1vIA5ZKFSGQhRe4KlIyFWj1I5TpDeBgM5zO7WktGwhgAkwIgeU+JuyV9EdIhD9CBRz5gVLAgikYBlPYA6qMBVKQgURYBAEAAUqQd0Iwq0EgBhYoAe7tpSZajuZYDheC7t2gnynQJeKIc1UgHypghSOoKYv/Zn49lOPQqgLb1z1MIAIghhg4gyYwguo4Ae7wgLppm+yA+Q/gDh+Apgj/4A8CuYAEGJALUI8VOAZuwAMPOIEH+I/wSAAL8AkOyAC4MY/wEBz2iICqTxAFiRv9iBsHqAC56flbAPiReoZAAwA3CIOucQU7CIAUCAc2EIAkuIYlAABcIIYQAIBTWIMc6YQiCIA3OAUbIIAsCIOISYY4GAAWaIQeGDcpLgAy4AMYAIA3EIZgowZRCIAZEIYiAIAksIMXEAAncIX0XYQsGIAbqATFPwJeKAECqANVMCtcwIQCSIFEoIICGIJK0IECoAFKoIEAQIJFiAwmCAOk6ICkMI7XqPHM8JT1Go7USo6SP5QFsAtRUIawVQIgAIIgOAH0IAEXsI4gOIMY+AIj/8ADPIiBEziBM6iAGPCGNiABro+PFeCAxnEdBnB6wEEcBriAEyABgHhgIUOCBw40XGhQgcEBhAo4cBDRYkQDERo0ZFDQwkKDCxc0MGhQ8MAEETsSJMAmIkMGC1U2ZeBQRcQ0HCEwFLCyC4aAAAIKFAAAYIABoQAQmBggAEOHAgNSYBAwAMcGCRtsIOiAYAGFEhCIIiBAYMuxZJKODfvwJUwJdqzkcMjQJcMDg8SOnaCkAlaoBSYCdEAVyxE7FTxoIADxA4IAoY2NQh4K4PEAoUQpVG5cGUCBAAggEOhpILTQAKZPo05tOjLr1q0F/CSAwNeKJkqCxPCxosIFDxV+A////fHjiRMaIqBUcICBAgsNFzKI4azJgQcRIlT4UOFAApMESTZg4KCChgfcIzxI0GD9+gQH3r+3zltEIMAGAjxb9jMOnaascBEAgiBLBMDDKD0QUIckJRBwBysF/EDHDwhoQQkGEHwiSQESOJIIADlEE0UBW5AiQwBjhCiAKq9AAAEonAwQxTBxDMBFMDngJwsLAPSiCwBPTOOFAJgEQ4MAj0hDQAG9pBJAD9rcIoAT7UwRgBTI/DDAINPAEEAY14TAGWsGGDAAAlsFNRRsAxRwJgGuFUBAAADE8YALuhlE0ggPkPCBBxrE4AFHEzSAXgMcPOBBRBZwcEAEO4xwQAb/BzSggALquceAeg/0pp17E3BgwaURWFoXdwqAygGhDGF3gAN1MRCrrK8eoNwF2D2AUHqOXkBCAueYAAAEBQzxiwoBMPEHDgLY0UkAGIBjRgA5XJNEAGBAY+QpmgSAQjB5BAAFOkUEgMk5TwQgyS40wIIJJ82Iksk3aoxxjRJAQOJDNewo8UEQPijhwjhHwGGdN0YgU04xMKTzRyWQaCFBLq4EgIU3ZczpmmOoNaZZAT997BgAsglFZplFlaaayqdp3HJkUjW2gAS+kKCEDy6sEAMJDkRwgUEROBC00Axc4KcGFZhq6QQPKQB0QRo0QKirvR1tHqMTuGeBBRNYkIAD//FVIEIVFtRVNnxg85ZBGAFUFYAfdCwFgQEdEIBCCVulgIIKC/AtwX0bbOATBQsAEAIEpmGAgZwmgEBUAVwZ8BkBEEigpARhAXXfAAvcBwAGplUOQAASdCZAWAEMsDkBBiyAAAASDFtACAhQIPdpLY48Wmz3tYiAUkYNQIEEryu5+poCELDZZpBp9noBaBR35wcxrEDCnx786a8HE3hwwUFQM+AcAxF8sOlDI+ygwAOxJqBAeBGAlwBD6q3qwAW/Ae0q0rFaHZf6JFlHaEKLgKYa4JzjmMdUmHpABTjQBhpEDgA16IUJBOCGXrBgAVCQAwZe4IcrQOAFtxiCAIawiP8QGKAQYxDABhDxgwC8oBAyMMANFiGDBZSBExCowx5SIQoBFCEQewBFBSohihMkQBWImMAFcOOCO1nCHI/oQTcesAonsKIXc6DABszQCytMYQgFAMEYXiAVybyGY0YRAGgIQIHJSIYoBODbBjCwANSlbGUqcxkf17ghCPjCX9TrkwNQ4gBZIfI9HfGN0G6lgBG0AFQTYMADmtOcSQXtOijBlEiSwygRcER+dRkBTChptrPJ5wItYEYAIBCVRTyiJ7f4BQUEMItawLANuABBFtrAhACEwhmBi0WTqNAOAuWhGTQIwCtigQAMoAMVAojCL8QgACoUYwgDqEO2AHAHaPj/TRqeEAALmpGGAESiGjwYACFqYQIOJaMARJjEEgQQh1rMAAC3mEMBNkAJRhQAB5CQQwCQYIohGCAJj7BCAApBChUMIAuU2IDcEPAYxzRmTk6xzBqlkrzIZIYAHQgAGzxwgg+4wDjo6dkHjOaCCkzABSRgwAmUUIGOvOdrEziIB0gingrgKgMTyFUh2xceDXigkJT8TV0SEMlDqkdTE8iACNSXALIJUIDzc86tzGNKQyUgAiJgBwhEigEcGAIErPMMBRAgAa5syAQoQMECAnQDCmAgBDZ4kwxAIIAOvIACBoCACTCA1xC8gBSj0EEBeLALUmABCblgwBx4wA0gVOME/yto6QoSAAQewEEJpfjBNowQDVCMoQApqEQusNABKCBhACywAgjipKQ+Mm8omYmMU1InlDcZRY8rwy1xlxSBm510O80JzwQmKZ6mTvI3lERP+5prSfM8JANfi8DRQhITUcEHJZSywErAGxIFsARrmzxbdbBzgR0swjMSCAAvHDG6LTAiBQQoQhKeKQYhEEAFbGBBAZKghQ0UoA5XWAAK3nADA2DhFikYQCQKYQAK3MINAEjBKJBAwzDQAABJsIMJDMCEPHSgBIkQRQEoYAchFEAKlLDBAtIgjLYCgpVDMEQRBLAFVBgpDIFAQAHu8AlyTgITACBCKYRkhVI8QQCiMP8Eg8xwirZudI1xRONkLqrl1hTgPlmIAM4+QIILuCc7KyhOcTzwgEJ95AM++8h1XGUQhiyHVtxRFa8KaZD3aQol4rFfBFSlKVSxp1LVScAErhM0gwAVO69SX1enZtLy9IwD2lDB6gbwAl/8BRPboPEl0PHMcwAjAFY4BhYCwAofGKkUvQgACJCRiABMoQmtHoQvA6CJbNiADNegxiCUkYwS0NoYrfDGOaaBB3XQlGoHUAIMJDGCNriAHMYwBxk6wQVf9IIGAbKGfWVQjkgEQElpIu4AMnbG18BsMkoR7h6Jy8efyKICJ0VIV+WHnAYI7c7uqY5IHjABilxHJMuhlHL/xMMA3jBnAjtowfrUYyn0ZoAiJGlaxbVmKUWHt70O2MEaBCCzACRDPxTojN8g4LvhsRABcwrLXwP3usNRYKSt/NzrSPcsmQvAcJ6RE+paTGSZA4BvAVjABibTgQ30hHOwWcDhBkA5+TpOAj2RQLsrMyfOSQYEFlUcUJS0gKD8zrdc3m1rKuP2jqUbnf7yQQyM85s/XYQ42jnAR7J3Ag+gxyB3/vgkv6aejDRg4QO/lHXWxxBWOcB9ZdtVTpFGKaB6xDzjqVqtOAW/gkj7ABXwQALwQAMJCPYFskgBAAqhh7tRgQsQCAEmmFCAEogCB/IUxfDQsIV+gqEHAigBGyCo/4MxqKADVChDCrpBiVd0YhAFgAAZpqEEJyAiHp5IQhtclT30rMABgUCCDxwhBmOUAhG98AURQsCEDgyBBW89gglsu+57A+/duV2el+mtGnu7TGUQwCxkh2+MXvdch0dknqw0XtRYCnlFCvu8h/xUx5txhCKpT3MhTSfRD3mJR+JVgMWpSqVYCgWu16uMwK1BQC2FgSS00segnpx0QG0FAAWYhgEMz9LZYLrJyQKEwB2xzmR8RbpRXQCUyZvUlWkgQJkAgAGEQNQRxQIMQPK4Uk8QwPCIhevMiZxggAnUFQWI3YWpju9YVOSwSZilW1sNhVt9jP7pHxwtDxxxlBwaxf/HjMHcVU/RWA/QZBLgAU3P/AagaIcCjM+jeVVBmAf9LE3UNIRAXIqr8MzQIA3WAI1BDFxYHcervIqptJf3MIRyrE+lhNVCTBJCRAAyzMAcCQAOzAIKWRTtpI7LIU5TSKHorI7oxIkVis6ZKMUV9kQJeIEsjIIYwMInmIExuMAcvEA1tIM3EIEWoNQJeMRJnQMfoEAmkAMDZAEBuEE2eAEd6EIfNAMPoE7rGGGcAAUAzqGWxWEc5pH/rYY6vsZkIMAvaMCadQ/2VMCrRAD2/Jt4sU94HAoHqM96eBV3iJ5ULQ3WcIp5oEcitc/WcMAOEGRLDMTSfNzAvcdPVUALrE3/i6CcIqSbDiyBkpRBHUwOJhyBAcxAMtDAABxBxAyAFjgBANgAFCBGDUxB6+iADlBODtwAAtAAE6wcCFxB4HTAFoAAAAyBEEyhFbwABoDAEoTAAGAAEmwAg/0ABmzADKiABJRADswOBdAAY7AAC3zGDUwYS5YA6+iAYGFACrROCJQYBHBFWIhO6rwb/0mGl7WdyJxJAGSBSZEACSBEDLjA0QBHBDSAebjKdeBPIa2H+7gHz/zh16wHpXCNchxSe0zXrexjWDnAqshKeFnHcDgenoUc+7hPpdAF0iRAbwCVM7yA6qiALNSfnGRhAGxIDaLAfQDGfAFAB9wRcfKmWvkE/9LhhE+YhgyYwA7BgR6oAS6Uwy3wAATYghhkwQU0wQmMjwWIAxYUgyY4gQQMwxuYxgsEgA38gSVwQuAsRWhE0BT+JUjB4ZqwBmVc1GPAI2rII5z8RC40UUp1zz4yxPc4QKIRSkHYD0lYACU11/qE1wTkWUgM1dFA1XMJHsOVRBeMgMclXq2Q4ATmWc+cADY0wtLJHC/YgWmMwjV0xjIIQwDcADuoAQAwgTFsQQAswjBUUCxQQgBcATJQAY+KQwkIACn8ggGUQDO4IBK0gRQIABOIA0PhwjjMQAA8QiksAAaQwyEQwBRoQ5XIARAMAQI4wjRoRTdMggBggS1EggDcQv854ICWGsLoXEOQ4sA1gIsX6GgAPIE4eEEAmAEy1AAwSUNdvaHIrCNkKIVfQsaz8IAAcAEQ3AZyndSt9MYhHehjVpxQuUp1LY1QuQ8lUUp4MNqkgEdIJJ570dljbqbSLId7GBJvXMd1mEfUiIq/UUoFpg9s1tkBaMNLfkYJ9AKSysAPJI8bvEFYcAITAAAIJMIMFEAR3EJVekEWjEYWYIEBsAAi2EAJ7dIAFIEfdEAfoMAQ2IEhuMIn8IEmlEMG7AEYeIMiSEIFkIAP+IBJPQAqZMMEtIMWQMM3vMEzBMAgwAEcfMMjqAAhaJgN5IEOWAYTqqM7vkxr9CfL/OfLGMD/T5TCChiBziCEgeaKR2jAq5QmfFwEAzTXCHRB+xDi/WgKQ1RcR7gAmrWE/NiPz3AHwO0Ky1IieLQmdxQEdtwjNvzB0t0HL+jC0qXADMhNW8nNV+zVnBQFrW1Ax2rh053d5GwACKgVCHTAheWAVUhADoxGDfxAVdIADEwfD7yAAWyADjRdCTyB38wADFAAAdwAVZgADKAAAsAAFRjOEOQA8hRBFPyVGBCYCWxBCdikFnSAAPAAF9RREkDByg3LxrKGUrQbAqDAtTQBEFhqDHzA0QAN9mgK/HiPR3wNelHa10xgomHKJm3SJw5ERhANAlnNqG4NqljKCBzSpYTHeNzP/z5iJmW6SkgMWiTFikg0QEsYAQ/MkQSEQCeEQAAIgjLowACkQi880y40bQ5YQ00mAjewAAG8wisIAAWgwycUFDgUaRrAwg14CSTgADCMwhzAwRAsgyKsQR4gQy9MAjZwwCsQER6MrqUqwy3IwjVoAtDEwis8AiXIghagQSokAlr5SA/swo4OBXBxLnFlbDyOsFQIYDF4ABCI7P1sYnDgj+XBB3aFynmQCgN0z+Q97wF4wExdldY05p9sZJ8xREkM1akGr6g05gCJgCA8S8euQYuerRNghhtgAgKEQBgIAQDIADOkQAGUwSFAwAawghsggA0QAgtQABLIQf1NgRi0Sf8cOEGLlYHu4UAa4AABwEAWsF4ODEJtRQIVAAAFcAELdAAMcEEIgEAUkMGwWEESGEAKTAGN1YAXDMsWCMESIoEOyMYWrNMCSIHW0UAOfDEL3C0E2IBPLsCicu5j8GcdBEEs68ZwjOxCWAfRMNDIkkpBLMQMJ1VJtASqNFdzdQ2HcgQDNRWq5K7WaI1QcQA2SNXCQaLglQ3PJKJADkRrSk2sWAAQyMAVFoAJ+ILuoYAO2BEEcMabgMAGCFYrlaHiHMUXbsDqFIAKJJ1hHQ4CfMI2ZMHHMMMo0IIkAMEkXMEbKIMepEIE9IsHBIo2eIIx7AIX1IEzdAIhvMKMBUAS8IH/MISusEwhaKCOCEPqCLNGCWfMCLtdKzVDAwCBDxhm1fBPIymg7L7HJcWFe7RmorSuAHHH0WhXCK6K08BH0Iho9D4oCV5c4lGSAInA2myAzC3CHPREJVwDm1CCHhTAMqpBAJQBMjiBAPTBOKTABswCHFTMOVwBAOjCOAxBAJzCLshWOUjLFLgAGAQAFRzDL8WBD4gBMFUDk57BHAAADNjCGKCTEZAQKnhDCBDANtxpGTQAGwSAKjQBOfIBNNBOOdBBAKhAK6ToFSjBFQipEZBLIpgDslGCMWDGsIz0fwrgZIQLELjAIPVwDNQd/Dwc664Ub4Tg44UXmV3AI4ESMxO3/1KHIoO+xzBLyqRMFUtERAsQ79nEynKoJgOhx0ZeUnNVygX8nXd+gbi1DgrMggwElBi0ZSHYQQdIgCsUggDMQC2UJBRMghndwih4jjCwQQE8QS1gAQFQQSYQQQGwASigAC+kwhZQQC2UghOYhiXEAzjMgTeMzdFMAAk0wAdkQwBUgj6IwB8gAzyYAzNUAg2wQil4wrNAgh1MBSRAq1PcH0m7jEnDuFSsMgLMQgyErGG6MJ5Ntw6fTXNsTShNhAI4ACPdj0fsI68wEGZ2kjQvXKWEB3lZHKIlIoMKDQcsQvseDi+MwlKAAFYMclUQgOEYTgqUiVQKz9MhYYvlXAHEZf/9ZXX9SQAPYMAU1gBQzO1ovAAMNCERmBEB0LnJ4cAYQ8A363EULCFtOSEPzLMM3MDZ/UBQQgASPDoK0B8AmAAUkA4LwFgAyEASHM7ZwXhHhYWckIEPoNSaucC9NAEJIMd4ENCtFNx48Dh8NKanLA0n0e7U9HJOSWZYRUTFedKlqOYEblIAWUf3oOx6DAQoJR6kRcAEtAJWPJO3HKoafIEUaHgmtJUpLMJgG0KVxEEp3IAAhIEjDEAHnIJhH4Ep/BITTEIPAIAcgAIM0IEe0MEl0MKh1sAcXMAj+ME77IEfGEECSKMF4ME9GoIzSAMrGMEsyIE4uIId8AE1oMFSYID/IGSBAKDAKGg7kVnsqGNsCYt8zFiCERiBC5zuRVzEIZ0Se9m6MhsEByicBuj48Z5srPAr8a6Hdp9NRDYNeYmK0lxKczQKHxqcH9TgfDUCKkQrULiVzAzOhXXpx2CA1lFUGxpA4qSO1bXJyMyR77BzLXXGVrRb60hFB8gbF9HaR8dJuv0E5JrjPI8G8fDNUiJA27RvuwXFKwKXAMwX6phJyP/nY4SZnMgBvrqAm/XKbwSNBrTUrSZg5IkASjQXBSIky2K+sSva+HgEdU0Ab7h8BaCKpJmSKFEXfHxc0/iJB7QU6iYHRLRABhRKanLAMagA62yACcACDAzA7gtP8kxO/xMqHQi0VSuVSSvdEefo5nJy7YY1wi5ogiNAgxAMQjNgwywMATicQDq8wBwgRL9EAAnEgDpUQw94wgWkAxagwRtcgpDdQRRIAxGgzlf8hNW+OB2K/DvCI0AAEDiQYEGDBQUEGGAg1gkfQFZEuKDhgocLDxxkTHCAY0eODw4osJChwQELCRgcqODBYoSUESI82BiBYwMREw4kmDBSQU8FDXo+aMCzAUoGChIoGDGBAUYHLRYFkCAhQBhAAUIM0GogIYEFAQAQ2DCggAGuCAZAQICg7AAAAQIU2AA3hIG4EOACKIAgAIS3CgfAFfAWwIICbjskREBVQIEOAQQgICAAwv8GvHrhEqAAdy1cA1/78g1AAEJZCAYwnB58kHVrgwIGTB4DBA8y28iafQHyQYMHEh4qXKgw/EKEoQ2KHkCO/OcBkkAVTFgOtGmECho0GOewsgLMjBEcpGQwfqPRng4ujH8pXHjGB++VHxCB9AAD9B40NLCFAsECCiVgkSEAClSQwIAQCFhsAQMqG5ACCAQggDQJOoiNAAMkIIstBCCgYIAF+HpjCQoYeYGJPtKQIQQ/cCGBkxISsSaSIlTpRopyRGHDgyzMYUaADiIBgQc4MhmkBLtAIACytxBwzcknD4JLyimplBJKKAMTYIFZIjjhDCWsw0849VLyyMyOorOJA47/EmiAgZgYSGAjoBJwQKgEWphAJjdzajM6pMJT7qc6GWjgAQZEIOmA97BJhjII8wBEAAPSuEVJSXQRQAVL5AhAjGZ+EGCQVyLTRRUApJAGhgAG+eYxVnSREJRBAODhFCIE+IEUGQTg4hUbAsjiDwJAoKaOAGDYFQArVglBgDp0MUuVOgTIwZQaAPBCkccWyaOAAsJ4BgAVKsGigB/+kGEAGRpBQSEBEgIA3rBWu/LJwdwCAIQQXkAhBBRsYKGEVA744AQSfqOot+zsDCmBB4zzyU0HShKJKJQOhTi44gp9eCUN1As0J49QUu6BCzLKKDiJKnDAOw8SUAacEUR+QIMV/z5ooA0T1EKgA2lYICCwAcZCDQKiDdigBAgk2AAFzSCobIGsDExrMwwW7E8CBBIagp0ywOqAQym6iSOaX87Bgx0d3IAmBBt6MQQMcJ4x5JG5bKCkGF5ioQEGng2YYTG96rXX8IKqTHzKw1uD98JoHjghiCBOsAg74+TciOQyS3qTvB3mY64BB+T0SU77crKJqY00qCBOn34CLyPkDrCzJPlOWtSBKqKSwK81riogj1AKoOCQNQawQRMoCjjikh8MyAKYtFBhJQAkNIFhADn4KGEARVA57RFEAmCiFyYEuEIaGgjIIpwaCAijlBJQCMeMAHSoBgoBCmFnVUakAQAD8P8hGQFYAix+AABc7AIDALjEKQb0i1EsIAfZsN4glPGEAPjhGDSATL4OMxgCMI41WoGNXhYkgcNARjJwecQDghCDFZDgAzX8gAc+EJPWWUAlH7ATRlRiHJlMgIgWUMABIuCB+jhgY91xAEdcRrrklElzHXFZcd6TRfQMJzjXiQAJMpALQIygKPZxgAZ+k4A2qMAsFAhBLF5AgCI8ogcBUAQoJBACQ3wCADAwhhsoUIdz3EAAetiFVHZxi+s5QwwAQEM5eFCVZoAAAwYwwQw+IQQMDOELR/AELMJwjUpAYRBKCAIyzqGBWfTiDrqoxRsy8Q1glAIJvXAFM9hRhw6E4xL/yNIGFATiFxIOU3HFHOZBGkOBbVRAhitYAUt844AJ+MQjZUoJSrbYMg5kwAIWeBNNdJIBQFnHdkpZ3QM+UAGdTBMptINPScJTkgSIwAIleU8X/PAoAXgCFVjRCwAqaQAKIKkEGICLBJQUAtF8JjIgSMiHILOBxxRGIANIgV0goIK3OAYuJtjMAkBQArp0BS0CSVABAFCahShpAe4ajF0CAIKvCE1KFBAahwonL50eE0rfylJYAqCHChhhhi7DDg6Lw8TuREADN+RNUl3yQzYpgAEXIAFIiCMc/NipUD+Z5gQ2UiaPJJEEEetJ5zCCkaU6gAPTKAYHwMqA7qAxPUbA/0EB1JICbuTgesKYAQHGMAYKgOAZUzBACnChrijEgQIIKIJhBzCGJyCgBFp4AQRoQAgEPaEQEKDg0gIQjUMgYA3k0EUkCxGOTPRCHFSIxgXIgQYmfEMTeciFFphhCURkQw4LkMAd2DGEHNRgsFMQnAGalFOeOqmYilsu4jqAjggAIQYfuMAFnPoAIhKxinRqilhBYoGbGFGuTzzKw1wWEzkBpZ7Iwch4lrOTDGQgriM71E8awAEe1ucBO3jGgPzCi1E05hnUmIshaBEAKxxDCwGIgzO8EIBQEIMypkjGAKQQjh4A4BaWcBYdqGGAnyVCAELoxBIG4FocBEANnWABAP+YAQoIvMAQaiiADCARBUr1AgcE6MMrAoCAQ3wiADwARQ08BYwOAMAMawAABQBBZBwA4wgCmIIweiCBI9DiBSh97nPjEgA4OKAJRojBb3jTMpjMFWEt88AKLoKy9JoRPPWpjwJAQoLirNkiMnlYnJDTnUVVkQFoNA5YG4CTkNhzPELJwAE0MAH6PsADEiGBBg4ABBwMYGss6IT27EKBDuCACBdKggwIgIEpyKAANpgCBgowAymAKAozSMECiLBkCDzBBBhgQRIgoINzcMEAXIiEH7agh1SggAKigIUgiEAF2nzCDxcIxi4U0YhpLMIUZlgGH55hgxpoIhpkoEARZt3/ATGwoAMUCEu+vszc5lbpuW4hy1620YAmuIA37qHYNudbspAYsYrlyUAXqrCUnwildjghT5umoxxxPuAnwCkUB3YwAguAtU9ymsAI9EtV7RyAA4r0rAEWYYfB+CEZD4rDFQBwA16U+gl/QIIB2PAJCTWiEANYAh16LIc5YEAAh2j5BiSRBgDkwBFIxgIlUDAATOzhBgW4xRwgIINJiIIA1vpBAepAjBoI4BN0wEoqEhEAIUBCCAGQQy3cJYxAFCYVazDAEIpBhgIM4hpRgAAZ2jGFxsTbcPBeTQEEMAkHBMEHLjjBCk6QnapS5Lp1NhTI8Gyf9/wQJJobSk6se1SK/3SnKRUACVBw2BSPNICpFGO9OsMD1wSABzyFoi8DJG0BO1nH9OKggU1LsAVwwAAAjMBDFBLfjAsdA8hWcMAgBGAGH3hwD94QQAm0YYcASIEBhQgAGowQqkDYggUL0AEGctCEMQSjElz4BSYCoQ3DbiASRghHM1wQizYo4hKveEMtViEQSgEX+IAR9AAUQCAANiAa+kkH2mEN+gJCCO9J5o3e4g3xIGAYHIC6rGv1tovjakI6FoVNaucBuok5eqKeEiADEkC/5kvROmInRocj0inRLGAERoC+NmInuskC9Es6DGUC1kQE8kAqIOQQXGE0AmM0FsQAlKQAFiAwICAr4v9iCdEiQtyiAJQkABagBBJiNDZDAGwqyAzgLagiM/4CpmLjLSDABARgKjQjNr4FQ0xqAWDDKyLEL8ACArYwMQKAQZRrAhuHIBQiAGohm1imIiqCJfotJ6jqAnRCrErQJGCwKbDDB2joBGqI9qwDizjC4kCiI9wkJsAqI0JC0uZD9eRKJjBC0ljQUA6lAcQBBiRgAQhABoYhBwTACewABBAAC9DAQ8ogCgYAA7YAQVigCDCg63QMAY6ABfIICyipBJIARF5gCNpwCEBgA24gBDDgCmKADugAFtKgAIogFdxhHWigE4IgB1ZBHCpBE9ghC6AhDMyAG7ggG4iBCFCAE2z/AAQowD9s4AV864QEsTUqkEomUAA2YBtWwAhcwCJC5lDIxEweIDiuafYuwL3YSwTmYwLGa77E6YfCYyTcZJouwhVF4Ad3sAe7SQRx4jw44A3eUAIE4A/oQAAMKjKIri+URKC4Ji1Sqhbh4kOaEC4WwA25EAMGQAASMC4aCBAPY4T2gjK4ggAyxKcAgC0WYAGWMdUwhAsR6g9VyDAMoCxARAyb0i0GYzC8LBAPkiDsDV60EAB+oQU2rp5aQAQcYAVigCUSpmVygqnapFCWw3ZykIpG5wGeaSUmYjwkoqnGRAEuTfVi8GFMAokqIL/EKdEyZ/bixE7aqZsOZSPagAe8/wIAUmAXkCwKC4MvsBIyVsgv7LAs5AWvBoMCCiAASoAAdhOiijEJgoAL+uIsDcAKrIEVCgEdUEAPnAEargAXpkEcrAEBQKAYIIEGymEKvqEXjkAbsKASXGEKsgELRsM6I7AxvCwuDSIhF+fLmhIycqECnGmGKuCGwiNlvONQdCeKsuhQZLAnOGAE5kMB9As6kGLNwkPSiiJRQoID9GskxAklmCMpfsI+EkDNPIADOAHAAsAThCEuZsAKfKcMyqAAMKAPekAAMosGFuAJwMAJi4AJBsAEikA3b+AKOEQIiiDImGAGJEAFtiABS4AKQGAAUIAJMGADcKDqDEAIaKAASv+gBzaANIKGAC5JC/+RQWBgAwCABXhgQVLABPZCRRBgA3iAAgySIOAF3tiTNeplDs1AE+7AE/5AEQ6hEdoAOCxCEWVHqQTlq1hPJ24HJVbwJ4zqOipgidAjzcIDOLKoI07iKE4CJhRABFjvKBKtJyj1YQwlAZZCA76jCXrgMwiABrhhBnQSQ2xSDLcQCpnQLkQMNjbADhsj1JDrDj0jBWqgLIsSAWZgA3TAD+oiIRCPCOaAGA7h1jrABtagCFCgBAoAByBADjihA1igJxkkM8ZCXtgSANxUEN3TSp6LLiFjGB6AhhAmiTYSiezEZfbkJ/7EPU5vOejrJYtomoridGD/wjkyYJvw619FgEBXkpu6SZzexDmMwlAOwKpmUie/wg+uYgAkYRiUxG4CgAbGoVOy4ATAphHGYQMoABIeIQC4YBw06A6MAQUKABRmYVymQRBMdhySIACgIBs06Ba+YOwA4RdIgx0WocSUIAsEQBS0YQgCQBCMQS2GYQ4UbB1+IADWwBtmIAAyARSejBuEQQBqwBbIB1x1Cl/A9k3hFPEEQioeIyG+ECvOQQH4DYcs4l2jCNCWo06AAiPkpCY2AmLwAz/U6xFdomBcoqkEs02YSDkSDWWwiasSjeJ2onQSTQQSoDgWVQl4ADUGgAaKoQYQgAKIAKGEAA2aBA1uAAEw/0AUWAABZEAOUsCRRGEAKIAQpEAAZoAXCHIIGCFJmIDrQEAM0IAL1wATTmgAVIEdEnALGAEBKmEPSAEYMoEIQgAAsKAbluD6EAoD4MARuJAAkkENvpQatqAxSoNsEWdcwWK5xBYugiFdEcYDLjICkKIik8Ild4JMDJQHd+KrIFQkBRaujoJ/58sHB9YjV3Kb9pdAWS+/7ouqGkADTiAD/CCmvsIMgCEAOiAHooA0CqBpbNK3GIQPfQahSoBnEKAuFqADUiBDNoAG+DAFKMB3oFEATEAFNsAAYOAGBCoFZAADEAAG4KcEbsAEUIAFliBDZEAIKAADioAHSpgJxoIGnP8AA0KgCIqgVoegVCXACXilIL6VfAdxMNDiaLySQxIEBbLBARCGBA5GVFPmO1Kmq0iHKUKxJtzkvZoirZSjTkrT9IyqImiidooDVCfAIj7TPorCJdiLmwLYjEwQCGRgjFEAElY0EloB+U7hGlItGyghAG7AFtIgAETBGyKJDqQhADBAGgJBAJhgGqhgAeIgHXQgAOYgHbwREvagAFJgHIRhCa00DJIgDrYBEMAhDpZgGHDhBSyYsu7ADSSENwtgDIRhSSchDARgCHyBDMgiQ7x4IMz3fL8sXmChAnzAB4LABWwGEvdVThD5A4lInuZ3u9qEI6Jj43aCA1qgCrqAJD7/bn//dQRaAAcP1hVFci/FKUEpDtLO6ANaQJGwJgASIcEMQAa8AGvWQA0QgApQAQkEAAkOoQYM4AoIIWpYwQ24lg1CIACKgBDK0AmoQIC24AYoyQpsYABgIA9SAFjlwN2EAApABAtQswN+YAP+pQeYMgfEoAyRQAeeTAfcDQamAAQgYAiGALl+4K4oYAhMwFvhcptbAwM2w6ec8EIowBkq4AwcD/I0wCm+oze2CihIh6rmeNE0j0waJimQI6z80wMir01QIj04oE5gZjmQSHZMTyk0juD0UwGO4a5OowRyYcNsYAhCwKY6oAsBoLIHawMKRKFqtUqVBGtmyqHiQk15/9ME+kICAhIKqYASVKAvpKEMnsAXIOEtbgAOcuEIGoEIvsIXIiEACkEQ8GIQ9IAOnRAvsLIwUCpc2bOby9UtkMsAtuECxjmGPmCGGIAk+BqLrqlzLDSdkyMnGu094sQCWmATquAkLpV/BxauPlAkIPQH4Rk9tCsBgAMmumANtIQveMEVJgUYasEyHKES1A4WykAAxqActsCOfqEAQoAP+mkMzEFAGsEaNsMUDGFczuF+3GAa2i4LyIEHBCAPzMFZKMEaKGQatI8JbAEKBsAMTqDtUMEZBgAEYIEUAuAIjgEJBqAP8OAxLCEcwBUWSlYHXOANvJmrnyRfVgM2zNZbIf+AG5qK8fzSnN8kvS7gYBQXzwqTipJib9vYPZRjJOLKUBZ1AhwgnXwwB60DI3hIPDiiAn6jYRQgAxLFUNo4AizAFmzgMyQABWYByXogC6T1DewAAzCgEeJgAG5gFYQgBI5gFGwAABABvzfgDqhl3KQApTUhBxBAFKIFAN4AFzZ4DtIuDrjhBYTgDnhgFfLgEZIBxqphFArgBkDhClBgEsrAFZjgE4DsDRZBDeZOEe6HBUwBbJCrKbmauZcrMACgLiBgGibAqRrWCBjABYLjN5gKO7IjKc5cnUSwIxJgUoUDJILidYpinrnpq8AKI2DHJ3zQzwwFh6RJAbLjJ6qAxD7/IwAOIRQGAAFSgAY2YAOKpxYXgkNiAy3EgkPYgkEkpM85JKQkwNfcCARewEs3wAQ2AAFwgBYJIAQApwRCQKYaa0lfoBZnQAj4cAh+oKWM9FTLIGqiAAtO4wmioCzQQFWRHEra0oQqSmzfYgPEQQOCQOiNgARiIAbgPKr8mNA0B77+ldA2LyOKowHoS17NHJ2HQ5r+9dHsA89fbzy6Az/Pir0UAD3SywEyAA9swHQRgAZ2oQdegA26oQcWQBdKASB9gRkAoAaCoUfBwBdsgABCwRF0MhPIxwp+4QkAYAqIYQgogBPgYAMk4BtWAQBMwBIC4TBigxPCoQ7owA5S4RLg/8AXtCAtvuLGYkENiAEM/hAB7IAZEiFEAaEPAAAFvgENAGADYGOrxdV8m7sAksQA6iANuKAO2EAUpmAQgCByYsh1tJ0iwMOBMQ0WR0YnkAg/ChcjYAJluGvjMEZjNlKwJcI56rjrvyMjHWAEILAzGEFSMl43+dC3JMQrfNMwJOQzdrM0IgQDMgQgJBgQUACCBAELDBQYMIAAQQkFKAQgQECCBBAQDJhISKCAAQMEDCxY4LFEB4QGAqhYgCDAwgATDQwQICAEwpkAcurcybOnz59AgQrgOQDATAEYVCjz4YDBhQQ7Jhg5ceKBiAskEjQ4cCCBVq5dtU6wcIABA65eG/80yJDgQYMJCuIqQHvAwYUHZ9XGhZuAgQMHFSYw+PDg74MJDfwy4JDhQQIFHi4wUHBmhgEKAGxUy8GCAgYDKQBAoJBQIUjRDgtsoAgyAEuZRgcEMCAB5gaJLlEMDCAK3I2GLa8YgnWnE7MohtIYcwMgAASYoTqB7DCQOsEFBAYgGHA6qPfvPGGKH09ePHjwBTAQoCBgfPsXeCp88KAhQYYL9DVc0HBiBQnJD2jgFlh+RVCBBx8k6IEDhdn1VAMPKNBAW3gBdgFdCURwgQMNjODABxc0oECAHzD4wAEViHBLABJI5ActExUQwAYGIdXQAiAwtBBNIGwQAEIEBIBATrL/yTaRjwJwNxFJEwUZgHYwIVBCSga5tkFLELVUQEuuPXcTQQUQhAABVxKAAAUpFXXemmz2lKROQxGpUwAylANEG+coo0w16SRwwQkeWKCBBwpMAFZXYBUqoQJnoaWWiFWwJaJcDUSwFgMVNKWXXHEdUJhfiUXgqVkWWDBXAiOIwEADFlTAAKpn2LBBbSqgM8R6C0CwEEUEhFDAAiUAgMACLqXUHkED5FqAjAQAIEBFCwgrgU0QYGACBgKUQYsN2UHQwQI2qILAFXK8cMsTfshQ5WxQPCOBkggMadoAWwIgE01t5ptTefyOp69PDRUAQgkSjDSsADJ8YRaCFQSowaCA/62wggeZOnBCBQmAdcEFFVQwKAkxrPBXBHZFENerZUVwooUPtLzyBxqcFQF9bz3gAQmZklwBB6q4NtAao7g2yBzNPqILACUUI0cATATzQwC8ULPABqTwMsAUxfAgABt7+GiGIgIgAIgoBfTgyA8A9OAKCwBskUoKAWDiCgYSUKJGADb8QYQAUawigwBx/PGuGawEYEIYOQQwxR2kZaEFjtvhm2Sc/1Yu1E9xPgvCECHkehsBXDywQgUrgNgwho1OlsEEGR/quggK2JcBp69uZZZYcMEloacOPHaioV9lwIEFIu4wwltsZWDBDk3IKgEAKPyiw7AuEbCAABJUtJB2CP8I0MEGxA6VLPgKmXkmCAV0YNACFGzwOQUUsCAjAhukBwKZJSBgAAImDGDQ9wSAAQqIdaYzsWABB3FW5pxluXz164ENJAoDnSUQANQADw8g3QqMEIOSXWBm/6nYBVYAoJYNSj8PI4ELTjAywDDAAoZiwAMioAEGOegvf/EUCUjwASOECDCFMZCBOnaBESBCABCAgADe4IewqeISaLKDIASgAlM4IQBF2EMPBvAJV7DvD88IgBAcwYMADKIWGCgAMyShHUOwogBPCMcRAvAEdMBAAFlIhw0G8AdLhMAAllgD3nZxBQG4IR1CEAAvhrEaS1QiAFRYRxHMCI0QBIAUvpj/iRKJoqYIepIolCNSAbKzLAYGoAwXmA8JSsexyTyqK2rJwAgmUJi49MUBJDuLVxQgggyICC4QwhijFFAq3cVlK3+ZQAYwJgKtqEUEIzDVBLoQFQ4MrwojaIELajAANIVAFjcIwBIukYNumiAAHYCGIwCgnjSyQhxJCMC+QiANQQQgBAjAVhzwMAUB4CIdNBAAKKQRAAzswhQFKAEs/hCAHBjjbmlAxhMCsIhybMAAfChGAFjgjDlkiwRgCEAymlECARhggijt5CeB8sB+rXQnFCnKQHgAhMjshwRBsKnHXBAzjmloQS2TYYKGqqAaGqYCG+uYUjnGMQ24ykJEjICG/1bloApIlYYfOMEHJpAH5yzADdzYxSp6ECYMoMkgzXJNRwBw0dnIqAACYRGXZAITA/hISDAJm2wo0p6O/IhePwpBkLpZGzLBZGrEKhg6ITKb57iGAmt96UtDqdJOcoc1vApAGg70ARes4AQk8IBbvFKWVymAA7DDpfIY9ZdVMSoBykwMqzJwAKlKKAHDO4Ba/OIY3Zo2ARYYnixHsDoO7ICa2GxBFXawgwyIwANREAAIJIAAYqAgAHXYhQ0AgJkOSAAXdaCJPAHwgzn0wEkACIEfrpAshgAgB3FQAQB4QIbPYOEKCARDGdrXBzAQwARmQAIGZKAF+eVADSWAABbcoP8+J+RASltQgQGkgIYFqAdzPAmlZFvKr0+qqZNogkkOVhADEjTFATfjIcxOICANgMgxE1LLAR72MJturDCFUapVR2WWHsswgxvb0KtYh0ukGtkuJwiCCw7gCRYVAAy78AUgYKAIUAyrFHMIQBTQUQgzVkMHAkjGMszqizsIgAvNIEIBErGLKR1CahvoxYqsYAkkAEAMk7juGCbBggAkQhMYAEAoVFEAHughCQIowilm4M9KbGcRiChADoRxgwJsoRIogAAuGOGZAuQEX5IN9U9GyavMxkEDJDhBDHzgAx6SbIYaYpBrE/AX0pa2dScSUV8mVdvDzEVCq7rlqtTSF63/lMoCGWCuqTKADXcstwUjMJ6pWuCBH3jECnwQxy66Ks+apOAyP9KfCnL01g5QQDdGEtYNvlcAWRkEBQJJgQkEG4IN+A8F7YPArGh0PwqYwAYiAQEFIAAAHLxAfzOgTgdoUBFRO5DD5Fnpm0yaTwTQIAA6iIERjEACA9EHRA9bgYA+2BTdpmXGRGyKDP3SQhxGaFGKAraFOMYgkzfoqiTjj5Ib8IkAUAAEAmBEI+RZBz94qw9OIAAN3vAEDNTgGf0DAyIMkgcnAOAJdsBBAMhgBgwsgBCLMAAERhEJCQzhGz1QXCYOfgRApKAAXQzJKjABABk4wgsD2EIpalAAP1wC/yJ0MIMAqLCNGwhAC9sIwQAy8QiHNEulDo88AEhd6iCNwQOqjoELdogfD9DnZpHJlMtwiZdh/zhTYTFLUEl2Mln3uCsSUkvNJ/QYZM9OASPARhVEIFsRZaALHsiB9YYgCXCAghUmlU0j2kGDAVikADooxxuA9DxgoKM2nyZCG9IAACc0gQsiPUNALzEM0TTDEgKYgTZAEYAaeEMQAHBDG6YQgDt4QwYBoEY0plaMVARgCBewNI1QGfUjeecBcREXamYyI2gQADAABC5gBEqwQ6PTMRoicn8xFwygMi4zQ0WmFbeFQxHQYyfiFSb4KLeEVDSXa21hIi7IHyHTAD3TAf9BEgj2lALtUUEGEGjURXCuEWgugQEwEWLcJSOTFyXvAgAdUBQJ4Sz+0xIYIISusSUu8Vbv4hK14VbtUS1GQQH6k08/MisnZYBkyBA6kllXsAI+0ARG4AIu0DFDtUqlQx9WZUP6cSKdAmSnkzEP0ErJNAEoVgF18TsogmMcszKi8hYcMCEW0EuC0VtmIQInkAMG0AE5YgpE4DPOQgSE8AJwZRAbEAc38BE0QQBbUAdD8mmhyC0hwAUsYAA/MAgmAABH4ARjcgRFkF5e8AMQEAJlcAMUcANsQAMQgARekD1EIAYd8QNRsB5sAAMIIANkQAEQQYbfgYD+InFwYhQ0AQP/Z6ABK6AEE7NCMKOCTQFbf5EYDiAhmZIxEfAYhZIArsKHjgEXLRMWpIdMG6MBJCMqsfMpurSBWBEyB/AM2LMBAhAIo/AsYbKDtbE/T0KD8pQSHgEBQTISM9EsBGGR9pJAMnEZB0MBHiEkLOEczTEUHTEUMiIQQZIeT4IADwkBzpc9/uOD1miAKpVZrLAD1oRNshQBm+cCQaAESsaPI2Mg89Ewk7IVQVaHRtYXjoEpG4IirWUhnkdzntIxvUM8sJUYaGEBGbJVH9ADdsU+tZB2TchO1kMAMukRBIQvPrgAakIQ2JMsJoUZ6CQbBRE+z4Mm1iMSMukSUyIkLeE/Qqgd/1f4PM+SHTcZFNhoHqImPjAhA03wARvkAjejHypjVSU4FsqzgXCxIRLiGHuBIqyiAFJlH2Rhcg0Ajg/AAW2hITFjIGuBGLwzMjGzgSswAT0DAcTiCcswGz3wAyPBBlcQAClACD0AACxQCAGVBFfwGWBQBAIjBqvxAj9gPT+ABBQRBdy0AULQER2ABBsAACCQBNHyAp7YftxkAFbQAfZiAyyBAeqDACyQAt5SA6OxHXCFARAQL41ZhjnBKwKABo8ACNSwCq8wB4rgQ6wWBEHgAzxFMi6nMrpkgvKoVBSqKZ6iIZliFvvIj33IMCrDFQ6gH7XzGK0DeyimAQ3gAEkwAP8bgAEbIAs6sCweYS9okj0mlRLyREAYIBsh5hJIZGEZ+Sz24iMAkB00QRpLahEMAT4s8iw5SCwKYRQiMV4zARsB+hOPCRM4iXFN4IZTgXlO1RQjqKIN0AI7MCK+JpoQcgB7kTHI9qIOoFtjMRe61YcM4Esduo6YAlte8WMV4gFShWoc4AcsUhtmMAfOMgfGABGm4KhJoAxZEABSYAxDUH/okD+Z4ApbRw5IEAB/AAsdEACgIAv3xA6KMABe4A2TxAXIkIlagAdphwrcQBrcoAgBcAPeAH5iUA6ZeAjB4CO7AAgBgAZ4MEf7oyMgwR1H0aUOd1kdgR1G8SMzMg4eAAT/PhChpQMz9JGmJOhjDWIYpfUqQEZyZoFzuGQgJGeCvDWI9wgWGZNKGqAATVADBKBwscADs5IjC1ADNwA+QzAD+iYGB2cCWSCSQpB0BTAFWIAQTZc+SYARMmAFdPMEaTcAbrAEbHkFVrAeYiADBhACTgACBjAEaIA+QiAEQ1IERCAaU8ACA8ACZFAw0uoTXzpekkU5stEDX+ADMQCBHjCHHwRjE4AYvwSaClBD9giPcdGIsPkYSRu1wYUYZvEWc+EYYOkqiTFDJ3IWmKIfVjUCnoA9p/oJocBWKGADvmIRNmECZRKkkAUCIOB1CNAjF0UAKQADISABKTAE7DMDG2CJ/zbQASUQP90TAkmAkC9ABNhBBC+QK08gWDkgBQJBA2BgVjmwRyiABUD3JkdRJDkbeQ3BKxZZMP9pdsgABE3QBEqGeTsEM3eqjvihMjikejjWMmh6Qg1zFqXncmJ7AGORMRPCW611KDajVQcgDjRwGQQAAtKQdmlwDVIQAKGQDghQAOHgCAJgA9YQCQGABbaQicJQDNazC6ggADyQDZgQAGIQBEUgAMBADi+AqnDgabFABypxDZUgADSwDokQAFygDJP0B0rwNHswDGLHDcjqq2wQAIXQDC8AWaW7EzvrcHEiGzlgBD4QGVJFFSACTIWiPHjhpzDEIGoRIUn7GBwwAv8ccACoJQIcoAAYMwLq0AKmQiqx80It0ABClkEeEGx6IVXFEwjOoURrJBOcoAhXAgmVAAA6sAsNyAR1JgCI4AgM8Q1qAABlsAowgAFqkAgL0AG3kAf5hApuQCdzMAMDdghvdwSLkAIEwAaMgBCLwATQcwgBpQOIgLI/kAUKQQhTAAA3UAcooGHbeMGiVmosoT8hIQAsoAxBwIZtiCAfwEM1pFtZqR93ejuPAhgWiEv4cabAaxZ1MYIiAkuSwgGCgRZ9wRVn4QAqJDJBgATDAgEmMAzEqQJukAMLgAMwQF09cHASUAPXEwI9YIkwgAPmBgIdgAEIAAMm0AEoQDCWyAL/BZMCJTBKJYAC1oMD6FMtdnUZEnAb13ElBZAC+CkB1ryjb/cjjLwvX2q6QxEARwAYuCUCFiCbT6FbCiA8vMdLGaA8q4OhMJQYAW0WypS0fLEWubcJsGMfrKNbzYVsrwKCxEZMGZO0VaALCNE9YSAJKXEItQCTf0AIAqADcLAEAZAEe4ADAuAHq5A9gKAGBSAFhpB2vJAJlkQHwjAAKRAOBikF07AEAjAF0FADAdAH1QA3gOALArAB1bAICOMMRTAAZVAOM1B/4SBwxqAIAAAGeLAE8yygRlFqlGc9CYUMJCa0EqhqFCN6KtoyOLPCj+FcGWSBjXKbuMRiEcJyJ2Iq/1pBtazzFoZtO32YIDR0BCGBASEQDVjAt04gWFPwCR2AAGiwBQjQAYjgBRgXCDJQAG7gB8PSB1fwc3lAsinADJVGBYJQAgQQCZwQEoxACMuyCHWAnHZABgUgA7TAA6QdBjQgxoRAHXZQCAAAA41wAwTgBqMAAmdNz49pgO3hBTFwAkpwAqn0BUl2AoJyGBOAWlxhTA59bLo0FoYyWwUt0Ksz3tDEGK7cF31aKrzXiCMQOydY2BbgDo9kEQHwCZTwI6UIAoflowSHRAj5gzAhhdcDEysxFBBhUqORLF9IEdSYLGL3PN4lzc8BVzs6LNmRuCFRAp/hadNtgJXHK2diAP8soA08RIFD/MEGwiB1faL8qCEq8xg4zjEEUq4RACKrQqgvVNGTIiHOxRUFHTtlEUQRQAK3IgGjwQdSIABi0ARxIAB/MAsS5guaIAApMAxrMABPAAvxxAu/cBC1wKsq4AxpEABWUA3gxwzV8Dd0AAcn9Q3AwD58cDQ1EAy3QAA/sA5QAABrMA2ZSAqQgLKX8AcEgASwAH5ZEA0bAXk5m8GihhMfQQNc4ARPIAS4+AOVECIfcAYkACEdsoEZvUvHZgGGIRdJ+xbH9sKLyBVrAW2z444Zsxi2d3vHVBZlwQHxwKvovAahMCPOUrJPAm+zUXG0ERIyMSQI1D0yOiQUES//9AMRo/QtEaEQY7I/7SF2LAIS0TtKv5Il1ypPdZXiklcU1Fpq9xIAKAAE9H2ngrGPdL21vasfR5tjWgnsFBJErXQi9HrQq6I7E8BcNhNbspxBNXQC52WRHRALISsBPTArcms980YRz9PNCwESFE4QNPokv7IlSUImq8sdIjETZhgmzlEkDsEi7IFOqrEsNDETT6LIpYvpGpwsDy7PMKEIB+ADQCAOQRDkDjACmCIq9PooyCREDcAY5/p6YVHCS54xFSBjt0ffBE+or/kOgYAUtcEMWSYQDTEAISDNYpcdU0MAXscSCSWTO3gZS9oREGEmDoGQSaIdA2BuDKGFIgEk/zLREHWVVizv7gxk6ez+Uji6EKXkljrQDddQDeuQDsYQDNkwIqb8GHbKOje2hyaIIXVhGDiES7oVYzW8FUd+WqryAMhW0X7hMQ7gAzogEpUoC08AHN5FcDCZHSkg3WztHLQhJLXhn3o/KwCQPVQyErPhfC5BLFgYIyUg858hEtbeAZ7maTyb89PN8z27yO4u7pJwACRkZCTD9SsK7LbOFTuep8q748dkWqYyIaO1Fuo4RKMcRBawCQMMEBIwBAhjJ0AAXssMDIBk8Ae7NADUtOshoFInACmkMQoQ6ZeNAYEmGQAgDJUAENFYARADTUeANLkgCFAj7UWAZI8MYICkJf+ADD5PAhzRZCIAoUMCACwdoHTAUqhRpU6lWtXqVaxZpyqd+lTA0wILNlBYIEEgBgO4OETwUMEBgwQKGsxtcIABgwcRDlgYoSDB3wMPHjh4kIBBhQd4Bzs4MLcxhwmGG0yg3EDBhMkcLPi16yDCBQdBZBAw28EXkg0GAgwIgQDCgAIAEBggYKMEBAkvKEDoAIJCAQIYSkhYQKDAcQQFKIAYkBzB0w4pNgAIASE5jRQCFrwovgDDAhAFMCBYYIMFV6hNta5nX/Xge/jx37enj/7pfQMLAthh4OJChQg+i+Auwew64EAEDTxwggw4u+uuAxKYbLMHKmDAsssUSFBCuRr/qAC0wC747wILqsgjgAUWECCMO44rJBkKCBjECwBYCGMIAY6wwwYBoNCFAAo8iYgIV1AIYJBkZjKDE+r+cMOAJFypYQAx5ngBADDoKCGARYBBQAJq1EBAh1mkWGCQYlQoYA1HAgDAzfvQo29OOrcSQL74BJCzKj2XulMp8lK0TkVVdqjggwsieKuBBCJMkAG9LBDBsAMZIMwBB+piTMMIE0gMLgU2s2sCC0rN4FQLMsDssgMqcGtAF4YAYAMIKICmCAGQ6OSGADxBBwMCTEElgBuMSSOAKcjBcQ5oADBgG0ACwKGNSAKwIgYvjlKGhQCosSQACGYxBAAQoDFIBWcS/wngiWOkAACXM25A4JFtQNjAElcC4Co2pfas81+o8BT4IICzihMAp/IL4BAHjNDg4Qs0ADBAvTbckIG9drAgrxFdLQxDzxhQIEPOEjwwgQDhOuAtvBpo4RYUBwggkTvAhQCtAlRAQQAKesAgLBxKIACEGgCAwIYQxEuaOAkIGACGDgygQILdFiAvuBT1W01mN/UTwOk7JTiIAgr01dMrP9UreG2s7hxY4D79heorhAEYYAAIBBX7ExE+8LstxjBWsDO46nJ05Ustm4vTA109gDLARKaM1MktYFRCBjTwwIMPKnBBiAAkuDkX0K2IJQkArMDFBAAYicOAEp7hwYAb+v9QgYAkRCkAATCWYE0LHmZQQYsZMMiBmRAWgCILCUBAQ4gCNmBDigE6EEUHAjbgwgYIbrhigwKcKCO5I4jYU222C34bz/SvopsphT2JoI0PNPC7/g8/vFBwkytVQITIPEBEA4zAAw7UgJDJRS4TMBDGBPNAUDWAQHcZQRgCkJwAfOIP+oLDL46zjUwIgAxAYEMAVHGGirxiHQUIATsCEQBciOMmtAgHBQDQiTkA4AXneIMAIuEMHghgEOKAQQG0wA4YBAAOxQAADKChBmIFAwkDwIQsOjAAXWhiT05pXxfntj4wni89djPOcQxgAAQQQD+fSIASXHACD/wHU4NRmV3/HliYBC0mAgnIgGbq0igF/aWAGPtLowr5F7gQ6GEkWAEJYmAF2IjOED9YQH4gAIENmIAAs8EAChAgAxQMgAJFiBoLYKBGqiUHBypCgAp+84IedEACIdDBbojAgwGYYAgyEED3XjAACeBgLBDAwSUXkDcDzGAGbkKP3LzIHjDG55lXMaMBLLKJA1wGMpDS3MMSc7JG3QWQEcKQAhwwsQ+9JUKQEtnILIOgRnlGUXBJQGTcgpgLiEAXKIKAAfIQLQgsgQwdQMATcsAaMtiAAjCAArBy4AXvYAIJBFBBJDDQgSWAgQAQ2MIUF+AGIkAgB2r4mQw4AQIIIGENLCjAFSIB/wATeEIIAkiBJ2CwACnYoZKMMIMzp5k+t0XzbT61293uVoC7AcA4fPNBEBr5AQ84QAECFAzLPOMWQjLKM5hqQAZGYAFK2aVUB4jAwwbUKTuezFKKKpADPLCCCgCBBwBYwG4sYb4jnAEJARgFMl4ggF3oQQA4GIccAlAGIFghAIrYhQAwEI1XBGAIx8AFAKhQATcIwA9t6MEAHFGNARhgFrWggACq8Y0AsAAcc7AWHhR7CyVMyRTQ6IAAZKEJff10bUKdj26nYhzjLOANmXiFHuhwilS8YhwP2JzEGCMhBnrmU3gZ0GQI2Zk5Kq6cE9AQpDD1XMIwgEETiEAFWvUBBf8kIwAUIGge6BAApCJAvgcxTgBgVwABFGAhAMDATNYLARRJAABhaQoFZuMmCshMAgjQl730U8k3LcAoF5yJUsWWmtz61otB5e36iLqVnRxiAi7YHGECwxa8VEADA8ILdR/wvxYwwAMfk2Be5slHDkiQYoRJTD0VUDgFDkYuzHXBA9qAgwF8BwPD6EEA5OAIHAjACmk4JheOIIESgOGUIRCDJnvABKRKgQgE6MAPTCCBDkxBaCZwwgYQIAQsPCUHQ0gyFXSANylMaQNHQEETibCbGRABjULglYYB1mE3GRoqwCEAAewGnz/BgQMP84BZBYOXqwJIxR5ggKQAg90AdQr/uiPzi6Uq0Ba7XOCbF2pVAjRAAgY8IwAlKNstqAGBErzpZvqKkZsMUIAAZE8pBm5KP/NDG30JOAA2ADYCWPcVDDYPYaQ5iAHEZl/VLADYtPmaoz+saK1wGNFDJepXzN0cUljgABzgjAM24YAL/Dhie6RLAwZTzxxLlS6WYllcuHugOxpQQZLLgAhEkJgMkNUDMbjAF14g31z+IgcC8EIHagVsEPx6NQzGG4O/NDYAr1c1B9GPBDZAAH42BQMYkBmyg40AhMkX2BbPb6MhAACxxQbcdEL0zp3V6EYXQHQpig0FYqEAvzFyBZUekaJc9SERiVfdB+Q3ph4EKlJjJjAa/1A1iuFdPwFe4AMnmMAa/sslagjAAGiQwyY9MYYCzKASnf1BIFgAATG8IW9jsIIAnMAKGgRADG0fQB22QC428KAAOuhDCABwA1aQhAaRSAEEsOAEBIDAC0OIXhEqDwECcPHbPreKuMft4aw4hQBaQAQb1ICJMYABDNNw8akZU+9Ls5qPjZHgWzpUFwg9yi9lrQB0M+DpFw9GRBU4hgoqaYAQFANHqgkBSQTgGplZ7frHCd1T4Bt62MnMbgjIL1JDJ4E7bfI5jU4/+m1uXwF/LUaORthTSN+enu/8OEi1GgT06526koYI8AEfiIEYcIEYuB/nuqPGeBB4qjoeE4x64v+uBrCAyICUC7AUidk0DVgZElixDPgEcFGNMBAGurKDVFiIS+CFAFgCblCsOqgGXlKEWqiRcAgEARCDZsCBXpGFnQCFYamBYjCsOtiGiVMFY+AWVWCHopmEX/iJVliEAPCCGNiC60uP/Bq9+4sK0zs9cuOT96GrN3mT9xCAYRixC0iAiAmcS7uUiakn8zKMTfGUz0AM3rMMRCKQCGGQBviqwlAMwjgGEzgj6JOFJmOBLUgjJBgDA8sCMMOAQqgB2mGFqIkDTBiA1VuCAmABP3gBYloDFCiAIvgEayoDNLA2OciC3cAELDCADUCEKUIBQoABACgDP+inBbC/pNrC9cj/v/sjAEJEuY0KgElwAB8wAiU4gRUIgguAI+dKkFBZGcT4LnmaGIrBGMtgkAYJjBdDGa4bJMxQNc3ghAAAnwAIhFUItjuhgIEIgPGgMF1LAdlIEQkADqs5JjdBgU2SGmvbqDtBgBQQGzVCi504DgkYABAIgQXLG6UaMKboF140GDL0wg5zH/gxo92ZjQHgBgXYHA8gARIYjA84q60aJAkpjHAKr7tQsQISOMuQQMoQmVRpABHgAEvBmETyhuQBRhPohJcgAw/AEU/IhrGoBkkYgCFog0IIADAgByLollIoR2kIhQDQAWugggCIg1Z4Sj9whhIYAFLwheCQBUrICGvw/4SfuAY1EIAi2AUZKAA5QIdlSqp+sb+IvApf3LmvYLRGIw8Au4QAIYEP8IEViwFnTJRKyaZSi8CAs7EAcRU+GgGv4gCUcQAJ8RQLqZABqacIUQVwERtmoARg5IJbiJFX4IQBwIJrmAIAyIJiqIECMINVGIASOAVMAAAy2IbsSIRl8A5PIIRNBAU0QIAySAUcKIA0EAYVQAAyUAQjWQP1MoE5WAIoQYVl6pezucv16EKKfBumsEssHDC+BDrYsAYGWIE3YqSIOQHE8JTvcpTIaZRTe4AJoEyJeTWJMaAHsDfLNKBQqQBSSYBFOYCCcwbu4KRoEILq8QL5IgBNahqx2P8kCtgAs8CNWumA58sb0Oun6xu5SkKqlYOvM/sZAhiO2TgmfgQb4PCTutFOq8hLvTyOvtwNa9oDzwBJt4IQOAIRBNGukZmcPuIADsiAQ5IQSRmBuOi9CLmMO3KgcyoMP0CRgQgDQFgKYYADnjEEmKGCXKCeKuoBAviDR0AAG+iEE0kDSwiBAKiEcUEAQKiEApCBaBiEABCFbniJPgiG7LgFbtDHWTCFAICBcsCFANACc8AVb9M5F20bSOvOaPIpsAA6vjSaaTBGHwBJqDqBE1gxCFSU90SQvGgMBgKNQ8lMRSGr4nPPC/CA+mwB8iovPvIrAwC9JUsCASCCSLgBAGD/Azt4DUW4TRqgBN+xAlrAAQRgBEqInkYwLBk4hSIoACEwBV1Vg0dIGkKA0wG4g2QoABCgg2dYgA6wg7UUAkiYODKIBRpoDpJY1KyAUXCDDaA7IwkNh47swBGYgEQhMcAxJN6jjCHto5o0OA4QAVL70VRJOAOiC1JJOAMJlcwJyQRghF4CsEAABFEKAXsBkn6aNpK4ILDhtrvxPzWaVeBoCphDo/yggIX4PpIQnZ2opFpBgCvi2D5hV6rgCu50VNSbm6iAV9oALkeTAHLQgBhYsZXRgBVIQNDwVJXkHwSBEAkZELfKFAZAFAHygGzKCw/ggC4AvrJClAbwhhfYpOzZ/4YkGAAw+AJNFIQ9cCVLqAQBeIFfgAIB4AJYqIEAeAZAII9vMIMAKIJfKIKhkAYkAIA3iIUOAIBG+IYBo4NGEIANMAQcrIFZ8AkisIQoGIBBAAUWIMQwtNmpcNd3hQ3YMCMQYANCgAIn8IIySII30AAH+EAAMQyX7KMREFIhBau5wBx+lYu4gIvbrUAh7ZSuItibPIA+4Kf9cIVZSSOUktlKuj75cqxKki8bgo0N6CXuWzBrU47UMBoCk95Zqb8zWorSGBpgoz/QLT2d7bA/2cWuIN3QajRRGodN4YsqYAAgiIE4ShRPvcNxOpnAeBw8+oAHUDcXIAEHeDWczAB1aP8BDtgql2ELBxCHKHsNEAiGJ2gOFNA2CPCNDgg240gyEDhI8WgK/dq+p6CN7GsOso0NNNKOBXuK1DAO0OulEIANbYve9XWPitROeK0vs3kPJDBgFyirC2ELCxFVzbBAIk3YBoiAyRhgxfyLCWiBDGiAgR2B2/2xbHIMqZK1fuKrYUG5l7Mv8qDhCypZ+JKZXqIv1YC2gwAfPSE/FFmAMQS2YCNDoYMN2gAOLVzUnG3fgSm/b2M0AYCBdcCDM1CGctAGdkCGD1iBz/AAOHIVlQEkwSEMuQiQ+jmnDDS1r7VMBdAGSCgMD0gAEaiAb+CGAEGGGWiOAUCBcDiog6RNECD/qG2jDamB4RhRDTEEpgHwDvwygA62m1yGjoP84wKwONdIo40qjo0iqLoBzx5eCtH9xaADRqDTNiQwgvN0q8Y4tSWuQN2VkLpY2LTKi0whNcUJFa+qAld1zAAxIEK4Y4vQhaVYAxFcgEx4g8MCB1whhFkwCkl4BQBAgVLQAgKQg14IJUCoUgkAhCgFAT0QgwJgAkdgHSeAA6PQgr0lgEXghPwixNmAYfi9ZoQh5NM7jhatCkyMVxjogRmAARRQgdQkgXSKmP59lXp+oABplP/gnLfwXzoUO/RUBz7AhBczYAU4gUGQhXPyhlpCORX4BRwBNvF4E/0CDuJQSExyDdGh/9DgAL3d2B00C50TJo3qc0U3yxv5grluBjZtU4p1bSaVzmafAw6+ZLT8IIAhEIcIOIHPuJBSxcbjS5C5qE+DW+CjPSsRIFK4wIzN+NGE+649ioAsODtJqBkAYAZFUCNKYOgooIbMTQNaYDZGSAQAqIFTgAIAiARKEJo8+JEB0AQ7SORJKAMI4AJ0lQhLYIEBWIRo2Jk9WAX7MJuXVmk/YelxsxutiNdcfAqwoZIJOIH6Ka9N6xwCwpTPsMzDYIt4g5TBYCtQfocLwAZ3OLgCimJ1qIJUPoYauCQB6IBZeAIBkIJU4BU24IMQNoV9egFxgKJBaAe8lYRwcBo+qBkryP8GNwgAN8iGJIAhPsAAAXCESwCAEgiGVAiAFzCGpDiCcViDYUQbnmXuqNDrnYtpSQXGFDEAHTgHB1iBHCWvtiicPrqMAP2LJjYnOfLPDMnGuWCMxrAA74LVKvADvBEbScDBDTgIFWhH8FGqLZlVBnNH/aC29cIvyA25DhBGEBibKxGAEDCBOxmL1TjIMUKYQL7LQXbuPCGY1ONm4/i1E50JMngAF9hf2FUxEmgLqHu6RFEAVZHGCphieHvGx9mBd/iCVKgAC/CMrwIFc9iBBPgCSWwa+54pMoCGIwgANYCDpgmEMKiVQxgCAigCVMABA9CCMEgOVUiDAZiBZMgBAND/ATuAAQG4gkMgiyxQhd1hhSeRgGdgAgKgAUVwggTrChQP3R+2WUbjawSoAWR4AA1Qxg9prrsw58soFcO4jD7K4kThEHVLAAsYUg3hKtqlRqlSADVQjoEYhWR4ikZohAIoAW6wgwHwAnI4AgBAhGr4K2CghcGKBs9EBD7QpDCYBNwwCQGogW7IljEwhRQoAE6YhVBSBTgAAQKQhEYYiJfGzmZ/czjHkw9TinjdR/2amgBAgwswgiD4wEZJ4HPy1P8I6oFtkMyxtwdZYADZTyFFB2Z4Awd4YAY4BjsohFnggCpQAhrID2fbBVRvihQ5CNfomu9gJmAMgUb7jq+gmjtR/5GusZsFCKUlDwHHSw0TiGtc0zmv4AprZm4Vv78gdprYIAIj8JQD6AJ12IEdeIAPsJTGWJnCwAw+EoEu6ILHyQD6ZKDIPhVVyYsXA9WqWowEWEuyCABJUIQB4wRduL5YzxVK0FUmEISBMAMp7IBRuAIDgAI7+A4tWITkYIZCQIASQAUsQIAr4ANdjwRX+A1OeASCAoRE4HIWxdmRL/nnjnupADrnDzr9AIMIeKOlOydMIefE+PH6BKvHKasT0+KRzBwGqAJ5oIZRqAd70INh4ABzyAIXsAd0IIYzMFb/w4D7zhFDyAEDSIRiAAgUAUw5EjDDGKYAWpz1CAAMloECuf/uCKBS7oqAMciOBLjTLYSAb3sCIOg2CQCGTnYCEAFyKMAAADIBxAQQAICAmTp38uzp8yfQnwGGEi1qdGjQpEqX4gRQgIABqAsE/EAW44w4Z+S4NTsQ44OGChEcVHjA4ECDBhMmcODwQEEGBmkVcMhgl4OFAw4eNDjgNwHgwBEaFAIgAUGAUYoCLECKeAACAgEKYLAZcygGxAAk0zSQk0CBAAIghIYKEwNopEgHIGXq+jXsmUdn065tu3bOnwIGEOgN2ncByAFEPYhBooIGH34fVLgQ4cGDsGYTHGDgQIOGDBMylD0wIUKEAycyOEgwT8GKPYn2zMugrsEuRN/wzED/IMEAhmhWhnP7kdEOAgCYwYoANggzxQBH3MECAGWYQUEBibAhwA2B9FBADoD0AAAYh4QgASLPALCAGlwIsMEnYAigQh5k2ERTbDHKKNRtRs14o09P9VYAAgtIgAMNMtBgQwkCEBHEASR4IBZ40ymgQAOANVBBAxkowABdFtiVgQUjKADeWX751QCUDTjQwCADHBZAKHeQtIEAEU1mAARxFgDBZBtEhABkCGxAwGi9dXBYnBB0QAAABiAQ1VQF+DRAbjhK+lqNlVpqW6SP+rZpb4kGoEY8I4wgggg7dMGBmRU4wAADF5T1gF8RXMBcBS2Q8BysI2zCwZkNvFNBPBH0/4HHJmUpUEUlqajTjgoULIAACLtYAQAEEBCAQAEC8DiUARIIEIABoi0QXAAEdPBtZJNR8O0CFEhWwFQCEIBBcKZpK0BOwU26L2yXtsbvjQMUMHABEsBLgcB8biaEDx948MFYsCaggAVQ6mWWBwlwoACVI2iZQV0tWBCBqtT5xSp11iWgBbV4urKIvCioANUUMxhQghghAGBCEgbLAAMBIOSgZw1TUADBBiAsAAEMKiBAARIYQADCDRRQgIEM2Q5Q00yZAvz1Tv6K7a/XPAlMMNqOIgrFNbnI4gskq6CihAUkuApdkweY/MAJm9jiyHHWNWABL9xskkADDLQwTSMZNP/A6wQuHNJNFw4AIYMEIQzQwS5RFGACBHw+RS9O2960QEzzgqZzn4wZ4O4CHSAgb7hOKcrn1aCVTnrZYPsutu+S8uZbVAVEFUASMZywggsngAUddA5I74CsETCQwAQTW7CdAtgroNdYZ6nFwFjUn8kytAGgkge+jpRCkjGuBOAEEFwEgEgrQgjARzgE0FAOMwKQiGmUIAB7GMbSivEHAfAADxNSgzkawghndOAmO+ld8Pj1rbFx8DYYlMkHBWaAy4jmJvA7QAUqsAISOEBvaHmAcxLwABFwYxkkUIALZhUBVICjAR/owgoaYI1VuIADH0jAc1BhCbMoowZPWQAKSsH/A5tMpgAomAFkXmCDqMCgAwPYAApIAwIcTEUGOAiABG4gOwnkwFookMGzcAAD+5hxhE9rCh4/mMFJAW+PscnJ8EATFdAgBgsfIMEhPeAq80nvAdNrofbqYgG8nMUC5JueXCZ5JVaxagJqCICzQmCHZLCAAkSQgqFmoAIJlAAHJihBCWogAQnUAAYLWIAQbCABFhBhAQT4wQ8MsIAtEKEAHSADDArAgiugRgdSgJQfownCDlKTNnoESiB5tLRbDiAE3rCAqiJmPlqt6nrYCFUEXHC9D1ShAUqYgN0u8I58IDEGD6hCFQ73AQvYggVo9FMnkiAAUXSjCAEQhDFeQIBg/5wiADP4gh8CkAVx6A8QwRjhMAQRgBtkIwsBwEI7khCARjiDBgGYhCUIsIBtpIIkUxEYa/C1L3zRlKZ+7KM0YfMU4+1UUQLYggaU5IGwlM+R0xsLdbbzMS7J8AAi+J6YyKSACZQpSm9hw2YAMAkj2KIJXlABESAgAS7ogAAm4AIKJKADN1AAAUTAggQW8IS0woAK1qJBDdYFg/pgIAc3gAAKpCABANjACtDM6R43WM3FDuWaPxnAINGmuxAY4wIucIEGLuAqzWq2LC2UBzrkoIQqKMADSRpENODhgAskYATgyIMPupCAILRAA1rQQwvgoYwSGFMCNtiDEBAQBV4Mgf8ANnjCAgDwhCdgAAZHsEEHSlAGDFCAB0gQ5g9YYNahEQAFNKBuD4gAIRv8dQAwgIFNccK1G+ELU+n9Gk4RuxTIEo+n4ZrCB2LAPCWF85HRCw/ioiSlA/BFZAKmGJQCkxYCJ4ANAQCBAXCgiEMsQQKkAEcANgALSgSACcrwggAWoQ0dBIAO7KAuHp5xUGfc4KTk8Aw0TBEAHRiBEQFYQxNanAdkUMCC8vWdYhlbTcf2JHXA2ZrACBACcHjABy4YS3M4e7cDZMARdtjGaiuADXMU4hRncIcDMkACYOQhHCMYqjqQwQg42AI95mDBBgLgBli4QBzCUOlUfiCFgWFBCBL/eMEUcAABFSRhAxvogRXi5IQnfBETNgAACsaAggH8gBUhQIATtjAVMWwBkDI5rIxoSjaZ8iu+P06KtramIwN4xgkX8MBzqoO9tShABBVzgAIyK5cEcJKTCuiCBcikFu3w2pHRk0sdEsWCAuiiMADIAXIRIIMZwEvQC0iBDSAQOxPYZwYdgEAKasDqF9wgMk8YAgIwUAYYDOAFafCRDLaw3lMDLMhC7iCRQaiTQP6mNwsowQbAEVQNwOoBigxnBUiApXR0AxsewAQfukCCakzMEmv4wAjK0Qx1fIATk4jHCrbBgR3s4RMeGMLScMAFaTzjB1TQhhsCsIps1AAAuRgJ/xF8oOIstOEHAaAGNHrDjVUEoAbISMgWvrAEASzDHDMAwCVmYYIAgKOhmZq3a9pLTVJLytR7BPVu9j0TrPcmKti6ASng8A1HaIIUoADFJGoBCUNMYhKvyAbfNDYCvKRlYhkYgV4O8KQJWCABDlMVWq6jBQHENQB/UIMBQOCoDUDrKRQwjLYDgAEJAGpPkA0ABI5XLgwMJfMkYVR7803v2Nx7sarfCb83pSYKFKMCCSCLIgc/gQscIAIcOIEHuqCENY9WBC2oRxhwUY7wiKAK2sBCLYzQAA2oYwdmyMMZgjCDBZAeANcQQgBQgAkaIIC8A1iACkJAAAnQoAQS6IAOQv9vgxpUqwYmIMAGqgYvW0qbBpQHAYRtQNO8XpFN070RoE94XQaFnadhnU9sCgJAAG/UyLesgQh4wOBwyZM8SQaQinWghbAZ3AMgzvbY3hswhmSEAicMAOmBS2pgQLj4iGcAAGKUy7YsG+jV4AhtjUzVxG6E3eoFT+sNWYwkGfH0BmKwADLsAFl8gA8EQQy4gBIowRm0gTJkgwYYwQeswDRcgAOcwFgAQRMoQReUhQicADjYQgskwJMxgDY0QyuIQD8hwOxIwDUsAas9RQdElqPwFGiURm9AAAUYgE0sSrUQwBGMgaI0FhUJzL/MiNYdIALyhAL60bw54E7Ul48I4qL/lN0t3VKPSN4ccIAHhMnEEJ4FbM8EQAdgKIAjdVYKhVML5AEKJsYbyIQo3OIGjIIbGEAOmMLTSUEq2IAAeAIuGIAJ6AImDMAYVEIHAAAj+AGi6AYmBiEfDSG+xchTDNKmRIUESAEYOAETbIEXMMEPPIEVJIEVEMEN3AA3wMM0CIGqQMd2OEEuVAEJYM8IZAIZKMGqoNAEeIEvYEMF4MELjEjBwIIVGA8ahUacUFEIhAsofUsBpAC+LAAI3ARvMB4B9MATZIsExEQDToq9td4k6kQl+tG3OAWRAYcvWQuEEA8d3g5+CMAcWABmacBznGL2oBB0CF7vKQn1PIzzPEAG//QB6AFKKKjC5QkDHwxACZwCI1DaLIiUGszCDATAMjyCACxALixCAHxCMLxAAHwDKIRL70AK11SjNcZISWJjpcjI2QTHXCqKZECKUSRMttgENyTACjTHCZCA3SRAWGiABVBPUGLPBcQA9ZTWBzxAE2RN6FEANARXCYyBCWSELvDWHfSBAKBAL0xIEuhBzeXBI5TLMshB+E0CEgiSL+HR2EnKW5rkjKTkAi7ABkCWSAYFp/whp7AacG6NBDhe3SCSTu7adTjHXqDFAXiAc0bAk/Ca9SQAgVhLYnwCKJUeoggTfSXKDn7inYDLUFDGUITkp+HESbbla8wmXNrG1/ghb/8AJ/HcjsHAggg0QSeswAVowAdMQBWwQxt8wAcwgAZUgRLIggt8wAlczwOEQzk8pg+UW2ZIQDAYVhFshADwAjGwAAKcQjKAUipoQQGQATHwAAF8giMwRiasQQHIgDSIQWRExIjAyNaQZHsaBddRir+c2onQAMGwpUx0Y9npSG8SQEz02Bw0wFAlHFiIhQYE5mCgUFGOBckQlQc8QATIAWSECy/4gbbcQiXg3yVgZxJwAxMEQCTMQg0EQDI0FAFYQh0wYzQQYyVQAup0DY2mp3oqxY1eip72xG78YVRw46YEx7g0gzmkAiNoAzasAAMowSMkQy+8Q8qEwygIQhuA0wf/WMMl3Bbh4QEPUADnSUA4iNRwjlDo+JuRIgYd1gkAXN4ttSCrgUsg6dFJsidcTqJtgk1OgEsFiYan/USh7kiRHmFjuMKTIodzOqer8BcJaACWNAB4MAnJeCEJPAAhIORBTSUBHAIdXMsdcAIC/AAw5MAAiMEqECMu0IKPnIIbEEAZUIMKAIAg/IHBnGfv5Oie4kifWsqf7ttuxGe/FenAjIsyZIIntJYeXIM8TIMWaIM6kAMfeAAHAEIobMcs/MIBsEMh2AI9XAMokEAN8MbmFIN/YAEdkBgv9IIKDAAkeIIBsMA4nGAZrIP+LAIsIM0sNEIAmIAxQAEE2MTV6YSe/+IqNurqjp7aH06FUhxh2RVrbxxGjwGDB5zAYkqPWPDFqkxSBvCaBqxQk4YPgSaAGRiPZDQCJwgAn3QLhDCe0C7iAKyLndCESskLazhFNf7rvvZEv8Ylv8QEvw0qsQ7pLaXDBzjAF0yCLmwDeExAA2QDHbiCF2IWEJiCIMjCCWiACDhAKfBCKfhAD5yfMUVDDggAFDSDEACAFtAChM2Bl6oAHeAhD2gCEQwAGNzB69xBHSgZMPxAjxGtBvUtjrJe0u4tNiHZXKYNwTzLuAhBDlhBETyBFGABFWyBGKABF6SBKERCJIABF0xBEkgBFUzBFFjvFbhBFshBcB2PLrDC1v9EhpEa2un5UkQoCggIUuhgC2W0y9EYL2IZbb8GD/JCLW8ggAmIgzyIgAYQgwKoAzyIAAfQwzQ0Az0owA7AgzqQgCk8wCbojQLAQzTEQgtUQBGwIH7kwhOIp/GMCAJoDgtWENIgxjZqXgEFAEgEQAksoPAehb4mxa76L1NABUMWhUgC8GzgC51siyKwD5+EnqPw4ACYQLc4hWEUD2QVLKQMIhD/7w7PRjQV650UTAjcASAswzJQQxgcgiLMwRyMAi0IAyqgAiVQgjDQAjDYgScsQh6ogif8QSh8AiLYzLhIwC+IlKFap3dCiGEgDAYsjQRYS5A6hR7qDq92cVG8F5//Fu8Wy0hvDlK1zFL+0uEC3I62feItlfKz0OH5BYAkeIILEmtE7IaP0YSofRqpicYmS5MR5+oXE2xUVEsJHTGODu+3bJC2RIaa7ILPlR3X1NSL4OUP4it6znK9WTKOvt4P5zJQQIUQP+0pj/I2Dq7gdjKrIaFWuvKqbQpsmg161qh6aXM07TJtqiQY+8mICOIsbVMESgAGSA33bUAHdAAIhIDU0ImoPjJUDGq3RMMyR8VuAu95RrRE67A12whTZDM890T97sggyecTI+9Df5qq1ejACIwASMIagEtPGU+NRgrW1QRM621GB4U8C5lMJwXU9khc3ccnZsb5kYbZJpko/z/yI1fLKCeMs7RLLkRBuUCFD8YmRMPEYYWdD960AVY0UageRs/0voE0THFK2ni1OwOso9gESk9Gb+5lMxMtJlo1V/NETRPhj/GbwDwLN5az8YQenYwLVPRIJ/rh0/qGj0jDMpc07DXFD6olCMF0YmH18C7FVr/1Oo8d1EItXNPEKt8BdvrGBcEeEIIaREs2r8b12PSwNA3PwAjqwEQWNz7FFT8toUYEMzt0VNTCEoiGYrOzeiX2YWeQYx/FRWuyaLsG4FZ2sU60U/RIAIQBLeoIcuNRbj/KcANZ37o1cXNzff0mkQoSkW73sALHUyAAJICfLeu2Y+WGdVPRbxNFcP9fynQXoXEXaWirWgDMQQAN0ntvMmnvKJD6jhF6d3wHOIA/BQRAgs/B837zcia7d36/RuwF+GVfsU3ygrZERYNvcSTO8+qdTfKmdoB/+I4IDAX4AlMj+HpfMmQL94UHBb+V9aOMNezRoQD8gRlopIuvuPEm+CVntXrCuEwAOIgbKUjTREljQCkggUbmso4PYb5F9oXTNSSGy1nrG45jOGOlN78AOYgD6lOgRCeQtzYvuYYHhZM3eIvDRqaExii4Mi1XuX7rOJbP1IMHudnsxuhIw22b+Ikz4oJbipsnBZTDBqSorWQoQiJYUH//+epluAfF+XsGOVg/FvftAhXgspL/7zmf+7CKvzejXzIgIZlSfFDoBcAh1PiNKzqGd7qnS7ZYq9rT0mVwoM1L08TT/AIWOLqNYnqTb7pki41pFyBU0wRMIMYaBFDoTTaqJzs8ZxOyk/kC7AERUDMQi/kBpjiDszpectCvX7cABRCfBKuyh/smG6HuECC4QDuibzKmZzqZ87qeJzipbfuLS0YiBNBeiju+j3t3K8W8lQskRAGud9267/q1zzS1r7pOGakAJAIvwIS85zvEn9rZhDieYhMtGwAxlHiYr3t7+zlXHzxwC/oEhoFGBXzEn7zIJzpbx8ksYIHDKznIV1PH+21Gx7wXV3xQDEwAmEHDo7zPN/gP/xpALmwBsKo8j9p8B818jRh8deuUADV8tjz8z0/93vYqAuTCbZs8e+25Vrt71XdxqLeXZNgBz9471Z99mNvEAhTDflC5up+4a5T5jyG9e/16TmgLby13GIgnjKC93wfPScIEtXy54Bs9ve15s/Ot1++prqcX4+WBCgQAM1CEMc2g4f895uMIya4kCMFLBFqCQdl54ku3blTzb+towU/7wPegTAgBCNSAI0gCF6QAabh95t++ABvpUIjk+2amHsDAZPDgxjs26nv82697Y1nQtzRCOZhDOZBBueC+9H/dCGU6SaRAIqDDMsjb+vnE3deUM4u0Sjq2uS++NdK9SRZACP8sAzOADgj02OVPv/SLWlZ7DckiRWIXwBFYwxcAhDY6EAYYAHAQoQABARg2dBhgIUSFCClWtHgR48GIDzl29PjxoYCMGUF2HHkSZcqTG0u2dPmS4cKFCAIACxUAAIQCKnn29PkTaFChQ4kWPTjgokKWH5UCGDBgIcUBGBYY0IME54IFCQHADCnSKMalXsnGBEo2bFqKY8u2LSmzoYA8nwAYKDBRbVGlCiXm9fsXcGC+ZfFq1AgBg4F1U3CKdDz4JWSzgNm6fRsUbWCiljm7jBgRQocCEgYsAKu5Z0SnBaBCRP0aduyknfFCPShhAYFvPxo7rdz2tN/fnUNi9irb53D/4rRjNiyA4CnylFERUNggoQBDhEild/cOVDJtABMXYBBgAARrsMs5BlernDhY9ykzfx/JHn/L83bn2x8PkYAFIIBOO/8MPLAi7uArazukFmAtofwc6i8sCRsqqj4EKbKQw7gCeIo7DTXa6zMRTfwOqQWBS3DEDvuiTEIKe8rQRBdtlPHEHHWUTkW3TvvRxsn+6lE/HFWiUcQgOyxsRyN3fLJCF1U7SiMlhRxSvChh2tHK/EqEEswwsbQSyC5dE4zICdVCUkMzLXRSRDjFnNOi8JYs8D835QzKTpCY1PIlLt2UkM5CDVUpzfjy1DO2PiVqyi82ERw0xkMtvXQtPzlM/5S9PS+V1KcQUxwvoxBJohQ/TzEVE4EH/zyQU1TxA8xU/0AVCq6hZO101V4TROrMOHeVVVWUajXw1p5SJMCgnZwidTsnh12uWL+i8xVXNYWdltJqSx1vVGSPI0pBAapDAAMCCvOU2yyxxXQA1wYgAFpY2x3U24se/PDY75INVT2oBDA13JXu9fHdXu8aDYF8Iz2YUaNYMA8i28Td0qgfuVorusb6XRRimBz+SamYXk24J3ULoKDhkcOKNeQVjVog3pO9+5cni09OMYCV67UoZpyHcrQjm1G2KF4MIACA3o+lC7pLlw+SCKc2xx36ZxCprCgAA0roKiOY2wWMM6kNnf9qAX6thlrJsArYKdiLA/2p1sdGrPfHgSGIuyKxuRWO2mePxggD1tRlMWwqza6S7bYHn/rqGXMaoGUI7VqZgKcGJgC6guC+ayS/h81LdJMXh/JaiwFwtu+jNJbKsNh5Kr3xkh6HHGOVLLbrQQpQaLUDCgboQEADRDOX8gdzSmzpsGsHqU4+adf2dq5wHPjHcP9EylnVp3vexuqFjnbe/wrYO4AQTL6wOYYMCEAC35wH36RMV3d6tiWr33rjDUMc+H9IqxP+6kS/DokvcrMTABbCwAkUqOATnMBAH9SwiDpwIQ1yGMIVPgEFGKihDyDwggmK0AMZTQ9ffcMJAViHEhT/tmd/4LJYvGwjH/eE6EV80ZxCCFhAA1oIgbnT3X/CwA1pIOIZl6jFFBBhDGsQQhHZgMQbwNGLT6zBGrLQwjcI8Yk8VK1OLzRTAevSwtCRqXrh6plZ4jKY33zmQ7Cb3Q8rdbvxOcU2ARBEGeogCFQM4RmcCMAfRBEAAqziBVG4SQDCkIUyHEIYvwjDGMDINTo6hIws7GFXohZDgQHgBm7AQgC8YAovPOEVqFjFM4SxCmGwAhiP6EMcMnEHCBziBoHIwf28971L8sqOCUwJsDzRDXCkYRk9QAQXAjAKLcDvEjh4gjX0MAQ/FEMWTGhEOs7xhEpu6JcV65tI3rZJN+0P/4ACUMEsXHEJK7zCFNHIQSJs8Q0tAOMYuKBDNOYwBUekwhdlqIYfKDEFARSAXiQLZ+CCKcQZ+YEYjICAHoLhDSgEYBnPRAAdaPAEaACjCINwwTAEEAZctIEK32ScATcyMjG2JIYDK0ExCJAKNtTiBbMoQQCkcYMAqAASAQjFIBgyBymMIhK1mMYltvChzJ1loe4a3B0H1hUBzEEXDIHDGmTBCQFQopAdMAUKnACI7BzCD9SYwSOW8IorqBRkdNRLt9C5gRLM4hylqIEhfpCKFBAgF97UQS0WsIZxDCMKggBCLmigB1B84AdPAd1PoirVo93RMAH4xiuyYwgq7AERAf+oxScC0IFY0EAIysiGIkKRiDvYoRZQ2MMbwIjDhRLlpfqJYWmHoQsiLIAc6KiGDQwAi1HKAB0bCEMvnLCAPATDEAEwBRO40QMEQOdniKqsZU53IswmpAxMgIoUZHCFGghADkyAjhpSEAJGLEIMSxBDD5gQhxcUYglwve3QdtXdOHWFArNgQQBAAA5MoMMGBZAFFQDAgmgYoBKaIIINKnGLXnChGFSAxBiQgt3+GWy7hNkfVaN1HobcZQAgGE9i0mOAiLyNL+jrz0I3OT9U+VdDwGLBNbz5gmsUARZJCIA1yCCAGwyjBHkIQhMosYw+6IIZsojEI55Zmtb5MsRewXH/koRprLpIIDEDCMFzrLyB6xaEABSQAAXSPC8QpPlULL0SeIa1ZQOJhAAQuMIGIBACK7AgCimAgBNoAIENHGEDNihCEngAAxywQAI4kAAPTCCBYKkqt2yz89rmRtk0Y6ADBhhQ8pRnAAp0BQGmNgAGWjUvCmV6SS6d1qZRBJWFdWDNAcBAV1xMgQWEmjQMiVeeu2IbAxgAKgLj2xmzHJnddnk6pAKLbaj9rOhQ25C1HQ85YR2j3vB3WoMTCXcaM+5wSRYpKVLI295GAJWlaEDZPcmEmu0RWk8K2qWaTy/Xsp1n8VBBnMRe+2ongPhthlv3TkvBTiKqqiLNMWGL+AZO/80sT3UbYjHEXaeHGK0P8+/hpxGVwCFCR1/zzyftUnhapi07+SXlW1Udt+C2vbrMSWBpcXw4iPUkkog926EuJHdkSl40TNYM4/gREALUFXHKJvxQ1xu5tbctH3CB7epnojYBjlCD2sIp6WoycSc1zsmge9kASfgEGzaQBkYoQgZcAAAVvDCFPLihAGRgBg560AdWbEEHbLgCBIgAhRmUQAYgYAGw6EcIXHgsjk//W6Ec0zN5C47pmXtK1xAqEgqcjzUdgI7P+bO6nUAFA/EjGJaVBJYCoKdLNB9xvs8YilmAYgyZ8AU1sJALEPRBEXL4wB1CkItuMOIN5lCCHQpxgv906AAS63jEFVJBhVIcNOxlC4AiRmEuZ1XrXoY6zwZcs/PVHYUAJU9/zwxAgPgxKwALKAECcMMahI765tjBwAAg4OLLM9txSGUUioDg3qTsNs4lUoNUDMAOOEELmEERsCIEJmEDxuAPBuAUNuAKDAEJlgEAriAUmOYQsiAHKqEEvoEJtAEKNCHnGmc97mAOLC9fwm8lTEQAFsAEZMIwvKcDBMERmKEAwoAUTmEL/sAA3gAKwiATwgAEQAEd4oANgiEaTiESZAEShIARwqEQmCAUjoASKqnGVkpKIiQVaKsAU+UAERCmUoM7/gARWEEVKMEZAIEFiIEAboEUAIAYUqD/CFKBCFwhAOrAFQpgASoBF36gEiTAFcAAGiCBDtIv+0QMWAQhq6wOqiYPIz7pzigC/mpOI8itAFSAG5ahFMRgGF6BEZhgDyCAF+4gDYKgEK5gDwDhEohAD3YhEmrgEgwhB/agDkqBC5whC06h/MAj04IDIk4BF+AiRlaOy84ubMhNEfpAC1TBFVIBCkDgEsCAFtAABAyBArAAHGIhGQIgC+hAIVCBEKIAFWgAGAYhCzIhGnAiXjxE5bgmEcpx6lJubDJRE/3D6bYt2frtIFbNEmqAGuTgEWQgAHJgGBDAE8JAAIhBBgghEG5gDwIgDR6BIcDgDlCAGCTAEooAD4ih/xIghc42RYVOQRU+5IWCwxnlJgEV6hAIwRMaQRdyYCEGoRwuwQBCwBQoAAlgoRTuwBzpYHVoIRKWYBQIQBg+oRDQQA9O42BOJgA+gRe65uXCUA1lRSxwAkLohB4lIAWiQQj0ABP04BoC4QXCYQPsQBUKoBQCTyknIQAKISMFgBMoAQf4gAbgYAsMARykoRj5xABV6BFuIfI6JSZrhPZI4qu+4BzIoBTGwRdqAAO0YQ0CQBOq4BXiYA/QICOZARQCQA5c4BqsgA+CgRreABjKYBsSKq7wBSWBhheyCgFQbkagbpx+ateMRkcWYtU0gQdWoQ6+IRJ8ig7uwBR6AAL24P8FmMAbjEEYAKAQSMHFMEESYIAbWMAXuCAQEoEP8IQr14JoRKY2q4QOFNNUxAY4gY7jEKUgqCAMFgED6uATEoEHDEAOCJATAEEQhEANhoARFmALIsEAssARvoEG3qAW4mAJcKEI/mADpO3G3nNq/uAm+G03Z41jwOYKaCAs6cTzIEATrnMQSGEMsKADrKACOJIKrMENIuEUsiAaBCASJiHNHAESdAAOBIEYRMEXwCAcmKQ8e5O7Lm8hVoG0zChWMHT2oFHfAAAByE8ATo0hIKD/KIACtAMBCqADDO5DUCA7AgB9niMAWOZr5CNqSm5G5qASqmYgFcpDPQ4pwuz/gvP/LsyFGNoAHSSAD4wAGZJgAAwBCgTAEJoAHMLAEbBgGwwgDopBALYgG8ZhCgLhBASBCRyBDPRghvKUJxDmPgLAFTwBrrYtMhpTUKQ0KdJtbw7i82wt/kqDEAkgMdrvOThH1BYAN7RCAiQAXXYNnFpPOywRjy4Co4zy+6SixiKxaC5C2VSVXBxDXWygBm5gAFJgCFDALkrg1FQAXEMgBSINXWiAAjDgBUIABDCgBkBAQDqAIJLN/HDrPB8lJe5iDgQBT8KIRPgCStPQ7OJzmMAGWDwRWGqmL1QHWPhidbCH5jBOJgYA9MwII0jVKLnjSMXwxhJk2jLWP2ooj4TNZKwK/47YqOhwokA+RE7n9UTSrxIqEWA147s8Dlo6Vj76RWGrKvIyxUr4Dztk8z7m4A/MT2K1xpzqzCLCcuZINCF0Rtr8zXVqlit2aCKM9US4431Q4Q92NmYfhlUTR47AFuLGFmiCRGJ7wAvsAmhJQhe2tmnd7TkM4khGx4UKBX8+5lgw1nUCSOZ0hDvSrxGysmsDY2a9o/JK7knbQ2IFoANg4H6itm8mMRDAEiHKNDfkxFmpZ3ApL3o6tyJoohEmd3P/onDtw0Pcs0AEAAKcMwA2IDF8Q2DGrariJQzCwCVTZAGGoNCW5noQor9GF2DjZRlCQVobSmChRABYQAXOUMvMAv+h4AczDQABck4A3G1vWkMp4mUNPGHd3JQHZGB6T7V1MnfZgBdMaqU8A+C1ytd8jeNrbRAAjuAICoK7JqK00OAFfqAPljdeYGAL1IAHmOUHROEIpoALOqBraJcZAqAGhkAGdMAEpkBdxPcrI7F429coynMhPuEQ2BeD+fF9c2w8DA1+dqJe6a0hngIComADaiAJfpZXUyAKvqYAeIAMZGAJsAAFKKcr7qAcowAJkuAIWEAMvjReQFXkAhaNPvhsdNPajkUAFsFtLxhlStc7JLYuCMAEKKc1XuIpclN1D6JV4g8BQAAHhEey1MkLaAAhRCM7AqGDDQA3DopprutwRmL/VGrIHjeFipnYyxCH4RokIQ4qADxBEijYj+njMa9WsmAMQvbiKyYCRAyAZljDIEqLAnjH3ZjubSTABqagBOInVwOgEuJUS0GPd33NSDBWIVwlSNIzkRFkaatuL3YCxgLycauXkYi3jxPGipEjIAtznIxGAtyt/ShACK7DX6s3c0zDkOYlO1YnALBKK5lmRNZ2JWJ3KV5yPno5kZcW2TSn82w5O3KVhRCK6ZyCJnThJkA1luPseH1l33yX/x6CBq4EWAkuKqh0kASBjhsuOPAWVcfwnUVkThu2IlgIAEyDcsB4YNqtarLjDhRhL6ikbjyXiX+ZR2QHRwJoLeqADkJB/xF4gRkEQRQ4UUDUQA6goAygwAm8AAlYaCHCUwbd2TydeDYZqqCv1qlS4AVwoARAoAN2LdWO7diSt2E+pABMIAS+dCEmOm5k96LP72e8WSbXkEQdVvaSAiafZRmq4AMugAM4gB5kQSYOKtR+IQNaQAMmwAImwChhYKcEQTEhl6uf5dtCB4WseqeR5ksNAQiQYRymgR3OwQ82Z/MGgA5gIRp+YRe2wRmWYWmgQhEUQSJWrz8c41pcbnM1mvLI7RM+4AyUYAV8wAJM4Vl2Ym8ygQFc4Ax8IAYqwA8CoAcQ2BNaUuBGNKGled0IEoqBqa9NJDrehw8u4AuUgASCIAG6D/8p3O0pfCECLuABIqACLMARAiDV1HcUAMRkAo5K4IZf+JrTZlL8cLZuu2IRKgAIjAC2GUAPxkMCOoCTauEEmuAETkAJGGAz3yYA1sAMBgZSZQEHmGQiJOCgckAWfoCShccwKKQzmMZjg1sz1gMOXMAWbMEIWuEDOjj9bDkAKCEGVoAEgOAMPoAOTkwA/AAVzBQAtqAQmq5vpBcCCjEuoXmrR9ezZWN2AUjfUgSHpuYTHCAIjMAFguACTgEDcmBpINEXNAAIVuADXCABslIC3ucPLBsptiATwrSbIaQHiCEJzmNrjIRI/NUANuCOJdxACCYALiEG8AAPjMAWPCCr6MX/3boCFaL8A04ACBxgKqlUAN6AEsxFACRhGxD4WJ4DADZAD/y5/xI5x2VD2V4OcXi83wLgFhJgBYIgAmJAA0AhBJLgQWgiAGShAr5gBSrAAxpAX2lGAALhAlEgz8x0szlxALj1Q0wAADogzfFY3d6CTQPEqtRcQw6KJiZhBYzgC1ygCSLgkCEEbiihtTWgAmKgAV4BJ2gClqrKrnwcdiFceGKiAKjidts30mFjIealA9LthjIn1B6uaFlDj9zhAS5AAR5AAS4BQKoi/bYhAVyABCLAASbAdvkjDHihA4TA1CAAmzHvObjUKWTzSPsVUsjtbog9xxqGGE7gC87ABZTA/wGyisyQLQBeQQFi4AIY4AQOABCdIgAI4RtucHp14oZW50EKYANcLH6wJ8KreJG9qwBQoAhMQzcLIgfIDyHcDW4D4BBaoRy04RzO4QRiQf6EoAeKAAMwIBw84ATOILYt4GKzgxMWQdeahWIH+deoFJp73oXaCOMRxEEMIBvg4QAsgAOqoB6+8NhCI16KYQQOQAEygAPiQRb4L/0QARBM7NX8jRAlVqFnGcd/Pk6EU8U4VkHWFqFYCDowIJNNgPNRwAsSAwU6gAee4gd+gAee4AmOYBCwoC7eBxcWmCAlTrPtQ2LZje3fPmceugDsIBMoARXmQBgsIREMae/fJhAuQf8TvsERgCEV1sCYAwAXrhuRzVO8HTOEReScFwCM/2fm+M88BAah2m8ATMALtIAFSkD0YCAScOC6DGmo+cIJoiAA1P/OU5zsMRdkDUTpAYJAAQAECxo8iDChwoUMGzp8CDGixIcDBFikgMFAgI0CAgDYIKGAAQQDNgwAsDFlAIsDCgQo5GglRAEAKk68iTOnzoUqe/rcuDMozgIFCCQ8edLAgKUQANBcSoBAyx9OrJiAYcXNmyUgABCggIDHDUZZcJjw0odVGZouzXwKMPDhU5o0hR6FGDVqXLt8+/r92/BkTQFFaSJYYMCAVBBLlQIwQAGASAkUCCCQAAFBgEGnPM7/BAw6NMSfpIGKBlyRLkHBggVIrRgAQoEBCIgSULwAJQYKLI4gAbBA5gY2JdKImlKEEKANFJYGZ+ZHgM2aC1WflphXoNPr3Lt7H1yw4uy6kqXOvi2yZQEBCyDcXrBAwCBTMh0K/o6/b2nS+YXep05QXUut11Fh0ullAGUEsDcAXBusBEEKKJRgQg6s3GADDixIsIAJSwWQjCpPQdRafwgRheJSS5nIYos40XVSXU8VVZQB4VkmEgIoRQLHSv8h9KOLQjq0309DvjiddAY1KAACEFgEAAQGEDWlUQW4R4EONigJgQkpSFCDHCbYQEAHAHSwgECahWFGfUEuaZ2Q5NWU/92Rdh7545yDiYRea1NuRFIAdaRSn0J63oloQUX6lChFdxEUQnApWdaSXoc1RhQFueW2EQQg0EBDSijBhUAHHQkSiEfSHWqQki6yWl5ejc6qn5EF1bVSSh15VpNiC6pUV2EBpAEMr7Qem9CiPSGLUwCNwFLLHnqc0ksjGGR3EiOl1MIHHHpMIshsjy0IwSLUKFJJI3bYMQZtGtlRSQAE8AprvQAu+V1RAhnFbL8KxbhdkyiEYMICHSCwQVcqjmdDDTa8MMMMKVCwkUj62pACCCBQQEEIX1okABi0FIqQq04dKuNBHa3qr13KqtTyaAFIokAMF9g8QieEKZZYAHckUP9BAhYwkAE0AbTkmkbBxONBBA800IIwHjUoyB8BGLCAS/wmpN16R+81J64rXqdvVDGf3SpsNnRyTjbTjHNOE6Ocp5gAFAiDhzXGeCOOMYrMBoEEAyiVShvGOFNONl/wcXSDWZAir48LRnl0q7nOhvR/SU4J5WpoT/SyqJ8nRJcAfzjQxhnHtHEB4wNkF0AeMcRAQgUkMFAMS/KuZ8oBTfgQwwkHKFJ5AInccfQGCMCQG+mvCyQBTQQIDmDKCGx9nXp7je5valcH88AXLhghDgOAyKtm1pRUYAsQKxihwCy1IQxBg5Qk8DsQRrQuwJ9Z0BcALMTBAB2QxBWwhivTEAT/MQFaypxoQxKjPJB7RAqdsSiopI78AX946KAHiGGRKdkoAJ6wgBJ8cIETJKAYUwNAbQKgiQMEIXgkSIAuZBIAM+hCABAIABvwkAOSrQY2QrBGJK72pFspagrN6MG9QgMrCvarQQjoRBDw4A1buEADr0CfCANwCA18wQhfAEICXBGAkNApAHNowBe+YIsvkAAU8tJIHPbQoD/ExAR8YIO46LKS3NDCET18SkWmsxJRbEMIQpRiQyx4QQp6bw4cAAIe2tCKCuisUkoRQCEcAATanaAB0VjJegKVih34YAUf+EACDlE8M8RLR1jQRQoaSRClqOAWUeifmUy2KiSAQgY2/7pOFB2JKCXFyCLFIIEymmCLNsQgJvsyAAYCoIsPAEEZ5giCA2hht/JoRBEOaAUcm6ABQ1gkJG4ghpMGJwEMSGcD66nJpACgBS0YxUbkEcxAZHCIIYztmMgcVeiQybKOzCEDTSCBC5RAAnfmpSgD0MIFlOC+CCiAhZSaTQAu0QLaeSBod3AhSpjhCgFcyyXNSwhJPvQYx9hkTi4xQA8LilOdzJQgAUBAMCJgixjA0QjnK0hRAjCKLnxBGW3wQQOWcTXl9SwPJPidEfbXCaXUhguWcIkWNGECCUjjFixzSq464q4nGmQgX+vcdnJ6EEgWdC4BcEULRsABBTygBdZoCv+fbBQGbFiAAxnIAAfAATHXSCUAlpBHBRjwgAeMYBXyCk4goBqXYx5SMnD5l1MEopg3wXW0oyHALw6ghCaswAcMEIaMVmWHERgBeC5IgCaitICKPOkQDfDAB1xwAgWEAwMYQAkZepE1NUhiAx1ABRceo6ejdcQp62HNE0nSOYIiU644hZIgYtGJWcyCD+uYBQtcQ5TchmEdwVBGN6CBB3TIwEPigoAelKANbXjDG0pYBUqCswhUdFaJDLnPdFoVINIqOCcWQYA1sOGBA+wgASOABNg0Aox3TGATHJhAFaxBAQlMTwASCMArNjGBCTRgE/E4Bz01QgZpJKYj0QMABhT/luAcj0YyC06WBY/1JgGZ7D8+KVXWonIYCWGgBFKCARcehIFKEeAGOahBDXTAAyY8wSkNUoUkIukfnfaYVmNjiJBPEgAQAOIRtNDEK06RiVEYgCaxEVwfUsGMRXjCE6GgRpSxFpUBYOIQa8BFHxDxCT9sAAPBQcMvlLKBHtYGM5W7iWjvUiJHcpdZMipAbUZ0XT5dSQIuTEyNNDMAikGgAwNQgQRGMjiB7Mori5VOg94Qr0vfSruPctSYuefWwRwoMgYFQI1rQpQQUCxXG9kAaBdAgaJISiVXWkD03LAN2VhGKhJg9eQWUubqsIrXn9v0rA5JHpJEqUENJHCv9FU2/wBQ4AaXEeE+fYUUydRoStRpECMoUem3lsyYv47ZuKkzFwSMZCQLOEwx2RKVAAhBBS68XtL2JRKvYK02ampJAKiwi3l5WoL6CjaCJ2LIFZGH3Mwyd6Jc1ZrDhCROJ7sVkvcVlTljgAiQuR688/Kf7KhmXrgo1k7CBuqCw9VeR0mM05++2ZYUFwkseJ2U86IYPuVc6xK0Qi408lbPsBxfC/G0wmvjOZy6fFYWkckUoqDy1bCKRiLJekmkchitc701thHIQMQjAFzQIWwo77XSu7vrtJsc2Vaie2tukyCbIkZ6OUdQdm5j+QAg4Rclfqt1q6NWcP9n5XBd+51SExVJ1f/vT15hd3h01RJ950VK8TEPW543Hi7PRljiCcAzuiiTsRsq7Qc+iq4PbyeptB4lLPF7kKxusoKUaTbMDYlHynb5rWN+AFIKABG2QbGA3er4vo4RsBJaUNOf3jXWFsIPcKACFuBgCDTIjASdkgIVhCB6CbrB5QmiAjSgPAgAAiMhFb5iI3PWdh0hT3TWB4+wOzXnWeGxU2R3ckDyVouHfC0CMKDlNcbCQwtyEgXAQPNiNlPzFAhgAsyWEoNzJfjWE7uCNfHRA8XwSwlYMc9XEzPVTyVzQSADhAcBMKOjfkOiGoNjYm2gDO1gDMoQAYbwGoDECyTQDuVwDuwwDdXwAoT/oSYCMAbTEAzDMAzQAA2QUAMBEBmc0we9YAm+AAl7IAurkBENogWdMSUG0xSkcxDbpnzbwXcCkTUKoYCitj0bKCSwwSAbMDAgYAIqYAIYcD0BUwA9oAMyoAIywAJEgAWTQxiZkQNFwAM1EDEwEAIEsAGhJRksIAQ5wAM8EAVFMAUhUAAllgPEQAEG4GwNIgdiIEQqMiAN93yDkxn1JIiP4XFwQSBp1zJFKHDCxxdLgTABAAke4APjAwQfsAcBYBJQYjwV0AYeEAM+4ADeoAKK9SdpYDsrEARKwABNgAOEQYIoEQoc4AEX4AAMIAKQoCIBIAeEMjhHBnqUB0FcFlco/4AA7zRwHjUAr1YAG1AC+RYUC0KCUEJ+hggns4EK5xAO4NAM04AHozBgThECmdAK+oUH7aAEuYAAM1JiwpABQeADwMMAv1A/B7MSArAGFyAO2vAFeOAB5AACIuF9uYACgIIBy5AJmuAJ8+JuTsEhK6kyMVUSJcYqAgECKtAUCMACK1mRs8KMCVZ83iEd8CEAkJA6QGALx1ABPTJnisILQQAEx3AGePAF6QADtLZYUHBVtmAL5qAE44ACHeARIwEAvNAEZ9AERqAET8h+AUAInbGQBRBtBDUAHYAZ4lIyWQcBUXYUASAK18ADAcAK6GACf5d0EmET7EaMFomaJBgAj/9Ajw/VBgwAB00CJRaxBxUQAyvwOxUwCSghHooxChfQBkAQkw6ADgd5inRmBhqgP0HwBR8wDrvhEkSQCxKgBoSAAIGgCZnQC28RMOhmMAeZhyozAGmSJoZiFEXQDGIgAIEQCx7ijHbylYd4EvNiCh9QRl/QBB+gBwWQEShCQiQQA2fgAq0QBOOgAnCBeQLgBiSghEoIBOvQAQUQAnP2JJXwAEqwAitAAg1gCFejEXfWJAiABsfgnlGkjb8wCI00F0kwDluQcUBCAEJwCC9gAFMwCiEAlZ8XEcoUgxfImmUXHKPwAWeQltqgBFKDSAFACi7QPmNUAbtgI1BhFGuwAsf/YAtnoAQpSQHMIRkV8Qwu8FDHYAQaQA6yqBlE4AsboAWTQAmugAKYQAzLcFODkRpmcAkYQBQ7mDIocQVG4AYgcyIDAAJsMDE1YAWFFHr9Up8Chx+EOi+g4AGpcwatoAG1QCNZFwCIoE22YARAcALtYANXw20GAAaHqQTQSQLHgAKQOJUBMIUn8AE44wukEgBqQEdOcQO4QAOsch8IkAhFoIcoQQA8cAczoIEmBRfFZTe/ZBf9gxJx0ZWsSRiasQwfUJxNcAwkQFnZ5aQegAxb6g0R8Au5BVoa8QknwJdtEJ3QEG00Mi9vcAKHOUYrYA4lcBgBUAO5AAKY8AhZUBGI/0AMiAB29xIATpAHVdqUj/ECY0AD4dZAUsIELIABPVAExcQ9RTiEkJof6wEKugk8QaABlnAYCBIAzKAAQGCgQfAA3vACcMGpaNAGM1QBJ+ACyqACIoQ1AxAGDHABF6ABFTABpSCZKKEFqTBdhOo828ERHmsQuqKHAsAK5BCaqsAO+zefJzc49wm1Q1p2mgEIJHBVPgAEF0BZlvMIH3BJSOoBv8BxeiEAqqCORnCYJDALEEBPSOaYJxQDRnAGPqAMpakZMhAOLCAFh/AKNnAJklAEAUeQDdKL0ZWDQDJnOjAOvJgI1YACZYU26qckhfi1qIGnGrEHItAAB3AAD7AD3f/QAXw4L2YgAi0QAUKzA60Qs/uiGWzQBQ4QARnQAAlAAj0gAA8CoAPACyLAAAwANC1gNPHhQ5oALOD2pxg4F374LwWwBIfAAgBQBIywAdvYQFs7umDbEEJJCSsABGS6Ag9wPjHCVt9AjR7gAjFQAdVAEvqiGaqgnxyqAQowDBBQGc8TAG/gAhWgAS6wAhHQCigAXTKwDTgwCNHACMVACS+ggj2IgWBJkJTZFAuAwbjIPH1Ybj9mKEhIGBWYLy4hCK8gCbSwCtRwCYqAGOjaIJhAB8JADY+wCpoACTnwPOYBBrFQC3DAB6WwDddABKUWEgXwB9YwC7kADsHgDNtwlxv/IQrUcJO50hDRFx7NeHwL2REjsRLX83nVqkSag8YWKT1OugMPkAAptgmTcB9sYQo7YAEjMAEWsAPIgK4iQTFmMAIK0AAZIALu4A0gcHFz5gkccAAJUMgZ8AU1UCU3gA4sQAWpQA594AuEIAjNcKdpU2CKByTi0RQbEWU9tcaIAroNInUY0HlgBhgwoijnJxkay1k+MWd14lEcARcoAGsutBSRJnMLsAE1IIsNMgZaLBUrs6zNiGCtEZY6Vh6SISXX01INixMda748ARck9AudQAyxAAmZYAe5ZRAQoAqnAAirEAh34AprMBBPkRiicAiYMAisQAiKcAcpMC6BNgWS/8ALfpAHhYALeRCgBjAD0FADBaACg7AAY/AESaAFc+ajyvhE2mURnvY6cZEgz9xyJiyIAqACRLCZbUfNoDGC45dbGCADsQIw2pMiP6d8K9MSaJZdPBVrfyITLlEHkNmoZKMYxgZrzTN63TwReYKnvEJkhrQqUbHRfycvy+bLpkETIyEAIWBWsPcV+qIRP0FRFhoOoVkxu3JBq9zFFlE/pPYkTFvCB9UQHZACsiaBpzFT+UZnGFADHd3Mq4Fz2Qd0RoVzykgY4+J0DbQSdagqJvJaK3fROYbW5utAPyIY/IJehRFPl7Eq4jGLITYZuUEYbCFvSGaA8KFwmEeC8NFwE//1KyUQDTNAXdTKHYckXeB2NuoXI7BR15EqfZjpK8pnE78N2AIxhF4NkUuCca/nmYTixZGKbmZmgUg9cO1GU5ij017hNWZ3kFNCggbmK7UhZbsmLgspwFJCUeYIeQtneR0RArHwjuhVMuQbEZHdKPWpwt1hEwNRJUaBI0AnQQuDIgGeriPod45X2P2Wb+JBEC6RBjGRJPkBMIb0xa1Cc9LtEH16ESExEgiDVswHnLYGAdncErKBOcpnJSoCbT63L69GEKgNb+qBeeqGArFgA9MqgkcB0klNXbSsaSLdme32HXSBAMXFfXTWmKgYGNmBi/sUSM26AERuGVUqQQdZYhr/wQU9wmMsIs1mtuUW7lksoW4EICW0MYL10xy4csskIUKK0pDQBgKodpCPUXtTEmIqTgGZoXAHISWBgzWkdj0BIAO/EAKTDeSuMdnyLYSsEYSed9s+HpUcuB1ZpyCRaGwgQCaQS6OVV6H1U9WxcZCn9NW6Ii/uEQBukAkUmeN/0cw+olmHNM1eLoQWMT3g3Tgd4B7usSQusRGkJnYjCBYDlhLVFUKC+RPTA9pcZtMjFCUuEeiMcWAnAW39k9t+8TqRU3ck/NYvc8KOnR8soYCHAAtsSAyZUAx0gHbTfhTVZBQ9YAjA4Ah04Ai0EAoz4BHuoRFLQAquMArLQAunkAgS/3CQgjIJleO53dF2rC6xBkEAGQHwiH54hpEUA6EZUXLNLUVipbgBCxACL7DXKncZNTAEOgB/NqADN1Dlj5ERPZAHZAAGYMAFU7AEIV6eAoADZIAFSJADWDAFY7CF8cECubCCeN0gdZMmDu+DCQIVHELfQ1KfwIQfUNFDq7ADtKoBGpABviDmGJ3pRUESS+ChJPABDmCPS+BxWI0LB+ADJHABEVYNIjYvWQAKPI4fUgseCtGnq2f0h6eAaCALnSALl2AIstALQTQ2AYAKyNAN5mAM6XAGvqBuFZEY35AAmFRGGgAN0XOLBAgAcjACX1ABDXABK7AON5CeAZIFD8BKH/+gAU3QBk8QALmFAsXwjpLBEhbBirS22KluH0wyrREkhI0O10D2zXPwAGfwRmegAaSQasKXGzrQCmdgBLOTszDQU5gjAH1QVSsQA0FwAbKQGPMiCj0iErP2JrTt1vhCZ0AhWtKh6w/uYxQF5LA+4T0TBxYg9hFwAQdaqknjEgARqMWDFRo+NMgkAEEBAgUMBEBloYmSGE1cQDNAAUKBAhsA1InQJIYLHx+4gRhAYMCAAgGeaGjSRtmZE95eAFhQoMSvGQEWBghAQMAAITkMGFg5AACAAhAABFgaVepUqksLMA0aBQcCBEqleq0aVuxYsmWnAkWbVi1as23dvgUwdED/AEEV2pw58+WCKQAQhr59yEMJEJE+YozriQDpAAFvKig54SLIg1gFfrrRE4DjDUtSoAJQyljp0AASHPXRTFXA0gA0TN0QELtqgQEowhT5DFaq5jWHGE/9C1f4cOLFq65O+VDKmSBNmnwJok1HgAEGHAbws6IJECBnSKQKWp0AggB/IhBucszHsAAQCCAl70YDdyMxTlQLMZ5AwwBLKqz4QpwmGNCmJ+tAkKUHjnLYxY24rBtgAQQAwAAAAgIohB0YMLgqLtXKSkkACjrJjKXVxDpxKd2MY3G3tV5kq0UZwxqtAAHCqOAM9C6opYAFkItqRapaquELJaALIoZ2YBCA/yOFsHMghg9OiOGBWa4SIAAoTgnAAAleoOaJz6RKMYAQUBkDKt3+CkCAIcLJAbQUg7TuhWKyyBKosASYAxQbhZxzRkEHdQvIobJcYoUVYvChpGN+aFOxlp7xwKLuNJhEs/32C8CTBwYD4pggtmFqAQneCwCNE4wwwocVPGCnBAEM2DSAIjRYwYcvzvjgGBkU0qkTGRgqQo8fEJAgNutou4oAAHRgJQQMHlpKNrcYg4oCJHRQ6EfQgBtLSELdgrHccQmF6qFGHvAhCHdJgISABUaLKtCvBBBqhlYki8yDJalrsyXHCiKBhAOKaQkoMVKZ9TqoVjtRrriUAgpflYJTkf/WhZKtSjyfONJzz4zc84tMe89FOeWJKWhpCRJ8UIJVu5KgjqELPbHAhQuAMIIBPtKllbE8GDAsiDZIgIVDCLxkDAoSpvzAAwbKSWE1WlsSIghWz1BiBSWGCOBHDGYBe2mgFupKXoAHWCjL2Lw6may3Q8PALwOKE1flqsqFUW8WvaJAgGVG8ECDwjOIZiWMxUrKQgBu+MKgCjSY+gUgH1Kjgg8m16CBXVrK0otaqCOAgotjA4ri4N5jasXfnkKAAmqPA6pDhtoUeaWNvvW7d0KFNLGIY5pYgQQgEmiDBwBo5TSRBk7YWQkeLWyI0zw+KJ6EIDxoxgQElkYAAwKgOOH/BA0cYGACZUqAar+HrIih+BOmvABSBATYoBghNEOWK9P5gwIZAqCRmjnkT6MJ1F+stRuWkI4AEpjXnBJYLd+9hW8vquBwZuWXAFAjBq1owxeA8IFOmGAB1cobaBjCEZVsoSKEsYUGgoCFsHWFAgG4xQQiUIELRGAE5wCBZgIghUx8LEILIAAGBlACDMwrJ6wZyp9k8zbagGYlQkGO6pZylCouby57S0lXvPWhDJbROCtJVcEY0IDOXcAJEeJIS+xQhQes0QJVCAcEksOpMOzgAAwQgQIygAwb7EcC4SsAJ9xRBQ5M4AA78EAULMYpMIggAxNInwUyMAU0dkB/ZjrK/4/YxhEISEIUAjjkieLYRbfFxpVW5MhvtDirBWxgXipKYApTmMELrsWMhVpK20KgAhOwAAc4uAEMTiUxxm0qibVEQg1ogAMa5GAMKajZUQBghUhcwQtTcEIc5NDEuSwBDkPZj2Um1AE6pGEoBkAdSxTDFXpyJZ20UclVVhJLFTLEOm4TD22uyKx9zoUjcWmSVXb5S4ZS5WJo8EY7nDENdmSjFXX43gpxWI1O8EEWnZiFK0DgTFqJYhKVCMQyQkEJRdgANBSYFgGKIIlbqIITcvjDN4oAR1o9KxCqUAUj8qCGW8iAehsoxRIUgpSIMSYjT8mSh1pns9N9KzQc4WI/U/+SE9wlZy7UWdY+LcQYgZa1oVHppVrOWpYmrYSpCK0WBShglhXuZwESKoAE0JIlCYCAISCwTloGsJFZPUQAVMiMMy3UFCakoCtIqZgVveIVm/nTZlyJ43gU0xAUYrWeCLgrAt6zT4fcDSiLeeJaVasbrxjgrjiQAAUkRAEWbIB5DBlAB0rQgaUxpW4LSScS9ZSwhhhgsw/8asVOCwHxXc24ALtQe/bDXFNMISi0StGsVJISZ/ETNO8x1WK+JyFaQQgsq7HMAiDkz4bgFp3uGwAEq7MaCExoob1La1rKCKG1uC0teXqRfy8I4PymDipQ4cpq0PIQ5VJBE21Cy1efcuD/JukXSJ+JJer2OmHqwBWqzHrPsmKZFNmwJEhdCtzrVHvW836XKawJiqlKIwHXSsqGTURB4DTWkPiyLQQL6EBOMjpYjxAgBEuzGQiQeEiWHHQo0yKvXn2yAVDsj2IBTquAlQthAqtFy17OsnVUdF+UFThkvhsNAepgh0T4AReFUMUi1mCGW+DiDayQAy4+gQhGvGENghDEM8wQCEF4YhGfYEQfCiGHLNTBDWhIQxyykIU4gAEKVygDF+oAhTHEAQ1jUAMnrhBNHeggClLoAQ9kIIMfHEEIT8iBDHDwAhtoQQ83uEEOdMADImxLBjeQwQtYgIISmAAFNJgBDV5ATBNI/wsCC2AuClIAgg1gILZNlAAKgowBa0OA2qKdS5f/C2EAjDd8sYtvh1bc0EC16ctYBnO80zrh1XwPpglrE7aooxR9toQCG8gSCkBxBBCEAAS0VgENZI2DGcBABzeYATWH0AMkCOEHvbbCEZggBiZYgQnghIITtuAEL5RhDFpQAyE44QdG4OIZc17DIhKRCGaE4RCHCMQdFFEJV9DiG45IxSTgMAlI9AILhV2rmcfku7sOIBnk6IU0irGLWUjjF9C4hjRAkYlY+AISviAGJE4Bh0yYgg+Q4EMpLDELWOxiG+AYRjDAAYt0sMMY60jHONpRjnLgvRidyEUnipELaUDDG/9K0AY5lGGOZlijGtAwRjPQUY1pNOMa5NgFOrRRCmOUIxvnOEcbJrp4ZDijHM44BzmMsfp0GCMdsIBFN5rRDWuwYx3kqAY4wjGMYcAdHN3gBjqgAYu52z0Ycd9G3ImfC1kM/hfP34bbczGMbYQjHMZQg2Zuue6znogxFGADJthQB0LcAhGc4MQhBMGMTzSCEqGQBEoVAQw4wEEPp9CDHh6xCkCc4hKguARTMIRciL5d4L1fyIVfoL5tCAYEDIZqsIZfKAU+2IO1KwViMIRfCIdggAZuuAZu6IZuqAZj4AZpaAJ06IZpuAZlcAZjMAc8KIeZcI42OAZvGIdsYId0sIb/ELwGy+sGYyCHdGiHcXAGb5iGdbgGdAiGXdgFBRwGaeiFTtiFaJCG6Ys+KuwFQ7g/OgAGSlgGapiDSqgERZAEV6AGKWgSLGoopcugI9K3veIyDqKNd4MwCPuRLavD9gEtCZCA+loa0QCAEriBJ4iCHOiBG+iBIYCBF0iBDQABG+ABGoCBGUgBMYADGqABXAM2QySCVzsCKWCCLaACK4iCHtCBHui1UouCInACNCCDJZACK0iCWQRFJxCDMriCS4MCKHADMEiDMaiDOIgENhCFNHDFMoACMBgDTFADUYCCOvACksPFNMiBL2oc7msRDQuwBSKTuVCBYegGJjQETdAD/1IABTr4hlQwR1J4BE14hFTQhFWohGUAhGVAhVEYhVAIhTkgNF74BFVQAzWQg0IoBE74hDVIhDXIA0IYhPFLAzCIAzVQhVswA1VQOVYgBDZgg4EshEjTgjqYtDEgA0N4gyJIgyuoxSSwAilYgk98NSE4gh+IOBtggRIIgQ3YAAkADWQJgRDoAAlwxA6QrT5cr3HDwy3LEwADMBI7KzasIAHAgNhxr2rRsHLjrtjAN3dzN4tZjU0JJYb4w5VgDQ7Lw3wbD7JEFXyppQA4AjiAp6Agj7IUMNo4sDqkt1n5qqTsL75RSjh8kbvBSm7ERuFwpSzjRkBELwbDMr3cy6PsS/++LMvGFCy0IAA42ILI5LDC1C+Begq2qbEr2g/RGo+KMZGlgxgyoSA58b6J8T6xZCinfMqESk2q4DcboQ0w+ANeCINFeIYwMAMQAC3qWIjJcpbFUhGEYgEwmAIpOIItmIIlKAGvqC8AoAEiiIIZ4IEooAImkIDboYI9MIGrAC7uIi0CeDb3USxXQhWl2I+rai9+A42j4Arj4goJAa7MyqcV4swpWrrBhAsCEze+TE15ip243CsEsCWVcBamog4KkAAT6AAOYQqkgACdZAgJwAAcYBkLMa4CSIEiuAEdqAFpooGcKK27GqYUSAEWsIEaiIISOIoK9QUm2IClsa3VqDb/JGIKHtuPDyuodGKe9xAKq4CAP7SMDJMq1wySFIEb/4RNMxINZhqSlOiUA4AeDXCBA7AGFYAnxpiTyRpLNiECJaiA8pmfCLgCPbyfZ1gBHcEDc2iCdegA74SEDgCt90AOCSCtwRKK0LgbD+HGQxkz11wlh9APpqisb7EWlhiPq5BPAPNPDQpQ2GwS1wIAGSAFTXgFaqADwYuCCEkJG5GDYLiES6iFWDCGWtDTTfkRNTAHcwgGbjgHZ7AGIjih8cCAAOCCFXAGcVi8cWAHHoBL1uECbWgDIGgDceCaJQib+ooFKHgnxQCB3lqhpKiOuViMgjKxVaLKxcEWiBkTjIEb/3qZGEA8jrhJmSd9yo7pGP54AwCJiVbwAVmYFkBt0slqMo4gjxowBh35gon4AmbFlwgJgDf4ACBwARGqgGwInJZggliAgPaALJVQjHpBDnxpiZwMV7D4iaAIEpZICupYgNNiGw/poriIrodREYaIqkgVDqWDN0DFHwCoASPQABK4AAcAAgXwAtHkFERIgBOYgAwQgR0YB/JIp4j1gy4ggRgggVc5gxxwEssYIhIwApJYgQMwgiHA2NthAiA4Hw8IgvkRE40pBSjwia9yLY7hnbgIztIJjdQMDgl6G6rYAKHkCqkCF6m6WL1tSjNzWZOllQDQAiUQh2MoB1v4gFwArP+F2tPR0AFzCIJ/bYIgsIUjAIDuvB1RiAEjwYM2WIFm0KsL2YJOiK0FCIEweKOILc6zAIA/QISeChI6YQFeOILWJRPOUoE04AEImCssAY4BoAIx8BEbIcy43T6/ZahJhdn/wsp5YYF2aIVxUAZtIJ6dAtIAYAUjaAMfsAVk8IF0+JHiaontfcHPdYE24JaoBJke8IHtuIsVMIcZKLfqEQAdKIcv+IL6OIEHoIIuYQlicAPqkIA7SJMOwN2JeYojgJMOIw4FCoBUiIYJSeDADQt1Hcwm8RHCJQE8aAVzGIcg2AUERs1zVTDGuAHJdY7KbQJm/V14ggIP8AESoAgf4Ib/DfCJABCDXtCIAZgBWHgGfPlT4FAIS9AEAcgJ4BGAJziH7NubvDKAHhCHZaghLwWOACCFZggB2SRMCMElOSEzlGHe5vWyoxgAGBCHE2iDVkCGfSmDLmEhwvUAI/CGVsADF4AFCq4VNfiANgiCM9gXbbgBy4gQZ+GBIGiFM1AGZXCBVsgB0LKZAGCBcgDkNrCFViABz+AsPgCD1SiBYlgDA6jQboyKHMgEIlAxdKWRQxGAMXiD0rLgssBgbISYiFUD7QgVTB4GCWUrBVuhGtAG7dBfIPiCJFAcTnGCFQiCFQACH9AAWAiB5TksXzihhTAV3bEXZekA11K3emmfDjAB/5AFlz+kABg4smTp5npBgBSQAbMhDp8otwlJkXTOoDEmY7VyFhhohw8wAiDAgzPwgEIYk7mAgkZRAm84gxgIh4UQM/WSAx/AAyM4g392BhkYANmp2BwIgsEAFW2oRtFiiEvVhmZ2gWNwWtzALk4WTqCo0Qn5CrdljFE+lDCuF7FEI/Ex3lgWi1leN7mYkAB4hgg4AQeYnBUYB1lxTTIzTx4gBxc4gXZpAjxYgn8bJQFI5rE9ASXQgG4IAZC9gUwYWdJ4GHULDtFok+Stl+PMruD1TBuBjz2ZF6VYCOKYC2exAjRYIAcuo3uGkQC1kBewBq+Bah/o5MkSADcYjBg4Bv9lWIF2UCLFEGI1aGYSkAwfOIEjoICUSA4dsIX0jYGuaWG28ZghcIYvaIMTaAUjOAE08AmVKIUBvp/TLGvWFNSBVuWOqVvr4LG21emzANzAtRpnMQMg0AZbGAcQUoYZiJjZpZG8CgAhUIIWyAALSIARmAAx0IzBegpMGIEDSAAHcIAG+AIaMLEeqIUoBVO9VbGxZJzVnIrzOpH+pIqAYW7hMJEawAKaThl7JmNxA4AZaAcNGIl2cQEw8FgFq4OxbYDziABzKAFCfpI3SAASmBwP+IAEQILr8hGiuIAGcIAJUIAJeIAjKACWQZUcaIIH0AAFGAEFaIFT6qlOYO0EblL/qlSctr3tXtbr3t6b3w5cNRkAHEi1IeABHsiBJYjKuKWrEzIBNgADMkADLsgCT9ABZDExATiCSggDTzADP/gEQbABCrifHvCFnK5vGmGrFTEUCZIT3r6XEsvx90aoK9Pvc+Fvvl6LHjgGAfcB1VYALaAOcP0EDfAG1MuGNugGHjAueKKNPjgDW4CFa7iGdOCGalQiJA6AKJiFXeCDSdCDTEAGtK0rAagBX9CDSSgFOCAFU9gChZgQaSgDfGnzJJXb2VTea4lzHifLeXNZxZGNeHOIW2ecE4qLtZCXCLLPPFyNCCUPJIiFC0ll2sSlXUpvIuZt0UCgvQHj4TDXDlmc/zK6czzfMgL4gSJAAlzLASsAgdkVABXYgh6wgUYEga0QKAAOARZIAQyI0BAogaWhT3kxHbWwARM4FSD1d2hDC/dQjAGYBSfoEgVebiCxdUW17+XW9bHg6RWbIIt1N2k/jvcOMdm1IhUJCnXiCs1+iCHIhW2f+C8V9rZwHdCQb9r8dkFZb/wS95zveG/eSwX+Vt3OJ/exGYPK1yZRr+o5CoyVp+roLQDoBC9g1LU2i5svlDrX6YxfsdFQ8o+t6XA9zZcuMfbCEpWNCmfCqlgKAB0ohkD3EMTkbSl9+RJmV6qP1Go3Dp1vXlgiC7vvGMUwrnTaFKpypntCz8CvLJV4ov8A8AU02FGpt3XHRU3XIVcyungYKzALtng3v/nb7lsgvRjm5i6kD9U2kYFYUBMmPRmLX5MvTmsUAUSrN6OKEcyXxfssYwtsWeWaZ820jiPxGHzA90oDui0uAv7QxJcAMIQBpmdaV2DVMOy0NtemmnzegX3VwvruoyCtX024h6I1gW+yOgrOqlupeI/D548AwIFSULHp3xOyL2H2B5FY/i/jCPfar8NXOo5tLVfWbByAEDAAwEAABQgYGGCAwEEEBwsYWMiwwMOFFRdaRCAAQYBJogIUACBSpICRJgueLFmSJICVK02OXIkSJs2aNm/izKnTZICePn8C7blzKNGiIgP/LCBAIICAnwgoEHi5AEJUpj1LThxAAULTn00LLBg4YEBXq00HIGyJw1fLsQLejiXLcuTAAADsklU58K1dgi9r9pVpdDDhlkd9/h0cdDHjxo4Z46y7UUBChYYBGMAwkKpdpg4NSBCJ4C7ilgQkKGy4IEBevwg0rr6EKQCBASFDwkws9m3NvG95iywo86/A4IWPIx/5OGjy5jcL2m6JyRQwYKskAaLToW/LAENO2fl0SNIhVDIAIIRIgMcfRXcO8fJk5kYBsRx7qHGThosXL1xCjyaDNBSNJoEBG9n2114LmPDMHxSUJFdMBWAAnE0CFCABVkrN5JyHypVWWFnLkVgi/3M3IWRAT2gpFFVBB0nwAmkLdPBCBxIsgF4BGOKgggkmlNABVfWlRwAEOtCQggkUhGADCKxxNIkWAUQ0kgEmKVjABgsMZxIBCAxkAEU7EtTWSfXxltiHa95kolBsfiiQWwH8ocAJJ3xwwQfmSMBaWwEwMYESJKzwgQutREGlQhwd4cMDFVQQgQMnXBHABhrdpYoIMXjggQ8ONJMCbQPwEAsAOdoWGlovCWebDLyoAYgVLtFlW1LPLVAABAB8Jiaca/LF1HEjulnsYzgJ8IQltABCCiml9JLoSAUEgAU30pQiCzTNkFPpayrhAIstzihzDDnNfAQBRVfOEMw4zYxjTf8zrbBB2VKXyEHbaxDBJSdMCCBEAF0RBtfBQVQppNdJLQkEFlxl/hoxaSZK3JyEKn4SAR5fnIHMF8FsyR0BVLhwjBGtOONDOT3QZgACCyFhRBN44NGKOOYIweuBdzGiAR5ANPGFC7LkKHAPvbwFQY5IaUUXSWR1sAAWtCzCA3cxAXyWmgYBYCBTEmxAUcVxIkessWcHtfVRSVzggwsVnOBBGzUICwAFAxQRRJ5KKPFFG1eg99pSLJATQytBaHBCA1m0yJAAHVxjwQp4VOCDBVMuJIAenIA0QE+5GhecQAnVdyXBe43JFwEUCCthTBSEDVHdY/9aLO3DdreaJxUA8UX/zRX8YuBMSzRhBBCGi4NHogxFBMEQZwTRRNBGePMEABCIqaIaGmjDcQxBzLIBBRoR0QtrEIRgSRwGUSXYUQXQwUkInrcVFUs10PGDbqZVaAIlUBCEIbcb4E3MhrYDzo4mAUiCEs6gDFvgQRzjmIHIBmAFIxhBCU0AwhlaQQYBpKc+LzBGG8zxBSPYYgViWECulFKAEFQjCG3Ag8ciEIkAgCkAj3gGbQgwCFHY5mpkIUsBaHAJKYwFMAPYwACWAQcNSWA0WDpKHqChoYcRcE22K9tyfmMU4QgkAMmowAEuAAQSVKATDqlNTwxwBR8EwQcfWEEQSPAD2ggAA1dSwTHa/xaEMzbBCqw5iIq0wIAgxIAEGnDAJFyULGLYpQAmGEUZ7KI2DK1CEQHAAGZcFBMA3KAalZxJhHQVgBvkQg4DQEBospib2xkQgQdskxSA0IZjeAMZbZgGDQJDkCHIrA1t0MYx8BCHr9RGADiwRhO0YbNjuIAJBlGPAUqAjg/EwAVN+BQYkKIiTayBKQuQxSMEsJqXoLMH6wADrU5CxDyYwQDY25kCvRAITg6wQx/a4k5IWSwvFgVDpFFEBILgggcUahhRyWFP0BDHGKwgBjH4ABKohBmAweAEFYjBnSLQhCWAUClLUYNHE6kEBuSiPnd5AiRWtJq+JHCIh5kLTMZCG//D6GZHTGmK41y5E7UNS5ZC9UmbhHCGoCFDHC5whg2EhaEA0OB4bWgFVZVww5KABQAYyMYJbHEMZJzBA27AkJhqA4JwUM8FRjiGB9SAlNUsIw9+ekEKyirTmRC1pgsTSkhcdxnP3dSnbOInUYJ1NqDSZIhkCcA3qoCNKjSAATtARghACNgAsOECEWhAAyZggRE8IQAQGAD6CkCEGHDAAgqYQAaMUIQARFEpAciDCE4QgTxFAB0v8xxLy1IbmqLzMmbyi3JIUhy1SQiLgi0J6CoWy6ESFiYBIII24EhVDygDB4HhyAyUEAMgYDAGGvjIWHSlVWv4oAknoKMHqSTSAJT/oBlq9UBEI8CItwaAEosAicAEAAJTJvaVFhLdK3uDWMEiJ7o6eW6JAJqTUlKpEZaggx6KAQlikGJ+9dkpGoJRi1LM4hewIIcQBLABhEDICePoxjVgEQxjNAEN6EHLgdZggTb4QBzp8EY2YACSAFjBF168im30qROU7AViNOFNqxBMEv526MBGYTB0S3Sh6QLhAQx4gAYmQAId9OUgAXjClh3AgARwoAuDUJTYYGCEFojAHdgQQQYKQRuIqIgGX0jAAxKQAAtkwBMCgAAEAkCHQCCFSgkZDZN3o+QhqiQmpPxk6JxcOzcVtsoJLKBfQuKTiRzoNwfBzEuFggCuJAQ9/yCUQAEQwEIJyGADSluAmAagghzAQAYzYMELeoABHAKZGPWJDlNYpNcIbU1BfjHywpidRaEkkaYeorKmj1WTknjBGtnIRi6u0Q1ysGyIYJLCNjLBB0hcOBdZYEqrqcUDQwADFcKQBC1MwQb+jtoGjyDFI6ihiECs4rWZm0MYqMRCA9CaYcRV8iuhE+VK12rhlm6Ogq+saQcH2HVXscpOmxJSvni8NJEmjUB4YD0qkQmEB0IMa4SylCTwYSlPg/jCyjTyCzl7igN25ULeJDFqV7sxFyIABlBAgRthYAMm4EpxKERoyfSEeQtZwIkjZBUdOGF+AQONAGhAAwq8IAkAyP8BCFYuCUHsNCZqUtgnydQWZDttinmR6cQpjukHAx1tkRFIcXBKYI8fhO40x1ASbYOBH6CBS7C9QgcEwOoXbqAkTKmN547ABxUx3MDDzfy1hyLlXyWZ0BgXrnPyHvQTLTlXPUxIFPv0oqeU4AZEAFtSekIBECQNA0pjgShQQANmFIIFYHLhBkpABS+8wAlpYAEYSgCVAJCnKZkXzsCWjBK+U1rAxvl8YdDE/eNUPDenD1FRojx5+11oyUWXZA2yhgAm1PVKBgABajR0KoIE4AiQOOeCN//gt19S3fXdzUWM6Y1fXi3ZQwDMAjxFlawEqwWAFKTBFbhMCHiBE/TAlbD/gBMADASwABQwngEMQQmcmguFhWZQQEQEwJPwBvQ1giWln83F3VzsRZTl3Ng4TtpFTPiByAGSH2HABUUUmUiMyUD010ksgARQgGacipjYRVTcRqvRAEVwSVMcgSUUmk1c3xTRXIDV3RdKlwGeHlAVmW0ghG1gCrUQQK48gRXowGlsABL8AAzUxwb0AAuhDwuwxgC8AAsEDCG9DELsSmgkhGxJgiYlU/bV1NrNxF0dFwEOUA5+H2HwoGH54FV4SBRdT1/JFgUQEtVhT7ENQAdsCdHtyFvUhnqEQAc64RHAwWp0XvrtXJmIxV3cIBi60iU22E9FGtxdiRStiEmMBiZK/wAEPMUSYs8a1RpDXAqt6ZFAGGMAKIInIIWCJJvTuAR0CIZfCZYkVkwl6qJX4A5BDMBUsBpgSQAIfIYxoocENF5XrEsJCEwPctyVjFYAUMEsVEhKGNcn+UtklFdITCIuOlc4PoaUJZl0rWEBUADYeJoAIGOqqcRP3AV66NGYGKORXAk58sqvoYAmIFqfcOHCoNM/Pg1DJYyWdCHtUITHkZ4W3d2SGSRFJsdToYEv6AE1AIIj9EI0VNRIYMACwAAopMIrpAJ1UEMU8IpcBAAUOEIjNEIgoEIo8AJqLMUSSMOTOE2S1eLbLdmSedEtEiQszaTQAWGZ3I0EwEAHIIQESP+A0X2JwHgOAfxAEvwAEghBFBDBC2AAmCQEAxKBDrCACuBAChBBDyCAZqgANehCNWIfw8lFQVzNZYAQprhMcOCFkw0kJcakdJUlJiZHbaCBB3QZB5BmDEhBJCXIDYgDfWmAZjWAGBAeSSRDBlzAAWjAAYiAN6TAoAnAD/DBdvSj2gnYY8qkWYwlGH5m2hDGXhRHAAhBO0yDMRgDOZRDE3jCokleCUADVYlDK5yQHVAGIQEAC2SDAxzDOZjDMTDAI+BQnxxCY8olgWGJc7oPcS1WdNhcjiTnYHUmTyznppWfX5TBzRTTz5zB8rzMQuiAM1QOELSCEqyA9XhSAHBCEBj/VBsYVDigBlccATSEAG1YhdhUH4CyxKRd1kv2p0+JYbVNIsHsZwCoADm4gAucQAwYwQXgApVgygp2g3fFwBcoQQu4AkhQEwb8QhPYQivgQRB4wCiwxlJIgjBQSVcM4EgKRd/RRQ9Rhg3oyjxy3opyJsUc53JuplfehRtEEB60AcfggdWIiXrwgDmcQBPM0BcAQQ6IlnKYwQP4jt9oQDC8BUcsASSEDQKwACQQgt1IUVuIBVOswiEcF00cBA6cwhScqZjGSYBeBfddX1cuhQ2UgzbFQAO5ACJUaV1IwC4AwQmczBdEQDLgEEP0VyesAC61whlcQCU0hUYkAi1QSQCA/wEvdMBGKghaYMApqELaaSmCBIAgcEMKGEQ7aSr4/SfDcKqA/pRkxsEZtMEZ2MIZfIEtWI0AiUkPIEMQeGsbGA+crkQA3IIZAcEfXUAwiISKUAEf9OUAzMAqXEGr6ZPnlMQfrIG0kYTS5EAx3JBYViuctGiVZSrE8N0LtMMJCE0DGcEbKJpKSMA2uEDfQFAFyKpEYJ6tsukJHUAoTF4A8AIlEJ4dZIL9zaBIlAAcIAK1GoZmNKUigIDfNWyCdebDBt1gtEoAjIHxGIGQyhDd9JeY5AAypBd4+QAQ3ICWBsAgnMEKrADffAA6qGEAOIElJASEpAAOtFqjaqNC2AXoDP+YyllEmEYMwyqnmZaemJhAM2iQD/SNB9wCaxyI52BANayAN7RCE7RCBLygSM2jL3yA7xyDLWiAyoJQAIQBsI6FQ6hLdyQWQvQipTlEB9xFocntz7bJf2YrTQ4LJpyAIq0XCQQBEYCESNSGELTqCTCAAlSAEsgAHtHmAbjABzAAGkFDVCwFGsSCQwyaDAwBwPjfRA5AFDEZcJjTt+zMLDZHcSQk6R7GZ0YsSrhXCVQDjsaAD3wBAzADDi2NQGTCd7nAHyXACxLSb0GCBshMK9hCAizDVwRAIOQvymGGSkHHUVxPQ25krTAZGxHh6GqvZ5IpPWbrsEQFJ0wDvEyDNYj/AzIkAWtIwEJ6QTt8gc00gy04QBxYFMPQAQN4wzF8ATKQQDqEQKsJABV0AuYRyUGAKTYmMKMlVtFoKZxcHyRWqyXqYsQCIOe+gDMkwAWQ5gmMgB3oC2AZQC6MgAUkAAMwgDqcghDkCKu5TClkgAZEgAJ4QBWAwk2JkSMUG1LsSm8kcFJszWf8r2Vs3wIXRXSd7g963o6QhQ2Yre4tAAXMgMHwCm5gQA3QwK5hgA4gXwDcDd8twRRYwQz0wBBgARnQmsAcwR7QE6f9n0nghoqyCVmsIdxqqtAaCxFjSWYAwBBwwzoEQzhswy7AAiIYiRQhQAhQQi/AgR68QiZUAzPc/0CVYAAIdAAwxMIqCAMovIIheAIIgMBSJMIp7CE/knLGGYRNERcqNyxhmfLFFYYZUouSSN9bVAbCccUCzEAJaEVvpsAM7GN37AjsrJxtqMgS1EJkdt4NXqMCE+1dYEAJfPICd7OJaLPVIUAHjMUGYAAGNCQCbAAh7giFGAy1+MRoCMz45ACYHchSSB8B1EDUCMAtUEMJM5xMUN+CdQg/0/HEWFlM3DECEgV0ZIgECIG0RoRGgslA7IgFMoGFUgEAFEEZbACzDkAIDEIInErhBcASmAIoF5gMAgdXPjXoNQXCrbRLXyLZfM6wvczZvgb2LMUAYMBB0BoIrAYBoEAqGv9JQxerqx1I9gQALlACI9enhHDjc3CaSmsvN7+0zwXUNHXHb9iFXxrE6shlRLzABoCAZWxEZWwJQwYeiwRAEaRCMF6bmkTbcOpcxSxWV1RzKR+g9X6z9ApErqgeZvCK3zIvWUQEA1q0ZqwSylHGoL0UWbwBsG7AXCAbcQCkIuo1HdtxX09ZcNWncCXEW+xIqokWCOWIy3wJBqzhL7KQpzmBJkzmkc1szQn2b4we7my3Nmvm+IF3AYEuhih0CiQFBrDAriShDdzAYqNACIDAEahAZhCBCdjADBxBEeRAB+hACMjAElgBtTxDGTsEd9Sg/32RXl31TvC1cF/vSBoElXj/IgtgQIwQAQgUms5CgASgtwTowAwEDgj0pQAUAR8UG0toqbOBETYCnWjHdGs0uNq56HBzd3crRxmUQAB0QNZBQQ8UAAykwQyszg0UgRYUAQIsAQ/AgB8kwQKwQB/8gBVcwRv0AS8MQR/kABrwQh+MVh/owZ2RIeex3Yx7CD8J8QP/9YnS4EmMylvAAAhswBD8QFB6Dgho3Q9IQA30ABl4DgxAgRcIAQQkgSywxnBINYMX0CmPt5kb11Dh+KI7xugJQGUNREOWAPsU6wLoEQAsCQCUQOT1pTxZhE8IQQ28wBGQxt1gwinMJpIpooT/tqMDaAN3B4QTLZKVUnKhRQDU/8AbOAEmXAEaiMEWnBgBPAETJKEKUEEU6AARLMEMWEFEUAsSZEJYdmoAc6SkHxCM0/pgpHmDebv4/dNw7MholU5mqAtDBnZn9ND4sIAJgISVhhH2tEQcuCeZzI42zvFdfbtzPPhLAy1xtVoBc40AIIEP+MAJ+ACn2IKIKwR0B8AzRIA4AAEeuIA21EJfRsUSXAJIJIRosZBwZaNToVOVAeGsi6kYjjuWhDtBEwRUjAlS5PRieUIqUAMwvMIlzAEiENpC9ADuoYIsfEMp+EIt9AIgsNBQ10EZMyRphcVvOKctci7XOPW/1zGmDfTQBlVpqBRJuIwA8IAtfAGeYqgywP9AOTJEhTDCAyjBjZ7BCfTCugAZihNAyLAS817bBtiAy+TK1qeNsmE9EL58xwUUdLUERBRZr55iTxiCBdzJA1wAPUzCL2rEWBjCAVRAFVvxLyAAniNAJHw8wrHAQKxG3nc2QyjeSrzt4BfGP/U1UBxHa9iGEGKVpOWA8dQo/XrDDRgER9xFHjTACtwJBxmCVjiEEOwBIw8ACHDB0h38IoYADZDW841how/+jbf8tV0cRBIv6CbTYoGCB9iCNMxCGygDILDAD3SAf/eBATRCBLRCN7ADpxhq2SGAG5gCSIAAQKDAgQIDBAodABQgAGBACgkmchCp8aKHAQgBBgDQuJH/Y0ePH0GGFDmSZMmOAVCmVLmSZUuXL2HGZGnS4wABAQpQALGBAoQFBTTaXHDRSptYsGClO9eOBwUCBmZQIaDGwQoj57Id4CNgAYEAVDIFIFBARbo+ACAgEMBQwNq1BgqgvClXZt2Wa2nm1buXb1+/c+0GXpDCyoAnEGxuDEAqBhBn1T64cKVjjRNGMkShUPRgHLJjTUjsMcAlzQAvtQAEqJPKGBMbLGigEEBgAEYUCMSc28PkBxOLfoEHFw4ycHHjx2fybRsAgIEFBsYCnS2gAAwVA6Z8KfdFyRltyKLM2KDDzBMBeRr4MNLki4daPwbd6uCkVgABS1RMwTKgxAKU/ww3EgA65uhCLjC8hktQQZHaWrAjwAyECQMaBDBhobVsCuCVD7TR4AJlHqBjABZmsEGCuFA5wBY8gDgmiF8wwEACA8TYQ0AMyqhDgugKMIAuBCgIgIUaELAIOgQd5KgtCJNLMq8IoYyyyb1uoq6AmzS6srkNIIBggyGcceGDFYD4oh0iolPhSkYqWEGDL4DwYBgJJMAAgCIyEWCDDRDocjYAFgJ0gCJrk/I4JJ1MVFG9EGXSUJcAQDIAQGIw4gwlgPBhlekIoACDAu7w4AtlkGnli18GNQABLywxoAP7AsAAgUgV2qg2QP/LCEDmElxSyQMRXfSkR4k1LliaqlQoI/8BBuhqAZ4I2CCAIi4QgQEPEmiglRsEQEClQkSoQAMNPlAgmE8NAGCJrbykAIEB0qIArkghkKBQR4u9S9h9+TVpuXz15ci+VRKIIAgSTkiADgAk4AkDr5L5oBVzvPnCBTgGQKEDCeQwhYCNfbphAWY1Irnfj/419mTFAG7ZpWORtU8hDKkDAAEbnFgCAiHAWISRSJ4xI489rrgBhhRQoOGFNPigphFeDtGEl66I0AGNSd4NYIEO4gqgyISei1QlfF22b+WzT065bLmQpM4REvCwxZZzEpCFACfC6GAACQA4hYMmPBDTgWlwU6SAJTKhIRkqQkhBFRTs0/VkyUs2FGb/J9fO3Oy/mFO25AV2vIGXOhbIgo0eUOLhsDHCcAWVQDhR5A9H/rhDDAEwuIWPOWi44xtBQJGCFjoCyaGGMlxRBYAhCGGkhAI1Dxjt6RONfiUlDUOChyGGIOIKMggIgQYDKChAAiHKYEKKJIpY4gkT4CrAiV4QkHUBCiRYIFKS8cKQX7Ij1C/rtexyfMnIslKTkkIRAEsrMUgADDAAVZUgBQtBgAkWsAAQUIAKe8BACmbgEAiYwApEMAAIagADrwzwZdRzoYMAWDaPrGQuGRrAWHzUEoYwkAq1eFfNIKAlF8YwQgVMEAvzlaQl3YWGLLHJkqoktrWgZAmkgBUUzVYg/yJqzogv9GJJtkjAoEQqQMzyX8kaZMb9KcYJlrgIgtwCoLOF0UDBUhvbUAZFKLIMiZaDIfRSgi8IlcwmiTGjTYASgCk8Aic35FVirkjHtXXxi5VEWR/lgrIBJIaTh+RIIRUzhT14C0CenJ4kkdM/OmLxZXfEZCod9KhIJaZks9RIALZwCrGMpVGvbKElgRkSyvmSVyE540cOiJfaTAEOpKRZLVeGyiJKk5iZoyRIaggXaspEmKkhwysaScvKVZMl1wzmC5dVTZJscgBAIclXSOEfyk2ulOS0Jwsb9BeGFKBQ+SpgAJxADbFgZJj3HNs5EXpJYo7khgRw6CZHEgAeSP8DBRA9GT+VtE2DbvRAw1miGD3CrAB4gRoJEVSAOJqShK6Uj75kqEMfSsaQSNQSJjAZv5qFAKBkJKU9LVY+/XLDDE1yjITEJR30ZwAD5NOnxWQpMD9KzAIqBKYlCYAO+AACjFx0XszRaFPBurng3PCrKlNMbZgAjIsUQIgQKivAzPlURbmymlOFaaAiqgNSSCuuwWHrXN4a1pT2lUEDbFtt0LCKJ/qviQYlrFwVRFd7ioSqDgUjDuDwqnkuiqeAFOxnYfLYmdonsHWBY23qsIyt9g+sooVscEorw5BUljYkEYANDKHVzXK2QaD1bWgXFNvifDIAaZgDr1jbVNe+di//nQUrZe9qEhzUAgM3PdtvsZtJJWKyf3EBgy4w4quwLpe5tm1pdv+zQ7xCU3I3gUEmKGDdk6EXu+Qlji9vEhc3JAMn4m1teYUlWfTGsSM8BdSVZpAJCWwVbfT9rX1DSswCLEAtdfDDVtMlXJdBGMDG1PA987msAgSRwgLAATCE2GAHg5bDv3plWwrgLUwkgjppHG+HE/VhjloXLt5CQA40EcRTrpjFSVKnUwJABjvAapOCbTGOg6LjwSqJwhAggAwcoQIUuDOaRP7sk8VWTQIgIARgaERz9iflYkF5u142bc0E5IUilKEbZlgDl+fr5hsHl5wA4IEZTlELE2xhBqT9/y+bI6vnmACGWZtEwAJqAAcW2EnFivYpmNXcUQmkYAyuQMAMXnVL5SJaQZa2C4IwwgI4lECceTZ1So1MTqUKgBOVEEs73XJpUh/x1aYNEA6iAQOnurrXBo11XSOlgyTEOC257imYoVxsmfRvABiQQwcQU2lpkxPak+0RP9PVzvM6dtfCybSTw/sU0E1v2yA+dh/dmhBxO/XZ0O5wu32dkCvtNsD4Vue7F4pMUe+43MLx96JlSr1zHxy4AHepkoq6cOQU3OAMf0lRqWdxeGNusgHSFao3au8OS3y8KGm1tjXOxep1vIzDArHIAUzyL3sx5TW3+c1xnnOd75znPff5zyKBHnShD53oRTf60ZGedKUvnelNd/rToR51qU+d6lVPekAAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Humphrey visual field showing a left complete homonymous hemianopia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Zhang X, Kedar S, Lynn MJ, et al. Homonymous hemianopias: clinical-anatomic correlations in 904 cases. Neurology 2006; 66:906. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7754=[""].join("\n");
var outline_f7_36_7754=null;
var title_f7_36_7755="GI motility disorders";
var content_f7_36_7755=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Gastrointestinal motility disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Region",
"       </td>",
"       <td class=\"subtitle1\">",
"        With dilatation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Without dilatation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Esophagus",
"       </td>",
"       <td>",
"        Achalasia with mega-esophagus",
"       </td>",
"       <td>",
"        Achalasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stomach",
"       </td>",
"       <td>",
"        Acute gastric dilatation",
"       </td>",
"       <td>",
"        Gastroparesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Small bowel",
"       </td>",
"       <td>",
"        Pseudo-obstruction",
"       </td>",
"       <td>",
"        Chronic intestinal dysmotility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colon",
"       </td>",
"       <td>",
"        Megacolon/pseudo-obstruction",
"       </td>",
"       <td>",
"        Slow transit constipation/colonic inertia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7755=[""].join("\n");
var outline_f7_36_7755=null;
var title_f7_36_7756="Lab eval men osteo";
var content_f7_36_7756=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F51140&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F51140&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory evaluation for men osteoporosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Initial laboratory tests",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete chemistry profile (including alkaline phosphatase)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete blood count",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium, phosphorus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25 hydroxyvitamin D",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Testosterone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urinary calcium excretion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Additional laboratory tests if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24 hour urine for free cortisol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FSH, LH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Estradiol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prolactin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Magnesium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1,25 dihydroxyvitamin D",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intact PTH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TSH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Celiac screen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum protein electrophoresis/urine protein electrophoresis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythrocyte sedimentation rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatoid factor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ferritin and carotene levels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iron and total iron binding capacity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum tryptase and histamine levels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Homocysteine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin biopsy for connective tissue disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        COL1A genetic testing for osteogenesis imperfecta",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum and urine markers of bone turnover",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7756=[""].join("\n");
var outline_f7_36_7756=null;
var title_f7_36_7757="Phys qualification for commercial driver cert";
var content_f7_36_7757=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F67247&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F67247&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physical qualification for commercial driver's certification",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <strong>",
"         A person is physically qualified to drive a commercial motor vehicle if that person:",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. Has no loss of a foot, leg, hand, or arm, or has been granted an SPE certificate*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2. Has no impairment of a hand or finger that interferes with prehension or power grasping; has no impairment of an arm, foot, or leg that interferes with the ability to perform normal tasks associated with operating a commercial motor vehicle; has no other significant limb defects or limitations that interfere with the ability to perform normal tasks associated with operating a commercial motor vehicle; or has been granted an SPE certificate*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. Has no established medical history or clinical diagnosis of diabetes mellitus currently requiring insulin for control",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Has no current clinical diagnosis of myocardial infarction, angina pectoris, coronary insufficiency, thrombosis, or any other cardiovascular disease of a variety known to be accompanied by syncope, dyspnea, collapse, or congestive cardiac failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5. Has no established medical history or clinical diagnosis of a respiratory dysfunction likely to interfere with the ability to control and drive a commercial motor vehicle safely",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        6. Has no current clinical diagnosis of high blood pressure likely to interfere with the ability to operate a commercial motor vehicle safely",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        7. Has no established medical history or clinical diagnosis of a rheumatic, arthritic, orthopedic, muscular, neuromuscular, or vascular disease that interferes with the ability to control and operate a commercial motor vehicle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        8. Has no established medical history or clinical diagnosis of epilepsy or any other condition likely to cause loss of consciousness, or any loss of ability to control a commercial motor vehicle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        9. Has no mental, nervous, organic, or functional disease or psychiatric disorder likely to interfere with the ability to drive a commercial motor vehicle safely",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10. Has a distant visual acuity of at least 20/40 (Snellen) in each eye with or without corrective lenses, or visual acuity separately corrected to 20/40 (Snellen) or better with corrective lenses; distant binocular acuity of at least 20/40 (Snellen) in both eyes with or without corrective lenses; field of vision of at least 70 degrees in the horizontal meridian in each eye; and the ability to recognize the colors of traffic control signals and devices showing standard red, green, and amber",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        11. First perceives a forced whispered voice in the better ear at not less than five feet with or without the use of a hearing aid or, if tested by use of an audiometric device, does not have an average hearing loss in the better ear greater than 40 decibels at 500 Hz, 1,000 Hz, and 2,000 Hz with or without a hearing aid when the audiometric device is calibrated to the American National Standard (formerly American Standard Association)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         12. Does not use a controlled substance&bull;, an amphetamine, a narcotic, or any other habit-forming drug",
"        </p>",
"        <p>",
"         <strong>",
"          Exception:",
"         </strong>",
"         a driver may use such a substance or drug if the substance or drug is prescribed by a licensed medical professional who is familiar with the driver's medical history and assigned duties and has advised the driver that the prescribed substance or drug will not adversely affect the driver's ability to safely operate a commercial motor vehicle; this exception does not apply to the use of methadone",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        13. Has no current clinical diagnosis of alcoholism",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Pursuant to 49 CFR 391.49.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Identified in 21 CFR 1308.11 Schedule 1.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: U.S. Department of Transportation, Federal Motor Carrier Saftey Administration. Physical qualifications for drivers. Available at: file://www.fmcsa.dot.gov/rules-regulations/administration/fmcsr/fmcsrruletext.aspx?section=391.41. Accessed September 2010.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7757=[""].join("\n");
var outline_f7_36_7757=null;
var title_f7_36_7758="Contents: Melanocytic lesions and disorders of pigmentation";
var content_f7_36_7758=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?2/59/3006\">",
"       Dermatology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Melanocytic lesions and disorders of pigmentation",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Melanocytic lesions and disorders of pigmentation",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Dermoscopy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/11/13497\">",
"           Dermoscopic evaluation of skin lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/57/38807\">",
"           Overview of dermoscopy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Disorders of pigmentation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/17/43287\">",
"           Benign pigmented skin lesions other than melanocytic nevi (moles)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/20/33092\">",
"           Melasma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/44/21193\">",
"           Vitiligo",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Melanocytic nevi",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/1/44056\">",
"           Acquired melanocytic nevi (moles)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/36/41545\">",
"           Atypical (dysplastic) nevi",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/17/7447\">",
"           Congenital melanocytic nevi and speckled lentiginous nevi",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/29/18906\">",
"           Spitzoid melanocytic neoplasms (Spitz nevus and atypical Spitz tumors)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Melanoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/60/37832\">",
"           Epidemiology and risk factors for skin cancer in solid organ transplant recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/61/26585\">",
"           Initial surgical management of melanoma of the skin and unusual sites",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/52/10057\">",
"           Lentigo maligna: Clinical manifestations, diagnosis, and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/8/2186\">",
"           Management of skin cancer in solid organ transplant recipients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/31/22009\">",
"           Pathologic characteristics of melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/11/1206\">",
"           Pathologic evaluation of regional lymph nodes in melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/41/18073\">",
"           Primary prevention of melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/53/24410\">",
"           Risk factors for the development of melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/16/16650\">",
"           Screening and early detection of melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/20/16713\">",
"           Skin examination and clinical features of melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/15/35065\">",
"           Staging work-up and surveillance after treatment of melanoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/31/42488\">",
"           Tumor node metastasis (TNM) staging system and other prognostic factors in cutaneous melanoma",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-983E831991-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f7_36_7758=[""].join("\n");
var outline_f7_36_7758=null;
var title_f7_36_7759="IVUS angiography comparison";
var content_f7_36_7759=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Comparison between angiography and intracoronary ultrasound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 204px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADMAUcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKry3trDdRW01zAlzLzHE0gDv8AQdTVivPtLitLLVdag1/RLq71C61Mzx3A057hJoiR5J80KVUIAFwxG0oT3BIB6DRXlsMOtRWNjdazd+I5LS51C6F7HAsnmwxq8wgCLEvmBD8hJGSfkyduaitZ/E0Wq+GpdQGrXkrxWsc1qqTwiHLsHmd0Uwu2wqXSTBGw7OWAIB6vRXAfC6XVfO1CDVRqVyEjhb7fdrcQieQl92IZlHlnhSRGTHyMYxz39ABRRRQAUUUUAFNd1jRndgqqMkk4AFOrmPidaz33w+8QWtnC89xLZyJHEiF2diOAFHJ+lAHSRyxyRebHIjRnnerAj86bNcwQW5uJ5o44FG4yO4CgeuTxXk91pOsWdh4m0ODTVOoazdwxrJZW721g1syhXcMA/lP5aSBskncUxkFak0qwv7BNBt9e0ieTTdBvLq3MNvC90iqyBrWRAEDSKkbmLcq8NngYOAD1aKRJoklhdZI3AZXU5DA9wafXKfD61kt4tcmW0lstOu9Se4sbaWMxMkRjjDHYQCm6VZXwQD8/IGa6ugAooooAKKKKACkJCgkkADkk0tZvieOSbw3q0UKNJI9pKqooyWJQgADuaANAuixmQsoQDcWJ4x65qO7u7azgM93cQwQjA8yVwq89OTXm+pTXWveBtG8P6bpl7JLObW3vo760uLOJYUTfKru8X3WERiOAf9YPXNVfD9ve2E+hSeK9KvLiDS7G40wGO1kvAkiSIElAVNz+ZCq/vAvZgdpOCAerghgCCCDyCKWuZ+HVlPYeGRFPbvaRNdXMttbSDDQW7zu0SEfw4Qr8v8P3e1dNQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGV4k1y18P6ct3eiRleVII0j2gvI7YVcsQo57sQPesTU/iFo2lywRX63EEjQpcTq+wG2jdiqs43fNkq3+r3nAz0IJ6HXNNGrae9o1zNbK5G5okjckf3SsispB9wa5qy+HemactsNLvL6yaKBbeRoxC3nIrs43B42CkGR8bAmA2OgUAAdrXjuKx0nUtQstJ1C9trOQxCdQqRTOsoidVOS3ysTyVAO04Jqf/hM4Vvbi0Njdy3izpBFZwqDMxMCzNu3EIuFPJ3Y6DOSBSy+CbWSw1DT/AO0tSXTLtpZBaK0eyB5H8wuh2b8hySAzMozjGMAEngq3a8e+TVNSj1Rp1n+2p5PmBhCIT8pjKYZVBIK4zyMYGACO5+IGkQwxzxxXs9ubSO+lkjhwIIHZl3vuIIwVIKgFhg8cHHXVyT+AtJOn3Nkkl3HDcaammPtdc+WrO2/JU/OTIxJOQfSutoAKKKKACiiigAqjrOqW2j2iXN6XWBpooC6rkKZHCKT6LuYZPbrV6qes6bb6xpN7pt6pa2u4XgkCnB2sCDg9jzwe1AHP3/jrS7K5k86TZZwC786Zlb71uYw+zAO7DOV9dykDNR2vxD0KaJmmkltmSR45FfY+wrA0/LRsynMaOwwT90g4IxT5/AOj3Gl2NhcNdywWtpPa5aUb5fOKM8jsBnzCyBtwxyScej5/BNnd6fHaalfXt6kd1FdK0iwRkFP4cRxqCrAsrZGSGIyOMAGn4f8AENhryyNprSOqRwyMzIVx5ib1Xn+LaQSO2RWvWT4d0Cz0BdQWw83F9ePey72Bw7BRhcAYUBVAHYCtagAooooAKKKKACqOs6pbaPaJc3pdYGmigLquQpkcIpPou5hk9utXqp6zptvrGk3um3qlra7heCQKcHawIOD2PPB7UAc/f+OtLsrmTzpNlnALvzpmVvvW5jD7MA7sM5X13KQM1Ha/EPQpomaaSW2ZJHjkV9j7CsDT8tGzKcxo7DBP3SDgjFPn8A6PcaXY2Fw13LBa2k9rlpRvl84ozyOwGfMLIG3DHJJx6Pn8E2d3p8dpqV9e3qR3UV0rSLBGQU/hxHGoKsCytkZIYjI4wAafh/xDYa8sjaa0jqkcMjMyFceYm9V5/i2kEjtkVr1k+HdAs9AXUFsPNxfXj3su9gcOwUYXAGFAVQB2ArWoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACoGn2sRt6HHWp6pS/fb6n+dVFXM6knFaE/2hccCjz1z0Oaq5+XPXPpXHeL/iDpfh27NjHHLqWqgjzLS2I/dAjOZHPCnHbrz0py5Yq7MlUkzuvtIycrx9aBcKf4TXis/wARfFl227TtI02zi3ghZQ877R1BOVHXuBV2z+Kl7ZkjxHoDhN+PO099wRfdHwSR7H8OOc+ddUx872ueufaR/dP50puAP4TisnRdV0/XdPW+0e8iu7RmKCRM8MOCpB5B9jV7GD1OPatUovVCc5rcn+0+i/rR9p4zt/Wq5+7k9B3oIPrT5UHtJE/2njOz9aU3Pomfxqt0xSkZHcUcqF7WXcn+1f7H60v2ng/IfzqqSCc80Zx70+RB7WXctfaR/cOe3vTZrmRIyywMzcADOB1xyew714n+0H4t13QLjRrPRdRnsoL2GZ52gQbyVZcfNglRgnpivFvD2v8AiLT7q4u/D2pasbkAyTNAz3AbHJaRTuB6fxVzSqWlypGicrXbPtOK7Zi6yRbWXB4bKsD3B4p/2of3P1rG8JahLq/hLRdSulRZ7yxhuJVUfKHdATj8a0icAdR71tFKSuRKck7XJ/tQ/ufrR9r/ANj9arE46njtSdDxV8qJ9rLuWTdeifrQbr/Y/Wq3b3pD25o5EHtZdy19r/2P1pftQxwvPfmqme5pueetHIhe1l3LougT8qEn2NBuGAyYjj6187ftGeLdYstcsvD+nXN1aWbWf2mdrV2Vpy7FdrEchQFPAPO7noK8n0C98SaebnUfDcusRyQ7mlmtBIyBuCfM/hPOM7q5pVbS5UjVOTV2z7g+1jH3f1pPtn+x+tY/hy/bVvDek6lMixy3lnFcOinIVmQEge2Sav8A4810RUZJNGbqTTtc00bcitjGRmimw/6lP90UVkzqWw+iiigYUV4tb/F64k+Nn/COl9OPhx7uTSUcN/pAvEjViWG77hYmMcckV63rmoDSdF1DUWjaVbS3kuDGpwXCKWwPc4oAvUVxqalq+kaDHrusahDfRywxk2dvbBB5sjKsaxuW4G5gpLZznPHSmnxndi8TSxpCHWjetZND9r/cqwt/PD+ZsyVKcfcznIx3IB2lFcfonjKXX3sho2lmVXs7e9ujNcCMwLMWCqvB3sNjk8qMAcnOKyLL4oxXdib2HR7p7WaGO4tHUsPMR5o4lDllCox85GADNkBuRigD0eiuDbxnqkmraXY2+lWwuH1OfT72NrgsEKQecGjfaM5BU8r6jHeoLn4i+RpNhrN7p09jpUtxOpZmSV5YobW5mdgFb5f+PfjPJzjAzkAHodFZ2i3Wo3UDNqunR2EnBVEuPO4IzgnaMMOhAyPQmtGgAqhJxI/1NX6oyn53PcE/zq4bmNbZHB/FfxTPoGjQ2ekT+VreoNtgfbuMUakeZJyMZ6KM92B7Vz3gPwTCbQXV4RkHzHeQ7ifVmY9T6k1V8cTJqXxXNuJC62NpHAVYYVHbLtj1yChz/hTfj/q0um+CNM0i1kMZ1K4In2HBMUa7tuQeMsV47gGs7rWo/RGDu2oFnUfip4E0xhDYRXeqkHBksoAE6dQzlQ3pxW3pN14U8eWUy6DPHJcRKJJYJIjHLGDxkqeoz3GR718tnjrjA44rV8MateaJr9lqelyiK8t5BtYrkYb5WUjuCD0/HrzUqrNat3HyRfQ9aiuL34deJxe26sdOlYLfWwbCyp0385wydQe4GO9e9LtdA8bhkIBVgcgjqCDXnHxgsEe137RgZyMdeK3PhI7yfDfRDK7OyJJECxzhVlZVH4AAfhWluSdlswi21Z9DqiCcE/lSHOPX8KXPPYGk549c+lbIQnUE8/SlGNppOAehyPWlOdtAmMzjpS0e1IaYjx34+6VeyX/hzW4l3WFmXt53B5jaR02Ej0JGM+uPWuouiB8Lb1YEUTXEflKsYAMkj/Ko4HJLECt/x0qt4H8RhgrY024bkZ5EZIP4EA/hXGeDNQ1Mv4CjuLxZLfUBdTSRrAsfKRHaCe+CSe3auaT5Ju3W3+Rpbmsd94X019F8M6RpU0qyTWNnFbO6AhWZFCkjPbitH0wc0vH6U010RiopJEN3dwH4CkP0NHOeevpRnmmIKPrS96aTigBBzz/SkJKgknjtx0FGe3p1pRx06Z/OgR4j8evD9xH4i0fxNHI8kDIunyoBjySCzI2c5O4kjpwQOea6/WEubv4TT2lsryXVxHHDGgOC7uwUDt3PU1t/EpVf4e+Jg67gNOmdc9mC5Vh7g4IPY1z3gmS6Nx4MW5vpbmObS7u6ZGRFUODEqsAAOQrsMn+8fWuaXuSaXX/hjS3Mk+x3Gh6eNH0PTdMExnWyto7bzSu3fsULnHbOKug80cDt3ppwce44zXSkopJGbk27mrB/qY/90UUQ/wCpT/dFFc73O+OyH0UUUDOP/wCFZ+EBpttYjRIhFbXX22KQSyecs28vv83d5hO5ieW9unFbmh6Bpmh2dza6XaiG3uJ5bmVC7OHkkO5z8xPUnp09q1KKAOdg8F6FDbPbLbXDWrRGEW8l5M8UaHHyxozlUxgY2gYwMYqxY+GNJspbeWC3laaCdrlJZriSWQytH5ZZndiXOz5fmJwAMYwK2qKAOfg8H6JbNZta209ubSFLePybuaPdGhJVH2uPMUEtgPn7x9TTYvBmhxRvEltcC3Yqwt/tkxhj2yLINke/YgDopwoHTHTIroqKAMW48L6TPP5zW0iz/bPt/mxTyRuJjH5ZYMrAgFBtK/dI6ih/C2jPp9jYyWKPaWTySQRO7Mqs8ckb5yfmBSaQYOR83sMbVFAGfo2j2mjwtFY/adhwP391LOQAMAAyMxAHoOK0KKKACqEhPmOBnqav1nyf6x/qf51cNzGtsjxz4qJ/Znj/AEzUJJFWG+tPL+50eInOT3JDj8q1PiJ4efx14BSLSiralYyi6t0JA84hSrR57EqTjtkDPFdf428NweKvD82mzS/Z5NyywXAXcYZF5Bx3B5BHcE15RpWvav4M1RdK1+1a1lzlDuzFMPWN+jD9R3AqWkrxlszB30muh4hdxvZXMtvepJaXMRKvDOpR0PoVPfmu0+F/ge88ZaxGypLBotvIpurzHGRhvLTJGWbjkZ2g5PYH3M+N9G1GNU1G3trjZkqJ41kAPTuOPSszxJ8R4Y7RvJkCBeOu3A6cVPs11ege0XRMi+L+twtG0SsdwGNvXdnsPftXd+ANJn0LwZpWnXpzdRRl5R/dd2LlfwLYz7V534H8I3viLWINf8SW0kGnwP5lvaToQ1zICcMynlVUgEAj5uO3X2Fjnk9a0j78uboNLlVnuwJIxz0pDwfShev0ptaIQue/pS9E+v60ynYwD2pksQ+9IfrR+PFHSmBxPxc8QQaP4TuLHcDf6wj2VshXPDDEkhA7Kpz9SB3rL0ewfSvD3h3W7m6R4vD8cimNIyvmJJ8rsSScFVyQB1I61y/7Qyu3ijwgYpFR/KuOWXII3x8EZzXX3SXz/CvUle6tIx5LAPFAxOzB/vNgN78j61ytc8pX6Ft8trHoSlWRXjdXjYBldTkMD0IPel/Oue+G6hPhz4WCjAGl23/osV0Psa3hLmimKSs7CHj0A7k0Ht3+lKeaace9USA4wDmjBJBo/LNIc/hQIB0GKQAE8dDQSCOh5oP0PrTEeffGnxBHpvhk6NGT9t1xZLVW4/dRYHmOQfY4HufamadGdA8LaP4gvZ2nXSLQ2/lwx7N8MjJ5jEEnLAKpGCBwfXjJ+Jvhm21vxgLtppLa9tbaFFlRA4dDvJVgSO/OQeKs3L3l94Xk0G4nt1tJVEby29uRLsz2y5AJHGcHFczi5Nt/L+vU05uWyR6gNrKrIweNgCrqcgg85B75pcccjnvWb4Wjjg8MaTDDH5cUdrHHGg7KBgD8q0yOMD+dbxd0myGtTTg4hjH+yP5UUQ/6pP8AdFFYM747IfRRRQMKKKKACiiigAooooAKKKKACiiigArPlyZX+taFZ8n+sf6mtKe5hX2QzHNVNV02y1ewksdUtIbu0k6xTLkZ9R6H3HNW/egnNaNJqzME7ao4e8+Ffhac5hgvbLLBiLa7cKR/dw2QAfbn3rU0bwJ4Z0i9iu7LS0N1ExaOaeR5mQ4xxuJxXTbGwMDFBUgjcuPes+SPRFc0gJyCScn60hPPAoHv0o479+laE3Exx/8AXo96KOufSgQnenE5HvTQMDil7HpQAhxQfaik6dTQByXjrwNZ+L57G5nvbm0vLFXWB4wrIQxUnepGT93sRVuPQbyXw5Pot3dW8cEimMzW6FnZCOcBuEPX+961Z8S+KNE8NQxS67qcNksuRGr5Z3x12ooLHHHP0rldO+Mng27nkimvLuxRc7Zru2ZUk9wVzjr/ABAVjKVOMnd6lpSa2O70yyt9M0uz0+zRktrSFIIlJyQigAZPc8VYJGcAc98GhGWREeJlkjdQysjZDKeQQe4pQOea1VraEu99QJ9eBTW+n50pB6ikzke/86ZIpxnmkXAwDwPrSHAA449jQePQc0AGQOh4HFHOOKQAMfbPr7UhOMY9etMRja74fg1SYXMczWt4E8vzVQOrqDkB1PXHOCCDyazLbwnctJIt9qKiLcQPs0GGZex3MTtP0H0NXvF3i3RPCNlFPrt59nE5YQRpG0kkpUZIVR6Z6ngZHNcnpfxp8H310Yrma+01d5VJru3xGw7EspO0H/axjvWMpU4ys2WoyavY9Hto4rW2ht7dPLgiQRoo/hAGAMnrUjHg+1GMLwRg85B7fWkKHnmtVtoQ/M1of9Un+6KKIP8AUx/7o/lRXO9z0I7IfRRRQMKKKKACiiigAooooAKKKKACiiigArOl/wBa/wBTWjWdL/rX+prSnuYV9kV7y5gs7Wa5vJo4LWFDJLK5wqKBkkmvGtW8beIfFt55HhsXGk6SHDRzINt1Lx/EckKpP8I545POK0vjTfSX2p6V4ZjZfs0i/bblQOWIYiJSfTIZsY6gGuu8HaDb6fpyyOgLdQaVvaSs9kYN8q03PC/G9vbeHNSs18RLqN7eXimaWUy72WLJXflj8zZHC+ldedA8TeGIVk0bVb+2jTayxrLviPf7jZGOelcB8cb7+0fibq6jJitY4rNQ3oE3HHtlzX0N8O7yHXvh7oU8wzJ9jSOTeQSWT5CT9SuazhGMpNNDleKTTKnw88dL4jd9N1WBLPXY0L7YwRFcIDy0eSSCMjKk55yMjNdswA7HI5NeH/EjRptI1KHUNPkaC6gkEsMikgqw57dj0PqCRXsPh/Vote0LT9VgTZFdRLJtJBKH+JfqCCK0i3GXIx3UlzF4460n0penoDSAg8jscdK1JDrQc47Gg0v8PFMQxgDgnPHoaCcdBQT0OM+9LjkUgPB/2k7eS617wrBHIsZeG5GWXI+9H171ztp8JtU/4R++1a/1Syt7eGNniWBWmaXAPXO0L9Oa7f8AaEslibwvrEkqxxw3MlkwY4H7wBwen/TMjr3FdDe6haL8LblftlqrToIIj5gO53bYoGM5+Y/oa5eWPPJyNG3ZJHR/Don/AIV34XGSf+JZbjnr/qxXQZ45wKqaRp0Wj6TYaZbEmGygS3QnqQigZP5VaIz3/I1vTVopMmbvJhnj0NNHQDkn8s0EZ6dqOnXrWhADr6UnRf60EAd/yoPvgUANPIwME/zoHB5xTuR3prD5cj1ycUCPnP8AaGglvviTptstxsA0tCqsNygtI+Tjt0HI9KoN8IryLwff63f6xbIkcZaKG1hLmRegLMxAU9eMH617T8RvBMXiu0t5rVYYtasyDbzOdokX+KN2AJK45Hofxqp4ems/FvhGLRoWnEDxRteM8bxER7yMIWX5txVhuXgAHnOK5XBKT5uuxtzOysdL4Ck8zwJ4aYsWJ023O4tkn92OSe9bZ9eB64pkUcUMUcMEUcUUYCpHGoVUAHAAHQe1CBiB5gXd/sE4rohHliomUndtmtB/qY/90fyooh/1Kf7oorF7nfHZD6KKKQz5P8Na/qafGiXbq13ct/wmV7YyWEOoTtP9mJIVmgOYxbocktgN1HYY+lLLXtP1/wAOXeoaLdGe2UTxCQIyEPGWVhhgDwwIz+VblFAHifhPWvsHgnTryz1zSpLieGyjvbmK5e4ks0kKh5ZVeRlBGcZIABOTwCK6e18RmXX4LKTxbbpZJBFJaXJWD/iaO00iuucbW2hEXEW05bPQgV6LRQB4tpvjnxJcadJcSX+mx3kkcJnsWkR57CZ7qGMp5QVWVQsjg+YSdyqQcE1p3OsaouuaXb3uvy21tZ69PYS3TiOMTobTzUWXACZ3NtHAycHGa9WooA8oHiDxB/YvhvV55Y9Quby/uRFaQwmIYjsr1lThjuLNGnXj0A4x1/gPU01TTzMPEMOtStHG8ojWNfs7sCSmEGVGeitlhjkmuoooAKKKKACs6bmR8+prRrOl/wBY/wBTWlPcwr7I8U8XK5+Lt39t8ox/ZoPI8s8iLB+977t/4Yr1pP8AkFAxYHydPwrzT412c2n6hpXiSOOH7NGv2K5fdh9zNmMnsRksPYmur8GeIoNRsQskgLYxgjtTpaNx63OepupdD5l+IO7/AIT7XhKG3/a8EHPHyrXv/wABlkHgnTmcnYVcqOw/ePXjPxxshpvxN1h1z5VzHFeKTjum04x2yhr6G8CW0Phz4faFbysRIlnG7lsZ3ONxHHuxFZUfjfzKqL3V8jF+LPlfYACDux257VsfCI/8W30fbjH7/p/12evNPHes3fiDXYtI0+MSXFxKsNvtySSRyxx0VRyfYE17bo2mwaLo1lplmALe0iWFSFA3YHLY9Sck/WtL809Ogoq0bls9eopCT3/Cj196Oo960EBpM8HmlHX6UdjxTAbkj6+1L255NNPIwOKUcADOcDqepoEeV/tFn/ildCIIH/E4jHT/AKZScU7xDFHb/Cu0ZIoYS99aksqBdx81cZ45PP61iftD3BfWfCNhJsa2k+0TeUw4dwUAPPoCfzrq7+ys4vhTfO1tbRbIGdXZAPLYA4YE9COxHPpXM1zOaNG7cp6NKf3j4IzuNRk4PH86y/COovrHhLRNTmJ828sYZ3JAGWZAT+taZ6cc49K3i+aKZMtHYXd9aTk4zxmjuff1FHGP6VRI1uQeo+lJyc9hTvTrSPn0zQIBwKM9yQBR3xj6UY9CKAHRf6wDj/Irzv4TTxyWlkElR8aLbn5WzgefPWH8cPF9xZahYeFbJnhN9D9ou5QceZDkqI1OcjJBLeo47muhu3/sj4ZnVLIQW95YRLPDKFVVGCMq2MZUjgj+uK5pPmndfZNF7qs+p3vNI3fGKqaFqMWsaHp+qW8TwxX1vHcrG5+ZQ6ggGrh98c8V0JqSujNqzszVh/1Mf+6KKIf9Sn+6KK53uehHYfRRRQMKKKKACiiigAooooAKKKKACiiigArNl/1j/wC8a0qzZv8AWSf7xrSnuYV9kV7u3gvbSa1uokntp1McsTjKupHIIrxzW/AWu+GbqS68Ks+oaSpTy7USF7uPjDdRh1zz1zg9DjNe05/Kk6jmqlC+vUwUraPVHzF4yjbXNTspPEtjrVvdWymJo/IZDJFknbyvHzfxD3rrBP4u8UtHFp2lXohlwonuEMMKLjhizckY9Aa9zEjjgO2PY0hbdyzE9uahU5XeoXhpoch8P/A9v4YjF5eut5r0iMk1yCdiKWzsjB6DAXJ6nH4V2LEc4phIBGaTnnnmtIxUVoJyuOJFHUdeab69xQemfbODVCHZBxRxg9qQ5JHOPXFGeD/OgAPPegnHUcUmc0HsM9TQB4d+0SiN4h8JCZVaNo7lfnHBO6PjnjNdhdWtpD8Lb+QWlsirAzbvLUBSFPPIru7q2tbyLy7y2guIs5CTRq4zjGeR6cVUtdH021XZBYwLF1EZBZV/3VOQv4YrH2bUm+5Tkml5FP4fRSweAfDUNxG8UyabAGRxgqdg4PpW99aaWbkk5+poLcHkgdM1pGPKkhSd3cd0603BJHTg5pcjGDz34pMdD+VMQd+T7ACkwB0Hal74zzikYjAznnmmAHjH+cUgxk+h6Up6ZzgfjSHOc55oEeB/H6ylTx9oN/PEhsprL7OjvggyI5LLz0OGB9+a7fWrazg+D15IbW3jUWwbcYl65HI4616DdQQXUQjuoIZ4mz8kqB1PHoR+FU7bSdNtQUtrK1jUNuCiPKjp0B4A4HSsfZtNtdS3JNIi8GWc1j4N0Czvo9l1b2MMciHkq4QAj61sZHf1pm4nk5OeaONvPQVpGPLFR7Eyld3NaH/VJ/uiiiH/AFSf7oorB7nfHZD6KKKBhRRRQAUUUUAFFFFABRRRQAUUUUAFZsx/fP8AU81pVmTf61/941pT3MK+yG5rnvFPjPQvCzxQ6xdul1MhkitoYmllZc4zhegPYtgcH0NZfxT8YN4R0BXs2g/tW6YpbrKciNQMvMR/EFHY4BJFeJeCNR8LXmpeZresXC31zIDJPewufOcnAy/vnPOAB6Up1NeVMwUbK7PTz8YIJCvkeG9SYbvnLzRqQnqMZ56cfrVvTPi9oM0xj1W0v9KjxlZ5UEqfjsyR9cYra1DQNB0HS7u91V4rWztkMk00nRR/UnoAOpIxXzb4u8bSatqLjQrVNM0xTiMPErzyAdGcnIXP90fnUzvD7Vxx97ofX8TpNDHNBIkkUi7kkRgysD0II4Ip3bBr5h+DnxAm0DW4bC6Xbpd5IFmhTJRWJAEqZ+7t/iUHBByORX1E6bSQQK0hPm33CUbER/SgY64/OnYP4+tJ2rQkaQOM/nS+w/Sl6fjSHgUCEwCMHnFJkdF6+nrS4OO9Ie4xxQI80+MvxCvvBaaZbaTaW0l5frI/nXGWWNUIBAQYyTuHU4GOleWaZ8avF9ncGW+lsdQgLbjFPbrHtXuFZSMcdM5rqP2j4UufEfhGOeJZEaG5BDDg/MlbkXg7wzYfDfUr+DQ7EXZgcmaVPMZeM/KWzt6DpXJKMpzdnsb3jGKuen6FqEOs6Hpmq26MkN9bR3KI/wB5VdQQD9M1dIBzj0rA+HkckXw98Mxyo0cq6ZbgqwwVOwdR2rfY8en410QbcU2ZzVpNITGe+QfWkI6EZGfbrSM6Ky7mVS52qC2CxxnA9eAaU/gDVokTgjvj8DTSOoA596eD6U05OCCck/5FAhT79OgH403gZ5IHSgkbSAOnr60oHXPBOO9AHnvxm8b3vgnRtPbS4LeS7vpXiSWfJWIKuSQn8R59cfWvGrL4zeNLW7eaa/tLlGbIgubZRGB6Dbggfia9B/aTiWSz8KrKiuhu5shxkfcFaHhPwn4btvA93qEWh2AvDb7jNJGJCDjHy78henauWUZTm0mbJxjFNnoPg/XI/E/hbTNbt4Wt4r2LzPKYhihyQRnuMg8961z79a5H4QRSwfDDw7HNE8T+QzbWGCAzsQce4IP411zHPGQPat6TbgmyJpKTSNSH/Upn+6KKIf8AVJ/uiisnudsdkPooopDPN/C3jbxH4r1a5utD0PTz4XttQfT3nnvGS5kCNteVECFdoOflLAnFdv4k1aLQdA1HVbiN5IrOB5zGn3n2gnaPc9PxrltP+GmnaX4hm1PStX12xtp7z7fLpdvdhbN5iclim3dgnqoYA+mOK3rDw1bQeFJPD9/dX+r2csc0U0uozmWaVJGYlWcY4AbaPQADtQBWfV9W0i2a78RQWP2d9iRx2LO8vnO6okQDAB8lgN3ygdwBkiCbxzYokaLY6lLfMZw9kkS+bEYQhkDZYLwHUghiCCME5GZZfCP2mz+z32vazdqhjaBpWhDQPG6ukilYxuYFF5fdkZBzk5Wz8G2NtdR3TXN5PdgXPmTyMm6ZpwgdmCqBkCJAMAAAdKAK6eP9Ka2knMF+sYW0kh3QjNxHcy+VC6DOcM/GG2kdSORVa6+IFpb3kBuI3tLOOK8a+W4X99byQeV8uFJByJQRgnIK4PNM1vwCkuk2tvpF7PBcwJpdqssrKdsNpdJNuHyEGTaGxkbSduQBmrU/w+0m6iZb+a9upJFuRPLI6q8zTeXudiqgBh5SBdoAGOlABb/ETQntZLi6lks4oZxb3DzFGS3Zk3pvdGZQGHAOSN3ynDcV0+m3i6hp9vdxxTRJOgkVJkKOAeRuU8g47Hkd8GucuPBFpfWH2HVtR1DULJpBJLBKIYkmwCFVxFGmQDhx33AZJAAro9MtWsdPt7V7m4u2hQJ59wQZJMd2IABPvigCzRRRQAVmTcSvx3NadZkwzK/Xqf51pT3OfEbI+bPj/cTax4ovoLIGaPS7WKGUQ8tgkyS5+mUJHoK8fUgrngqRwexFfQfj2L+x/iwbhRCiX9tFcDaAAxUlHLDueB+BqaT4J+HdYmF7pmo32m2sikvawbZPnznKs+do/wBnB9sVnyN6ojnSdmeGatruq6ppmn6bqV/cXOn6cCLWBjwhPc92I6DdnA6V6X4R+Edj4n8LWd5aa5cW+pTQCVy0SyW7E5IUAYYY+6Tk9Dx2q/43+EtraaTcS6NC8L2FvJKkm8bpSFLHzGbhhx1OMdq4r4R+PrvwhqsMSh7jRruVRPak/dLEDzEz0YZ5HAPf1ocVTdpISbkrxJZvh/4j8O6uf7btFhskjkDXMMqyRygrjavRufcDGK+k/hrqE2pfD/Qrm6wZjB5TEd9jFAfqQua4P4z6jGitEJARHneM89K734dadcaR4F0SyvV23CQb5ExgoXYvtI9Rux+FacqjJJCUuZNnQN/KkJzRSYzWpIdO5o/Ak0Uh6cnGaBBwPWm8nFHQdhRkg9KBHkn7SKrH4f8AD12iI1xFqgjQuSBtaJiw49Sq89sVa1W9u4fhXDm0tRDd3ENtJm4ZiI3cK2MKOefX39qzf2kruP8AsTw3YoC11LqRnSMYz5aRsrH25dava0tzP8KLYLaTIlrcw3EzSugCxo4ZjwSScA4A6muaV7zt2Nf5T1pxtdgOg4/KmHjtxSLNHcIJoHV4pQJEdTkMpGQRQO5zx2roWqRnLcRlVgCQCVOQcZx7ikkLqjFFDNjgE4B/Ggnp+tB4HI46UxCgnJxk44FNz8oPJA7nikz8o2jpQ/XJ6mgYHPGc0dgepH6Uh5PAHtRgD6+5piPMf2iBjwHaz4Uyw6nCY92cAlWU5x7Gqsep6hY/BXUL2K3sywtgvzTM2ATgnG0c89M1L+0bcIvgWytgQbm41KLyo84LbQzN+QqCK2vNQ+CWoWFtYyCdrcYaSRFXAIJOQxPA9q5nfnlbsaacsb9z1qCGO2s4IIVxHHEqIuegCgAZp5PcZNQafeQajp1peWb77e4hSaNvVSuR+NTEhTnt6VvDWKsRLd3NaHPkx+u0UUQ/6mP/AHR/Kiud7nfHZD6KKKBhRRRQAUUUUAFFFFABRRRQAUUUUAFZkw/ev/vGtOs2XHmv/vGtKe5z4jZHEfE/wg3inR4W05oodXsXM1tIy/6wY+aInsG457EA1wPgnxzJpjyWOqxzW09uSJ7eVNsqEDO3b6+nrXuWAR0rnvFfgzQvFJSTWLLfdInlxXUTmOaNc5wGHvzg5FU4tPmiYaSVpHzp46+MeveJre6sLdI9I0udWikgRN1xLGcjDsRkZHBCj2zWX4c8JpEY7/xK/wBktI9ssdokg86fv8xB/dqO+fm7cda9vk+D1r57PB4j1VEzlA0UTso9N2Mn61o6N8JvD1oztq7XWtyHOBeMBGoP+wmAT9c1movqrmjtaydjk/BuhXnj7xFHrmrRzxaFbuJlYjYLuUMCqp38sdSw64wO9e4OxJJzmo1CoioiqkaAKqqMBQOgA7ClycHjP41qovd7kNrZbCnrz+NJ3zzSFjnA55oz1BHNUTcOvX9KOMeue1J+XWl6A0CEOM8gHNJxkf5xRg5AycUdOP09KYHgn7SDOvinwgyR+YfIuMqDg/fToeldje3Fx/wqHUBHYTZa3cfvJIwoBB5OGOfp1pnxh8C6n4rvtD1DRnt3l0/zI5LeZ/L3K5Dbg3TIKgYx368VqnTdTvPAdzow064ivJkMLGd0VEJ4JyGO4DOeOuK51pKRpLVRsbPw5keX4eeF2lcyOdMttznufLFb4Hofyqh4d0xdD8O6XpMcrXC2FrHbCUrtMmxQN2O2cdO1XzyOmK1gmopMmbvJsG6f54qN9zKdmA3bP+FSdSKTj/GqJDA98+9NI65JH1NKFPB6fQ0be/txTAZgDg/lS49f/wBdLx26CjBzjigDxf8AaYLiy8KFEDn7ZN8pOM/uxxmuh8LXE4+Gt3t06Xd9nOS00QB985JwPp2qx8YPBl/4w03ShpM9ul3p9w0vlTkqsqsu04bnBHXpz7VY0LTdWtfB1zpUmlzC+MJiAeaMRE9iHBOR9BWCVqjbNHrFE/waeSX4WeHGnkZ5BA6kn2kYAD2A4FdicdeTjpjtWP4L0MeGPCmm6N9o+0m0jKtNt272LFjgdhknFbBzgnsDV0k4wSZNR3k2jWg/1Mf+6P5UUQf6mPt8o/lRWT3O6OyH0UUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFU3tpC7EFeSTVyimpNbETgp7lEWj/wCx+dKbWTPVcfWrtFV7RkexiUDaS5GGU/jTvssmOq1doo9ox+xiUfsr+q0G0c55AHpV6ij2jF7CJR+ySZHK0fZH9Vq9RR7Rh7CJR+yOBwRmlNrIc/MtXaKPaMPYRKAtJB3Wl+xtxggY6cVeoo9pIPYRKBs34AIwKPsj8cj8qv0Ue0YewiUBaOO4Io+xtjhhn6Vfoo9pIPYRKJtG5569xR9kf+9+lXqKPaMPYRM/7G/qPypTZuQBkYB9P/r1foo9pIPYRM82LEYzxnpR9ibGCcj0x1rQoo9pIPYRKH2R92SR+VH2R85J/wA/nV+ij2jD2ETPFm/94/l/9ek+xNn/AD/jWjRR7Ri9hEbGu2NF9ABRTqKg3Ssf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Luminal irregularity is often not adequately appreciated on angiography, but can be well visualized on a cross-sectional image obtained with intracoronary ultrasound. Panel A: A concentric stenosis will appear similar in orthogonal angiographic views, ie, right (RAO) and left anterior oblique (LAO). Panel B: In comparison, an eccentric lesion will appear markedly different in the two angiographic views. Panel C: A complex lesion with marked luminal irregularity cannot be appreciated in any angiographic view and requires intracoronary ultrasound to be delineated.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Neil Weissman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_36_7759=[""].join("\n");
var outline_f7_36_7759=null;
